Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Prostatic Neoplasms: HELP
Fred Saad
Based on 224 articles published since 2010
(Why 224 articles?)
||||
Expertise Level
The expertise of Fred Saad ranks in the
  • Top 0.0047%
  • ... of 147,799 published authors worldwide on Prostatic Neoplasms
  • ... from 2010 through 2020
  • ... based on contributions to 224 articles on the topic.
Graphical view (beta)
Get your prestigious
World Expert badge
similar to this:
 
Work Locations
Details
Most likely:    Universite de Montreal      
2020
  • Division of Hematology/Medical Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA. · Duke University Medical Center, Durham, NC. · University of Washington School of Medicine, Fred Hutchinson Cancer Research Center, Seattle, WA. · Department of Urology, University of California San Francisco, San Francisco, CA. · Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA. · Department of Medicine, Division of Hematology/Oncology, University of California San Diego, San Diego, CA. · Department of Psychiatry and Center for Behavior Genetics of Aging, University of California San Diego, San Diego, CA. · School of Medical and Health Sciences, Exercise Medicine Research Institute, Edith Cowan University, Joondalup, Western Australia, Australia. · Department of Medicine, University of Chicago, Chicago, IL. · Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL. · Department of Radiation Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA. · Department of Medical Oncology and Developmental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA. · Department of Medicine, Cardio-oncology Program, Vanderbilt University Medical Center, Nashville, TN. · Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA. · Department of Urology, Moores Comprehensive Cancer Center, University of California San Diego, San Diego, CA. · Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada. · Prostate Cancer Foundation, Santa Monica, CA. · Department of Hematology and Oncology, Northwestern University, Chicago, IL. · Division of Hematology, Medical Oncology, and Transplantation, University of Minnesota, Minneapolis, MN. Electronic address: · Pubmed 31734020
  • Centre Hospitalier de l'Université de Montréal, University of Montreal, Montreal, Quebec, Canada. · Mount Sinai Hospital, Princess Margaret Cancer Centre (UHN), Toronto General Hospital (UHN), University of Toronto, Toronto, Ontario, Canada. · British Colombia Cancer Agency, University of British Columbia (UBC), Vancouver, British Columbia. · McGill University, Montreal, Quebec, Canada. · McMaster University, Hamilton, Ontario, Canada. · Laval University, Quebec City, Quebec, Canada. · Kaleidoscope Strategic Inc., Toronto, Ontario, Canada. · Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada. · Pubmed 32096678
  • Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; Universita della Svizzera Italiana, Lugano, Switzerland; Cantonal Hospital, St. Gallen, Switzerland; University of Bern, Bern, Switzerland; Division of Cancer Science, University of Manchester, Manchester, UK. Electronic address: · University College London Cancer Institute, London, UK. · Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA. · Dana-Farber Cancer Institute, Boston, MA, USA; Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Department of Urology, Skåne University Hospital, Malmö, Sweden. · Genito Urinary Oncology, Prostate Brachytherapy Unit, Goustave Roussy, Paris, France. · Unit of Urology/Division of Oncology, URI, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy. · Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK; Christie NHS Trust, Manchester, UK; CRUK Manchester Institute and Cancer Centre, Manchester, UK. · BC Cancer, Vancouver Prostate Centre, University of British Columbia, Vancouver, British Columbia, Canada. · The Christie and Salford Royal Hospitals, Manchester, UK. · Monash University and Eastern Health, Victoria, Australia. · The Institute of Cancer Research/Royal Marsden NHS Foundation Trust, Surrey, UK. · Division of Haematology/Oncology, Columbia University Medical Center, New York, NY, USA. · Department of Medical Oncology, Hospital Universitario Marques de Valdecilla, IDIVAL, Santander, Cantabria, Spain. · The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · University of California Davis School of Medicine, Sacramento, CA, USA. · Policlinico S.Orsola, Università di Bologna, Italy. · University of California San Francisco, San Francisco, CA, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Department of Surgery, Monash University, Melbourne, Australia; Prostate Cancer Research Program, Monash University, Melbourne, Australia; Department Anatomy & Developmental Biology, Faculty of Nursing, Medicine & Health Sciences, Monash University, Melbourne, Australia. · Urological Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada. · Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, USA. · Department of Urology, Uro-Oncology, Robot-Assisted and Reconstructive Urology, University of Cologne, Cologne, Germany; Department of Urology, Medical University, Vienna, Austria. · Department of Oncology, Akershus University Hospital, Lørenskog, Norway. · University of Washington, Seattle, WA, USA; Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia. · Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA. · The Institute of Cancer Research, London, UK. · Division of Medical Oncology, National Cancer Centre, Singapore. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell Medical College, New York, NY, USA. · Department of Urology, American University of Beirut Medical Center, Beirut, Lebanon; Naef K. Basile Cancer Institute (NKBCI), American University of Beirut Medical Center, Beirut, Lebanon. · Oncology institute, Shamir Medical Center and Faculty of medicine, Tel-Aviv University, Israel. · Department of Genitourinary Medical Oncology, MD Anderson Cancer Centre, Houston, TX, USA; Department of Clinical Therapeutics, David H. Koch Centre, University of Athens Alexandra Hospital, Athens, Greece. · Beneficiência Portuguesa de São Paulo, São Paulo, SP, Brazil; Departamento de Oncologia, Hospital Israelita Albert Einstein, São Paulo, SP, Brazil. · UK. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · University Hospital Nord, St Etienne, France. · National Institute of Oncology, University hospital, Rabat, Morocco. · Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia. · Tata Memorial Centre, Mumbai, India. · Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, The Tisch Cancer Institute, New York, NY, USA. · Radiation Oncology, Ghent University Hospital, Ghent, Belgium. · Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, Northern Ireland, UK; Radiotherapy Department, Cancer Centre, Belfast City Hospital, Belfast, Northern Ireland, UK. · Mount Vernon Cancer Centre and Institute of Cancer Research, London, UK. · Royal Marsden Hospital and Institute of Cancer Research, Sutton, UK. · Comprehensive Oncology Centre, Hong Kong Sanatorium & Hospital, The Chinese University of Hong Kong, Hong Kong. · Department of Laboratory Medicine, University of Washington, Seattle, WA, USA. · University of California Los Angeles, Los Angeles, CA, USA. · UCSF Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Bern Center for Precision Medicine, Bern, Switzerland; Department for Biomedical Research, University of Bern, Bern, Switzerland. · Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA. · Centre Hospitalier de Université de Montréal, Montreal, Canada. · Instituto Alexander Fleming, Buenos Aires, Argentina. · Tulane Cancer Center, New Orleans, LA, USA. · Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weill Cornell Medical College, New York, NY, USA. · Carolina Urologic Research Center, Myrtle Beach, SC, USA. · Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Prostate Cancer Foundation, Santa Monica, CA, USA. · Division of Hematology and Oncology, Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, USA. · Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Toho University Sakura Medical Center, Chiba, Japan. · MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK. · Cliniques Universitaires Saint Luc, Brussels, Belgium. · Department of Urology, M.A. Aydınlar Acıbadem University, Altunizade Hospital, Istanbul, Turkey. · Radboud University Medical Center, Nijmegen, The Netherlands. · Department of Radiation Oncology, University Hospital La Princesa, Health Research Institute, Madrid, Spain. · University of Bern, Bern, Switzerland; Department of Medical Oncology and Haematology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland. · Pubmed 32001144
  • Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada. Electronic address: · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Urology Unit, ASST Spedali Civili of Brescia, Department of Medical and Surgical Specialties, Radiological Science and Public Health, University of Brescia, Italy. · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology, San Luigi Gonzaga Hospital, University of Turin, Turin, Italy. · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy. · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada. · Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy. · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Brunswick Science and Technology, Montreal, Quebec, Canada. · Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Pubmed 31653563
2019
  • Department of Urology, La Paz University Hospital, Madrid, Spain - · Instituto de Investigación Hospital Universitario La Paz (IdiPAZ), Madrid, Spain - · Department of Urology, La Paz University Hospital, Madrid, Spain. · Instituto de Investigación Hospital Universitario La Paz (IdiPAZ), Madrid, Spain. · Department of Urology, Institute Mutualiste Montsouris, Paris, France. · Department of Medical Oncology, Federico II University, Naples, Italy. · Division of Medical Oncology, Mauriziano Hospital, Turin, Italy. · Department of Oncology, University of Turin, Turin, Italy. · Virginia Commonwealth University, Richmond, VA, USA. · Tulane Cancer Center, Tulane University Medical School, New Orleans, LA, USA. · Unit of Cancer Prognostics and Health Outcomes, University of Montreal Health Center, Montreal, QC, Canada. · Department of Urology, Andros Men's and Gynos Women's Health Institutes, Arnhem, the Netherlands. · Pubmed 31353876
  • Centre Hospitalier de l'Université de Montréal/CRCHUM, Montréal, Quebec, Canada. Electronic address: · Carolina Urologic Research Center, Myrtle Beach, SC, USA. · Duke Cancer Institute, Durham, NC, USA. · Pfizer, San Diego, CA, USA. · Pfizer, New York, NY, USA. · Pubmed 30913454
  • Department of Urology, University Hospital Cologne, Cologne, Germany. · Division of Cancer Sciences, University of Manchester and the Christie, Manchester, UK. · Medical Oncology and Haematology, Kantonsspital St Gallen, St Gallen, Switzerland. · University of Bern, Bern, Switzerland. · Department of Oncology, Akershus University Hospital, Lørenskog, Norway. · Genitourinary Oncology Service, Institute of Oncology, Meir Medical Center, Kfar-Saba, Israel. · Department of Clinical Oncology, The Centre for Cancer Research and Cell Biology, Queen's University Belfast and the Northern Ireland Cancer Centre, Belfast, Northern Ireland, UK. · Department of Medical Oncology, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Department of Urology, University Hospital Carl-Gustav Carus, Dresden, Germany. · Department of Urology, Charité University Medicine Berlin, Berlin, Germany. · Pharmaceutical Division of Bayer, Whippany, NJ, USA. · Department of Oncology, Karolinska University Hospital, Stockholm, Sweden. · Department of Urology, Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, QC, Canada. · Pubmed 30612558
  • Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address: · Medical Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA. · Oncology Strategic Advisor and Board Member (formerly Tokai Pharmaceuticals), East Greenwich, RI, USA. · Vertex Pharmaceuticals (formerly Tokai Pharmaceuticals), Boston, MA, USA. · Trial Architecture Consulting, Chevy Chase, MD, USA. · Urology, University of Montreal Hospital Center, Montreal, Canada. · Urology, Johns Hopkins University, Baltimore, MD, USA. · Medical Oncology, Royal Marsden/The Institute of Cancer Research, London, UK. · Pubmed 31542304
  • Goodman Cancer Research Center, McGill University, Montréal, Québec, Canada. · Department of Biochemistry, McGill University, Montréal, Québec, Canada. · Institut de Pharmacologie de Sherbrooke, Department of Surgery and Urology, Université de Sherbrooke, Sherbrooke, Québec, Canada. · Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Institut du Cancer de Montréal, Montréal, Québec, Canada. · Department of Pathology, CHUM, Université de Montréal, Montréal, Québec, Canada. · Prostate Cancer Translational Research Laboratory, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Cancer Program, Biomedicine Discovery Institute, Department of Anatomy and Developmental Biology, Monash University, Melbourne, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia. · Department of Medicine, Université de Montréal, Montréal, Québec, Canada. · Department of Surgery, CHUM, Université de Montréal, Montréal, Québec, Canada. · Pubmed 31452834
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Division of Experimental Oncology/Unit of Urology, Urological Research Institute (URI), IRCCS San Raffaele Scientific Institute, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy. Electronic address: · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Martini Klinik, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Academic Department of Urology, IRCCS Policlinico San Donato, University of Milan, Milan, Italy. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Division of Experimental Oncology/Unit of Urology, Urological Research Institute (URI), IRCCS San Raffaele Scientific Institute, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy. · Division of Experimental Oncology/Unit of Urology, Urological Research Institute (URI), IRCCS San Raffaele Scientific Institute, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy. · Martini Klinik, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Department of Urology, Medical University of Vienna, Vienna, Austria. · Pubmed 31411992
  • Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology, University Hospital Frankfurt am Main, Frankfurt am Main, Germany. Electronic address: · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy. · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Academic Department of Urology, IRCCS Policlinico San Donato, University of Milan, Milan, Italy. · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology, SS Annunziata Hospital, "G.D'Annunzio" University of Chieti, Chieti, Italy. · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada. · Department of Urology, University Hospital Frankfurt am Main, Frankfurt am Main, Germany. · Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy. · Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Pubmed 31411975
  • Division of Urology, Centre Hospitalier de I'Université de Montréal, Montreal, Quebec, Canada. · Pubmed 31312041
  • Centre de recherche du Centre hospitalier de l'Université de Montréal, Centre hospitalier de l'Université de Montréal, Montreal, Quebec, Canada. · Institut du cancer de Montréal, Montreal, Quebec, Canada. · Research Institute of the McGill University Health Centre, McGill University Health Centre, Montreal, Quebec, Canada. · Axe Oncologie, Centre de recherche du Centre hospitalier universitaire de Québec-Université Laval, Centre hospitalier universitaire de Québec-Université Laval, Quebec, Quebec, Canada. · Centre de recherche sur le cancer, Université Laval, Quebec, Quebec, Canada. · Département de chirurgie, Université Laval, Quebec, Quebec, Canada. · Vancouver Prostate Centre, Vancouver, British Columbia, Canada. · University Health Network, Toronto, Ontario, Canada. · Pubmed 31265453
  • Goodman Cancer Research Centre, Department of Medicine, McGill University, Montréal, Québec, Canada. · Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada; Institut du Cancer de Montréal, Montréal, Québec, Canada. · Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada; Institut du Cancer de Montréal, Montréal, Québec, Canada; Department of Medicine, Université de Montréal, Montréal, Québec, Canada. · Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada; Institut du Cancer de Montréal, Montréal, Québec, Canada; Department of Surgery, Université de Montréal, Montréal, Québec, Canada. · Goodman Cancer Research Centre, Department of Medicine, McGill University, Montréal, Québec, Canada. Electronic address: · Pubmed 31202437
  • Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada. Electronic address: · Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy. · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology, European Institute of Oncology, Milan, Italy. · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Urology Unit, ASST Spedali Civili of Brescia. Department of Medical and Surgical Specialties, Radiological Science and Public Health, University of Brescia, Italy. · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology, San Luigi Gonzaga Hospital, University of Turin, Turin, Italy. · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada. · Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy. · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Division of Urology, University of Montréal Hospital Center, Montréal, Québec, Canada. · Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Pubmed 31129038
  • Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada. Electronic address: · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology, University Frankfurt am Main, Frankfurt, Germany. · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology, Division of Experimental Oncology, Urological Research Institute (URI), IRCCS San Raffaele Scientific Institute, Milan, Italy. · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology, European Institute of Oncology, Milan, Italy. · Department of Urology, Spedali Civili Hospital, University of Brescia, Brescia, Italy. · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada. · Department of Urology, Division of Experimental Oncology, Urological Research Institute (URI), IRCCS San Raffaele Scientific Institute, Milan, Italy. · Department of Urology, Medical University of Vienna, Vienna, Austria. · Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Pubmed 31103337
  • Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada. Electronic address: · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology, University Frankfurt am Main, Frankfurt, Germany. · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy. · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology, European Institute of Oncology, Milan, Italy. · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada. · Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy. · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada. · Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Pubmed 31080021
  • Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Axe Cancer, Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, QC, Canada. · T. Boone Pickens Academic Tower, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Département de pharmacologie et de physiologie, Université de Montréal, Montreal, QC, Canada. · Centre de Recherche du Centre Hospitalier Universitaire de Montréal (CRCHUM)/Institut du Cancer de Montréal, Montreal, QC, Canada. · Département d'Urologie du Centre Hospitalier Universitaire de Montréal (CHUM) et Institut du Cancer de Montréal / CRCHUM, Montreal, QC, Canada. · Centre Hospitalier de l'Université de Montréal (Département de pathologie), Département de pathologie et axe cancer, Université de Montréal (Département de pathologie et de biologie cellulaire) et Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, Canada. · NIDCR, National Institutes of Health, Bethesda, MD, USA. · Faculté de Pharmacie, Université de Montréal et Institut du Cancer de Montréal / CRCHUM, Axe Cancer, Montreal, QC, Canada. · Pubmed 31069142
  • Department of Pathology, Centre hospitalier de l'Université de Montréal, 1051 Sanguinet, Montréal, Québec, H2X 0C1, Canada. · Centre de recherche du Centre hospitalier de l'Université de Montréal and Institut du cancer de Montréal, 900 Saint-Denis, Montréal, Québec, H2X 0A9, Canada. · Department of Radiation Oncology, Centre Hospitalier de l'Université de Montréal, 1051 Sanguinet, Montréal, Québec, H2X 0C1, Canada. · Department of Medicine, Université de Montréal, Montréal, Québec, H3C 3J7, Canada. · Laboratoire d'Uro-Oncologie Expérimentale, Centre de Recherche du Centre Hospitalier Universitaire de Québec-Université-Laval, Hôpital L'Hôtel-Dieu de Québec, 10 McMahon, Québec, G1R 3S1, Canada. · Department of Urology, Centre Hospitalier de l'Université de Montréal, 1051 Sanguinet, Montréal, Québec, H2X 0C1, Canada. · Department of Urology, Centre Hospitalier Universitaire de Québec-Université-Laval, Hôpital L'Hôtel-Dieu de Québec, 11 Côte du Palais, Québec, G1R 2J6, Canada. · Department of Pathology, Centre hospitalier de l'Université de Montréal, 1051 Sanguinet, Montréal, Québec, H2X 0C1, Canada. · Centre de recherche du Centre hospitalier de l'Université de Montréal and Institut du cancer de Montréal, 900 Saint-Denis, Montréal, Québec, H2X 0A9, Canada. · Pubmed 31018850
  • Division of Urology, Department of Surgery, McGill University Health Centre, Montreal, Quebec, Canada. · Department of Oncology, McGill University, Montreal, Quebec, Canada. · Biobank, PROCURE, Mount Royal, Quebec, Canada. · Department of Surgery, Université de Montréal, Montreal, Quebec, Canada. · Department of Surgery, Université de Sherbrooke, Sherbrooke, Quebec, Canada. · Department of Surgery, Laval University, Quebec City, Quebec, Canada. · Psychosocial Oncology Program, McGill University Health Centre, Montreal, Quebec, Canada. · Pubmed 30762265
  • Division of Urology, Department of Surgery and Cancer Research Center, Centre Hospitalier Universitaire (CHU) de Québec-Université Laval, Québec, Québec, Canada. · Biochemistry Service, Medical Laboratory Department, CHU de Québec-Université Laval, Québec, Québec, Canada. · Pharmacy Faculty, Université Laval and CHU de Québec-Université Laval, Québec, Québec, Canada. · Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada. · Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada. · Pubmed 30673630
  • Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany. Electronic address: · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology and Division of Experimental Oncology, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy. · Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Academic Department of Urology, IRCCS Policlinico San Donato, University of Milan, Milan, Italy. · Department of Urology, Medical University of Vienna, Vienna, Austria. · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada. · Department of Urology and Division of Experimental Oncology, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy. · Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Pubmed 30366880
  • Division of Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy; Centre de recherche du Centre Hospitalier de l'Université de Montréal (CR-CHUM) and Institut du cancer de Montréal, Montréal, Québec, Canada. Electronic address: · Centre de recherche du Centre Hospitalier de l'Université de Montréal (CR-CHUM) and Institut du cancer de Montréal, Montréal, Québec, Canada; Academic Department of Urology, IRCCS Policlinico San Donato, University of Milan, Milan, Italy. · Centre de recherche du Centre Hospitalier de l'Université de Montréal (CR-CHUM) and Institut du cancer de Montréal, Montréal, Québec, Canada; Department of Urology, SS Annunziata Hospital, "G. D'Annunzio" University of Chieti, Chieti, Italy. · Centre de recherche du Centre Hospitalier de l'Université de Montréal (CR-CHUM) and Institut du cancer de Montréal, Montréal, Québec, Canada; Martini Klinik, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Centre de recherche du Centre Hospitalier de l'Université de Montréal (CR-CHUM) and Institut du cancer de Montréal, Montréal, Québec, Canada. · Division of Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy. · Vattikuti Urology Institute and VUI Center for Outcomes Research Analytics and Evaluation (VCORE), Henry Ford Hospital, Henry Ford Health System, Detroit, MI. · Martini Klinik, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Department of Urology, Medical University of Vienna, Vienna, Austria. · Pubmed 30342845
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, QC, Canada. · Centre de recherche du Centre Hospitalier de l'Université de Montréal (CR-CHUM) and Institut du Cancer de Montréal, Montreal, QC, Canada. · Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany. · Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, QC, Canada. · Centre de recherche du Centre Hospitalier de l'Université de Montréal (CR-CHUM) and Institut du Cancer de Montréal, Montreal, QC, Canada. · Academic Department of Urology, IRCCS Policlinico San Donato, University of Milan, Milan, Italy. · Division of Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy. · Vita-Salute San Raffaele University, Milan, Italy. · Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany. · Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Department of Urology, Medical University of Vienna, Vienna, Austria. · Pubmed 30315358
  • Department of Urology, University Hospitals Leuven, Leuven, Belgium; Nuclear Medicine & Molecular Imaging, KU Leuven, Leuven, Belgium. Electronic address: · Division of Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy. · Department of Radiation Oncology, Brigham and Women's Hospital and Dana Farber Cancer Institute, Boston, MA, USA. · Urology Service at the Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Oncology in the Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Medical Institutions, Baltimore, MD, USA. · The Vancouver Prostate Centre & Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada. · Department of Radiation Oncology, University Hospitals Leuven, Leuven, Belgium. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Urology, Centre Hospitalier de l'Université de Montréal, University of Montreal, Montreal, Quebec, Canada. · Dana-Farber Cancer Institute, Boston, MA, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Pubmed 30286948
  • Department of Urology, McGill University Health Centre, Montreal, QC, Canada. · Department of Oncology, McGill University, 5100 Boulevard de Maisonneuve West, Room 720F, Montreal, QC, H4A 3T2, Canada. · Department of Urology, McGill University Health Centre, Montreal, QC, Canada. · Cancer Research Program, McGill University Health Centre - Research Institute, Montreal, QC, Canada. · PROCURE, Mont-Royal, Montreal, QC, Canada. · Department of Oncology, McGill University, 5100 Boulevard de Maisonneuve West, Room 720F, Montreal, QC, H4A 3T2, Canada. · Department of Surgery, Université de Montréal, Montreal, QC, Canada. · Department of Surgery, Université de Sherbrooke, Sherbrooke, QC, Canada. · Department of Surgery, Laval University, Laval, QC, Canada. · Department of Pathology, McGill University, Montreal, QC, Canada. · Department of Pathology and Cell Biology, Université de Montreal, Montreal, QC, Canada. · Department of Pathology, Université de Sherbrooke, Sherbrooke, QC, Canada. · Department of Pathology, Laval University, Laval, QC, Canada. · Pubmed 30136199
  • Department of Urology, McGill University Health Centre, Montreal, QC, Canada. · Division of Cancer Epidemiology, Department of Oncology, McGill University, Montreal, QC, Canada. · Department of Pathology, McGill University Health Centre, Montreal, QC, Canada. · PROCURE, Mount Royal, QC, Canada. · Department of Surgery, Université de Montréal, Montreal, QC, Canada. · Department of Surgery, Université de Sherbrooke, Sherbrooke, QC, Canada. · Department of Surgery, Laval University, Quebec City, QC, Canada. · Department of Pathology, Laval University, Quebec City, QC, Canada. · Department of Pathology, Université de Sherbrooke, Sherbrooke, QC, Canada. · Department of Pathology and Cell Biology, Université de Montreal, Montreal, QC, Canada. · Pubmed 30113732
  • Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada. Electronic address: · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy. · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Academic Department of Urology, IRCCS Policlinico San Donato, University of Milan, Milan, Italy. · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology, SS Annunziata Hospital, "G.D'Annunzio" University of Chieti, Chieti, Italy. · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada. · Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Department of Urology, Medical University of Vienna, Vienna, Austria. · Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy. · Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Pubmed 29802052
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada. · Martini-Clinic, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany. · Department of Pathology and Cellular Biology, Université de Montréal, Montreal, Canada. · Department of Medecine, Université de Montréal, Montreal, Canada. · Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy. · Institut du Cancer de Montreal and Centre de recherche du centre hospitalier de l'Université de Montréal, Montreal, QC, Canada. · Research Institute of McGill University Health Center and Department of Surgery (Urology), McGill University, Montreal, QC, Canada. · CHU de Québec, Quebec City, Quebec, Canada. · Division of Urology, Department of Surgery, University Health Network, University of Toronto, Toronto, ON, Canada. · Vancouver Prostate Centre & Department of Urologic Science, University of British Columbia, Vancouver, BC, Canada. · Department of Surgery, Université de Montréal, Montreal, Canada. · Pubmed 29623528
  • Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Division of Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy. Electronic address: · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Academic Department of Urology, IRCCS Policlinico San Donato, University of Milan, Milan, Italy. · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology, SS Annunziata Hospital, "G. D'Annunzio" University of Chieti, Chieti, Italy. · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada. · Division of Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy. · Vattikuti Urology Institute and VUI Center for Outcomes Research Analytics and Evaluation (VCORE), Henry Ford Hospital, Henry Ford Health System, Detroit, MI, USA. · Department of Urology, Medical University of Vienna, Vienna, Austria. · Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Pubmed 29366856
  • Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, QC, Canada. Electronic address: · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, QC, Canada; Department of Urology, SS Annunziata Hospital, "G.D'Annunzio" University of Chieti, Chieti, Italy. · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, QC, Canada; Academic Department of Urology, IRCCS Policlinico San Donato, University of Milan, Milan, Italy. · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, QC, Canada; Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy. · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, QC, Canada. · Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, QC, Canada. · Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy. · VUI Center for Outcomes Research, Analytics and Evaluation, Vattikuti Urology Institute, Henry Ford Health System, Detroit, MI, USA. · Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Pubmed 29306731
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Division of Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy. Electronic address: · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology, SS Annunziata Hospital, "G. D'Annunzio" University of Chieti, Chieti, Italy. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Martini Klinik, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Academic Department of Urology, IRCCS Policlinico San Donato, University of Milan, Milan, Italy. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada. · Division of Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy. · Department of Urology, Medical University of Vienna, Vienna, Austria. · Martini Klinik, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Pubmed 29249688
2018
  • Centre Hospitalier de l'Université de Montreal, Montreal Cancer Institute/CRCHUM, Montreal, Canada. · Pubmed 30074925
  • The Royal Marsden National Health Service Foundation Trust-Institute of Cancer Research, Sutton, United Kingdom. · King's College, London, United Kingdom. · Carolina Urologic Research Center, Myrtle Beach, South Carolina. · University Hospital Heidelberg, Heidelberg, Germany. · Baylor University Medical Center, Dallas, Texas. · Skåne University Hospital, Lund, Sweden. · Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, the Netherlands. · Memorial Sloan Kettering Cancer Center, New York, New York. · Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada. · Pubmed 30326033
  • Department of Urology, University of Minnesota, Minneapolis, MN, USA. · University of Melbourne, Department of Surgery, Urology Unit and Olivia Newton-John Cancer Research Institute Austin Health, Melbourne, Victoria, Australia. · Department of Surgical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Department of Urology, University of Minnesota, Minneapolis, MN, USA. · Department of Radiation Oncology and Developmental Radiotherapeutics, University of British Columbia, Kelowna, British Columbia, Canada. · Division of Urology, Centre Hospitalier de l'Université de Montreal, University of Montreal, Montreal, Québec, Canada. · University of Melbourne, Department of Surgery, Urology Unit and Olivia Newton-John Cancer Research Institute Austin Health, Melbourne, Victoria, Australia. · Department of Surgical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Pubmed 30065357
  • Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada. · Département De Médecine Oncologique, Institut Gustave Roussy, Université Paris-Saclay, Paris, France. · Pubmed 30015691
  • Division of Urology, Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada. · Department of Medical Oncology, San Camillo-Forlanini Hospital, Rome, Italy. · Radboud University Medical Centre, Nijmegen, Netherlands. · Amgen (Europe) GmbH, Zug, Switzerland. · Service d'Urologie, Institut de Recherche Clinique, Université Catholique de Louvain, Brussels, Belgium. Electronic address: · Pubmed 29787892
  • Centre Hospitalier de l'Université de Montréal, Université de Montréal, Montreal, QC, Canada. Electronic address: · Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. · Cancer Outcomes Research Program, Lineberger Comprehensive Cancer Center, University of North Carolina, NC, USA. · University of Duisburg-Essen, German Cancer Consortium (DKTK), partner site University Hospital Essen, Essen, Germany; Ruprecht-Karls University Heidelberg, Heidelberg, Germany. · Center for Personalized Nanomedicine, University of Queensland, Brisbane, QLD, Australia. · Georges Pompidou Hospital, Paris, France. · VA Portland Health Care System, Portland and Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA. · Janssen Research & Development, Horsham, PA, USA. · Janssen Research & Development, Spring House, PA, USA. · Clinical Outcomes Solutions, Tucson, AZ, USA. · Janssen Research & Development, Raritan, NJ, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Pubmed 30213449
  • Erasmus MC Cancer Institute, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands. · Erasmus MC Cancer Institute, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands. · Janssen Research & Development, 1400 McKean Road, Spring House, PA, 19477, USA. · Janssen Research & Development BE, Turnhoutseweg 30, Beerse, Belgium. · Janssen Research & Development, 920 Route 202 South, Raritan, NJ, 08869, USA. · Janssen Research & Development, 10990 Wilshire Blvd., Suite 1200, Los Angeles, CA, 90024, USA. · Research Department of Oncology, UCL Cancer Institute, 72 Huntley Street, London, WC1E 6DD, UK. · ARENSIA Exploratory Medicine's Research Unit, The Institute of Oncology, 30 N.Testemitanu str., 2025, Chişinău, Republic of Moldova. · GHS Cancer Institute, 900 West Faris Road, Greenville, SC, 29615, USA. · Centre Hospitalier de l'Université de Montréal/CRCHUM, 900, rue St-Denis, porte R04-446, Montreal, Québec, H2X 0A9, Canada. · Pubmed 29974203
  • From the Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago (M.H.), and Astellas Pharma, Northbrook (D.P., A.K.) - both in Illinois · Institut Gustave Roussy, University of Paris Sud, Villejuif, France (K.F.) · the University of Montreal Hospital Center, Montreal (F.S.) · Herlev Hospital, Herlev, Denmark (P.R.) · Carolina Urologic Research Center, Myrtle Beach, SC (N.S.) · State University of Campinas (Unicamp), Campinas, Brazil (U.F.) · Kiev City Clinical Hospital 3, Kiev, Ukraine (P.I.) · Pfizer, San Francisco (E.D., K.M.) · and the Department of Medical Oncology, San Camillo Forlanini Hospital, Rome (C.N.S.). · Pubmed 29949494
  • The Christie and Salford Royal Hospitals, Manchester, UK. Electronic address: · Maria Skłodowska-Curie Memorial Cancer Centre, Warsaw, Poland. · Hertzen Moscow Cancer Research Institute, Moscow, Russia. · Catalan Institute of Oncology, Hospital Josep Trueta, Girona, Spain. · Velindre Cancer Centre, Cardiff University, Cardiff, UK. · Masaryk Memorial Cancer Institute, Brno, Czech Republic. · Ospedale Vito Fazzi, Lecce, Italy. · Medical University of Gdańsk, Gdańsk, Poland. · Centre Léon Bérard, Lyon, France. · Sharp HealthCare, San Diego, CA, USA. · AstraZeneca, Gaithersburg, MD, USA. · AstraZeneca, Cambridge, UK. · AstraZeneca, Macclesfield, UK. · Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada. · Pubmed 29880291
  • Division of Urology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada. Electronic address: · Division of Radiation Oncology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada. · Department of Urology, Queen's University, Kingston, Ontario, Canada. · Division of Urology, Paul Ouellette Clinic, Granby, Quebec, Canada. · Division of Urology, McMaster University, Hamilton, Ontario, Canada. · Division of Urology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada. · Division of Urology, Université de Montreal, Montreal, Quebec, Canada. · Pubmed 29534997
  • From the Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston (M.R.S.) · Centre Hospitalier de l'Université de Montréal, Université de Montréal, Montreal (F.S.) · Guy's, King's and St. Thomas' Hospitals, Great Maze Pond, London (S.C.) · Georges Pompidou Hospital, Paris (S.O.) · University of Duisburg-Essen and German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany (B.A.H.) · Veterans Affairs Portland Health Care System, Portland, and Knight Cancer Institute, Oregon Health and Science University, Portland (J.N.G.) · Spanish National Cancer Research Center, Madrid, and Hospitales Universitarios Virgen de la Victoria y Regional, Institute of Biomedical Research in Malaga, Malaga - both in Spain (D.O.) · Centre for Personalised Nanomedicine, University of Queensland, Brisbane, Australia (P.N.M.) · St. Mary's Hospital of Catholic University, Seoul, South Korea (J.Y.L.) · Yokohama City University Medical Center, Yokohama, Japan (H.U.) · Janssen Research and Development, Los Angeles (A.L.-G., G.C.T., B.M.E., Y.S., Y.C.P., W.R.R., M.K.Y.) · and Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco (E.J.S.). · Pubmed 29420164
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada; Centre de Recherche du Centre Hospitalier de l'Université de Montréal and Institut du Cancer de Montréal, Montreal, Canada; Division of Oncology/Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy. Electronic address: · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada; Centre de Recherche du Centre Hospitalier de l'Université de Montréal and Institut du Cancer de Montréal, Montreal, Canada; Martini Klinik, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada; Centre de Recherche du Centre Hospitalier de l'Université de Montréal and Institut du Cancer de Montréal, Montreal, Canada; Academic Department of Urology, IRCCS Policlinico San Donato, University of Milan, Milan, Italy. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada; Centre de Recherche du Centre Hospitalier de l'Université de Montréal and Institut du Cancer de Montréal, Montreal, Canada; Department of Urology, SS Annunziata Hospital, G. D'Annunzio University of Chieti, Chieti, Italy. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada; Centre de Recherche du Centre Hospitalier de l'Université de Montréal and Institut du Cancer de Montréal, Montreal, Canada. · Division of Oncology/Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy. · Martini Klinik, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Department of Urology, Medical University of Vienna, Vienna, Austria. · Pubmed 31102624
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Centre de recherche du Centre Hospitalier de l'Université de Montréal, Institut du cancer de Montréal, Montréal, Québec, Canada; Division of Oncology, Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy. Electronic address: · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Centre de recherche du Centre Hospitalier de l'Université de Montréal, Institut du cancer de Montréal, Montréal, Québec, Canada; Division of Oncology, Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Centre de recherche du Centre Hospitalier de l'Université de Montréal, Institut du cancer de Montréal, Montréal, Québec, Canada; Martini Klinik, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Centre de recherche du Centre Hospitalier de l'Université de Montréal, Institut du cancer de Montréal, Montréal, Québec, Canada; Academic Department of Urology, IRCCS Policlinico San Donato, University of Milan, Milan, Italy. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Centre de recherche du Centre Hospitalier de l'Université de Montréal, Institut du cancer de Montréal, Montréal, Québec, Canada; Department of Urology, SS Annunziata Hospital, G. D'Annunzio University of Chieti, Chieti, Italy. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Centre de recherche du Centre Hospitalier de l'Université de Montréal, Institut du cancer de Montréal, Montréal, Québec, Canada. · Martini Klinik, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Department of Urology, Medical University of Vienna, Vienna, Austria. · Division of Oncology, Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy. · Pubmed 31100253
  • Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada. Electronic address: · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology, SS Annunziata Hospital, G. D'Annunzio University of Chieti, Chieti, Italy. · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Academic Department of Urology, IRCCS Policlinico San Donato, University of Milan, Milan, Italy. · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology and Division of Experimental Oncology, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy. · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada. · Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Department of Urology and Division of Experimental Oncology, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy. · Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Pubmed 31100241
  • Department of Radiation Oncology, Centre hospitalier de l'Université de Montréal, Montréal, QC, Canada. · CRCHUM-Centre de recherche du Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada. · Department of Epidemiology, Biostatistics and Occupational Health, McGill University, 1020 Pine Avenue West, Montreal, QC H3A 1A2, Canada. · Lady Davis Institute for Medical Research, Jewish General Hospital, 3755 Côte Ste. Catherine, Montreal, QC H3T 1E2, Canada. · Department of Urology, University of Montreal Health Center, Montreal, Canada. · Pubmed 30471220
  • Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada. · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada. · Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy. · Academic Department of Urology, IRCCS Policlinico San Donato, University of Milan, Milan, Italy. · Department of Urology, SS Annunziata Hospital, "G. D'Annunzio" University of Chieti, Chieti, Italy. · Centre Hospitalier de l'Université de Montréal, Montreal, Canada. · Department of Urology, Medical University of Vienna, Vienna, Austria. · Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Pubmed 30425350
  • Genetics and Molecular Biology PhD Program, Emory University, Atlanta 30322, Georgia. · Department of Urology, Emory University School of Medicine, Atlanta 30322, Georgia. · Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM)/Institut du cancer de Montréal, Montreal, QC H2X 0A9, Canada. · MSTP/MD PhD, Emory University, Atlanta 30322, Georgia. · Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta 30322, Georgia. · Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta 30322, Georgia. · Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM)/Institut du cancer de Montréal, Montreal, QC H2X 0A9, Canada. · Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM)/Institut du cancer de Montréal, Montreal, QC H2X 0A9, Canada. · Division of Cancer Biology and Therapeutics, Departments of Surgery & Biomedical Sciences, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA. · Division of Cancer Biology and Therapeutics, Departments of Surgery & Biomedical Sciences, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA. · Department of Radiation Oncology, Emory University School of Medicine, Atlanta 30322, Georgia. · Winship Cancer Institute of Emory University, Atlanta 30322, Georgia. · Winship Cancer Institute of Emory University, Atlanta 30322, Georgia. · Department of Human Genetics, Emory University, Atlanta 30322, Georgia. · Department of Urology, Emory University School of Medicine, Atlanta 30322, Georgia. · Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta 30322, Georgia. · Winship Cancer Institute of Emory University, Atlanta 30322, Georgia. · Atlanta VA Medical Center, Decatur, GA 30033, USA. · Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM)/Institut du cancer de Montréal, Montreal, QC H2X 0A9, Canada. · Department of Pathology and Cellular Biology, Université de Montréal, Montreal, QC H3C 3J7, Canada. · Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM)/Institut du cancer de Montréal, Montreal, QC H2X 0A9, Canada. · Department of Medicine, Université de Montréal, Montreal, QC H3C 3J7, Canada. · Department of Urology, Emory University School of Medicine, Atlanta 30322, Georgia. · Winship Cancer Institute of Emory University, Atlanta 30322, Georgia. · Atlanta VA Medical Center, Decatur, GA 30033, USA. · Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM)/Institut du cancer de Montréal, Montreal, QC H2X 0A9, Canada. · Department of Surgery, Université de Montréal, Montreal, QC H3C 3J7, Canada. · Université de Montréal Endowed Chair in Prostate Cancer, Montreal, QC H3C 3J7, Canada. · Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta 30322, Georgia. · Winship Cancer Institute of Emory University, Atlanta 30322, Georgia. · Pubmed 30314329
  • Urologic Oncology, Studienpraxis Urologie, Steinengrabenstr. 17, Nürtingen, 72622, Germany. Electronic address: · Urologic Oncology, Centre Hospitalier de L'Université de Montréal/CRCHUM, 900 Rue St-Denis, Porte R10-464, Montréal, Québec, H2X 0A9, Canada. Electronic address: · Global Market Access Oncology, Janssen Global Services, 700 US Highway 202 South Raritan, NJ, 08869, USA. Electronic address: · Health Economics & Market Access EMEA, Janssen, 50-100 Holmers Farm Way, High Wycombe, Buckinghamshire, HP12 4EG, UK. Electronic address: · Health Economics & Market Access EMEA, Janssen, Turnhoutseweg 30, 2340, Beerse, Belgium. Electronic address: · Health Economics & Market Access EMEA, Janssen, Turnhoutseweg 30, 2340, Beerse, Belgium. Electronic address: · Clinical Oncology, Janssen Research & Development BE, Antwerpsesteenweg 15, 2340, Beerse, Belgium. Electronic address: · Modeling & Simulation, Evidera, Metro Building, Sixth Floor, 1 Butterwick, London, W6 8DL, UK. Electronic address: · Meta Research, Evidera, Metro Building, Sixth Floor, 1 Butterwick, London, W6 8DL, UK. Electronic address: · Meta Research, Evidera, Metro Building, Sixth Floor, 1 Butterwick, London, W6 8DL, UK. Electronic address: · Gustave Roussy, University of Paris Sud, 114 Rue Edouard Vaillant, 94800 Villejuif, France. Electronic address: · Pubmed 30218976
  • Institut du cancer de Montréal and Centre de recherche du Centre hospitalier de l'Université de Montréal, 900, St-Denis St, room R10-464, Montréal, Québec, H2X 0A9, Canada. · Research Institute of McGill University Health Center and Department of Surgery (Urology), McGill University, Montréal, Québec, Canada. · CHU de Québec-Université Laval and Department of Surgery, Université Laval, Québec City, Québec, Canada. · Department of Pathology, McGill University Health Centre, Montréal, Québec, Canada. · Department of Medical Biophysics and Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada. · University Health Network, Toronto, ON, Canada. · University of Manitoba and Manitoba Prostate Centre, Winnipeg, MB, Canada. · Vancouver Prostate Centre, Vancouver, BC, Canada. · Division of Urology, Department of Surgery of University Health Network, University of Toronto, Toronto, ON, Canada. · Department of Urologic Sciences, Vancouver, BC, Canada. · Cancer Prognostics and Health Outcomes Unit, Centre hospitalier de l'Université de Montréal, Montréal, Québec, Canada. · Department of Surgery, Université de Montréal, Montréal, Québec, Canada. · Sunnybrook Health Sciences Centre, Toronto, ON, Canada. · Department of Pathology and Molecular Medicine, Queen's University, Kingston, ON, Canada. · Department of Genetics and Pathology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil. · Department of Pathology and Cellular Biology, Université de Montréal, Montréal, Québec, Canada. · Department of Medicine, Université de Montréal, Montréal, Québec, Canada. · Institut du cancer de Montréal and Centre de recherche du Centre hospitalier de l'Université de Montréal, 900, St-Denis St, room R10-464, Montréal, Québec, H2X 0A9, Canada. · Department of Surgery, Université de Montréal, Montréal, Québec, Canada. · Pubmed 30200929
  • Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada. · Academic Department of Urology, IRCCS Policlinico San Donato, University of Milan, Milan, Italy. · Department of Urology and Division of Experimental Oncology, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy. · Department of Urology, SS Annunziata Hospital, "G.D'Annunzio" University of Chieti, Chieti, Italy. · Department of Urology, University Hospital Frankfurt am Main, Frankfurt am Main, Germany. · Department of Urology, Medical University of Vienna, Vienna, Austria. · Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Pubmed 30146729
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CR-CHUM), Montréal, Québec, Canada; Institut du Cancer de Montréal, Montréal, Québec, Canada; Martini-Klinik, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Electronic address: · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CR-CHUM), Montréal, Québec, Canada; Institut du Cancer de Montréal, Montréal, Québec, Canada; Division of Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CR-CHUM), Montréal, Québec, Canada; Institut du Cancer de Montréal, Montréal, Québec, Canada; Academic Department of Urology, IRCCS Policlinico San Donato, University of Milan, Milan, Italy. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology, SS Annunziata Hospital, "G. D'Annunzio" University of Chieti, Chieti, Italy. · Martini-Klinik, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CR-CHUM), Montréal, Québec, Canada; Institut du Cancer de Montréal, Montréal, Québec, Canada. · Division of Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy. · Department of Urology, Medical University of Vienna, Vienna, Austria. · Martini-Klinik, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Pubmed 30037529
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Division of Oncology, Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy. Electronic address: · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Martini Klinik, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Academic Department of Urology, IRCCS Policlinico San Donato, University of Milan, Milan, Italy. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Division of Oncology, Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy. · Division of Oncology, Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy. · Martini Klinik, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Department of Urology, Medical University of Vienna, Vienna, Austria. · Pubmed 29954690
  • Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Division of Urology, Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada. Electronic address: · Division of Urology, Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Academic Department of Urology, IRCCS Policlinico San Donato, University of Milan, Milan, Italy. · Division of Urology, Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy. · Division of Urology, Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology, SS Annunziata Hospital, "G.D'Annunzio" University of Chieti, Chieti, Italy. · Division of Urology, Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada. · Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy. · Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Pubmed 29887241
  • Sunnybrook Health Sciences Centre, 2075 Bayview Ave, Toronto, ON, Canada. · Bloomberg Faculty of Nursing, University of Toronto, Toronto, ON, Canada. · Institut du cancer de Montréal and Centre de recherche du Centre hospitalier de l'Université de Montréal, 900, St Denis St, Montréal, QC, Canada. · McGill University and McGill University Health Centre, 1001 Decarie Blvd, Montreal, QC, Canada. · Manitoba Prostate Centre, 675 McDermot Ave, Winnipeg, MB, Canada. · University Health Network, 610 University Ave, Toronto, ON, Canada. · Department of Surgery Université de Montréal, 2900 Edouard Montpetit Blvd, Montreal, QC, Canada. · Vancouver Prostate Centre, 2660 Oak St, Vancouver, BC, Canada. · Terry Fox Research Institute, 675 West 10th Avenue, Vancouver, BC, Canada. · Institut du cancer de Montréal and Centre de recherche du Centre hospitalier de l'Université de Montréal, 900, St Denis St, Montréal, QC, Canada. · Department of Surgery Université de Montréal, 2900 Edouard Montpetit Blvd, Montreal, QC, Canada. · U of M Endowed Chair in Prostate Cancer, University of Montreal Hospital Center (CHUM), Montreal Cancer Institute/CRCHUM, CHUM - Pavillon R, 900, rue St-Denis, porte R10-464, Montréal, QC, H2X 0A9, Canada. · Department of Medicine, Université de Montréal, 2900 Edouard-Montpetit Blvd, Montreal, QC, Canada. · Pubmed 29884180
  • University of Montreal Hospital Center, Montreal, Quebec, Canada. · Pubmed 29799991
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Centre de recherche du Centre Hospitalier de l'Université de Montréal (CR-CHUM) and Institut du cancer de Montréal, Montréal, Québec, Canada; Academic Department of Urology, IRCCS Policlinico San Donato, University of Milan, Milan, Italy. Electronic address: · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Centre de recherche du Centre Hospitalier de l'Université de Montréal (CR-CHUM) and Institut du cancer de Montréal, Montréal, Québec, Canada; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg- Eppendorf, Hamburg, Germany. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Centre de recherche du Centre Hospitalier de l'Université de Montréal (CR-CHUM) and Institut du cancer de Montréal, Montréal, Québec, Canada; Division of Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy, Vita-Salute San Raffaele University, Milan, Italy. · Centre de recherche du Centre Hospitalier de l'Université de Montréal (CR-CHUM) and Institut du cancer de Montréal, Montréal, Québec, Canada. · Department of Urology, Istituto Europeo di Oncologia, Milan, Italy. · Department of Urology, Medical University of Vienna, Vienna, Austria. · Martini-Klinik Prostate Cancer Center, University Hospital Hamburg- Eppendorf, Hamburg, Germany. · Martini-Klinik Prostate Cancer Center, University Hospital Hamburg- Eppendorf, Hamburg, Germany; Department of Urology, University Hospital Hamburg- Eppendorf, Hamburg, Germany. · Department of Urology, IRCCS Fondazione Ca' Granda-Ospedale Maggiore Policlinico University of Milan, Milan, Italy. · Division of Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy, Vita-Salute San Raffaele University, Milan, Italy. · Academic Department of Urology, IRCCS Policlinico San Donato, University of Milan, Milan, Italy. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Centre de recherche du Centre Hospitalier de l'Université de Montréal (CR-CHUM) and Institut du cancer de Montréal, Montréal, Québec, Canada. · Pubmed 29784507
  • Exercise Medicine Research Institute, Edith Cowan University, Perth, Western Australia, Australia. · School of Human Movement and Nutrition Sciences, University of Queensland, Brisbane, Queensland, Australia. · School of Medical and Health Science, Edith Cowan University, Perth, Western Australia, Australia. · Department of Urology, University of California San Francisco, San Francisco, California, USA. · Institute for Health Research, University of Notre Dame Australia, Fremantle, Western Australia, Australia. · Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USA. · Faculty of Kinesiology, Sport, and Recreation, University of Alberta, Edmonton, Alberta, Canada. · Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK. · School of Medicine, Trinity College Dublin, Dublin, Ireland. · University Hospitals Bristol, NHS Foundation Trust, Bristol, UK. · Institute for Health Promotion Research, University of Texas Health, San Antonio, Texas, UK. · Department of Epidemiology, Harvard TH Chan School of Public Health, Boston, Massachusetts, USA. · Division of Gerontology and Geriatric Medicine, University of Washington, Seattle, Washington, USA. · University of Canberra Research Institute for Sport and Exercise, University of Canberra, Canberra, Australia. · Cancer Trials Ireland, Dublin, Ireland. · Movember Foundation, Melbourne, Victoria, Australia. · Department of Medicine, University of California San Francisco, San Francisco, California, USA. · Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA. · Department of Urology, Centre Hospitalier de L'Universite de Montreal, Montreal, Quebec, Canada. · Pubmed 29764892
  • Urology, Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada. · Pubmed 29750917
  • Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada. · Département de Radiologie, Radio-oncologie et Médecine Nucléaire, Université de Montréal, Montréal, Québec, Canada. · Département de Chirurgie, Service d'urologie, Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada. · Pubmed 29722070
  • Division of Oncology/Unit of Urology URI, IRCCS Ospedale San Raffaele, Via Olgettina 60, 20132, Milan, MI, Italy. · Vita-Salute San Raffaele University, Milan, Italy. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, QC, Canada. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, QC, Canada. · Department of Urology, SS Annunziata Hospital, "G. D'Annunzio" University of Chieti, Chieti, Italy. · Martini Klinik, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Division of Oncology/Unit of Urology URI, IRCCS Ospedale San Raffaele, Via Olgettina 60, 20132, Milan, MI, Italy. · Vita-Salute San Raffaele University, Milan, Italy. · Department of Urology, Medical University of Vienna, Vienna, Austria. · Pubmed 29717358
  • Department of Pathology, Centre hospitalier de l'Université de Montréal (CHUM), Montréal, Québec, Canada. · Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Institut du cancer de Montréal, Montréal, Québec, Canada. · CHU de Québec-Université Laval, Québec, Canada. · Département de Médecine, Faculté de Médecine, Université de Montréal, Montréal, Montréal, Canada. · Laboratoire d'Uro-Oncologie Expérimentale, Centre de recherche du CHU de Québec-Université Laval, Hôpital L'Hôtel-Dieu de Québec, Québec, Canada. · Department of Urology, Centre Hospitalier de l'Université de Montréal (CHUM), Québec, Canada. · Pubmed 29603326
  • Centre de recherche du Centre hospitalier de l'Université de Montréal, Montreal, QC, Canada. · Institut du cancer de Montréal, Montreal, QC, Canada. · Department of Pathology, Centre hospitalier de l'Université de Montréal, Montreal, QC, Canada. · Department of Pathology and Cellular Biology, University of Montréal, Montreal, QC, Canada. · Department of Engineering Physics, Polytechnique Montréal, Montreal, QC, Canada. · Thayer School of Engineering, Dartmouth College, Hanover, NH, USA. · Télécom Physique Strasbourg, University of Strasbourg, Strasbourg, France. · Division of Urology, Centre hospitalier de l'Université de Montréal, Montreal, QC, Canada. · Department of Surgery, Université de Montréal, Montréal, QC, Canada. · Pubmed 29542855
  • Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada. · Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy. · Department of Urology, SS Annunziata Hospital, "G.D'Annunzio" University of Chieti, Chieti, Italy. · Academic Department of Urology, IRCCS Policlinico San Donato, University of Milan, Milan, Italy. · Department of Urology, Medical University of Vienna, Vienna, Austria. · Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Pubmed 29460290
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Division of Oncology/Unit of Urology; Urological Research Institute; IRCCS Ospedale San Raffaele, Milan, Italy. Electronic address: · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Division of Oncology/Unit of Urology; Urological Research Institute; IRCCS Ospedale San Raffaele, Milan, Italy. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Martini-Clinic, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology, University of Montreal Health Center, Montreal, Quebec, Canada. · Division of Oncology/Unit of Urology; Urological Research Institute; IRCCS Ospedale San Raffaele, Milan, Italy. · Martini-Clinic, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany. · Department of Urology, University of Montreal Health Center, Montreal, Quebec, Canada. · Pubmed 29426698
  • Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, QC, Canada. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, QC, Canada. · Department of Urology, University of Montreal Health Center, Montreal, QC, Canada. · Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy. · Department of Urology, SS Annunziata Hospital, "G.D'Annunzio" University of Chieti, Chieti, Italy. · Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Department of Urology, Academic Hospital Braunschweig, Braunschweig, Germany. · Department of Urology, University of Vienna, Vienna, Austria. · Pubmed 29339806
  • Glenn Heller, Martin Fleisher, and Howard I. Scher, Memorial Sloan Kettering Cancer Center · Howard I. Scher, Weill Cornell Medical College, New York, NY · Robert McCormack, Janssen Research & Development, Raritan, NJ · Thian Kheoh and Arturo Molina, Janssen Research & Development, Los Angeles · Dana T. Aftab, Exelixis, South San Francisco · Mohammad Hirmand, Medivation, San Francisco, CA · Matthew R. Smith, Massachusetts General Hospital, Boston · Ana Limon, Takeda Oncology, Cambridge, MA · Robert Dreicer, University of Virginia Medical School, Charlottesville, VA · Fred Saad, University of Montreal, Montreal, Quebec, Canada · Ronald de Wit, Erasmus Medical Center, Rotterdam, the Netherlands · Karim Fizazi, Institut Gustave Roussy, Villejuif, and University of Paris Sud, Orsay, France · and Johann S. de Bono, The Institute of Cancer Research, and The Royal Marsden Hospital, Sutton, Surrey, United Kingdom. · Pubmed 29272162
  • Division of Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Via Olgettina 60, 20132, Milan, MI, Italy. · Vita-Salute San Raffaele University, Milan, Italy. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, QC, Canada. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, QC, Canada. · Martini Klinik, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Department of Urology, SS Annunziata Hospital, "G. D'Annunzio" University of Chieti, Chieti, Italy. · Division of Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Via Olgettina 60, 20132, Milan, MI, Italy. · Vita-Salute San Raffaele University, Milan, Italy. · Department of Urology, ASL Abruzzo 2, Chieti, Italy. · Pubmed 29129028
  • Division of Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele and Vita-Salute San Raffaele University, Milan, Italy. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, QC, Canada. · Department of Urology, SS Annunziata Hospital, 'G. D'Annunzio' University of Chieti, Chieti, Italy. · Martini Klinik, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Vattikuti Urology Institute and VUI Center for Outcomes Research Analytics and Evaluation (VCORE), Henry Ford Hospital, Henry Ford Health System, Detroit, MI, USA. · Department of Urology, Medical University of Vienna, Vienna, Austria. · Pubmed 29124911
  • Division of Oncology/Unit of Urology URI, IRCCS Ospedale San Raffaele, Via Olgettina 60, 20132, Milan, MI, Italy. · Vita-Salute San Raffaele University, Milan, Italy. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, QC, Canada. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, QC, Canada. · Martini Klinik, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Department of Urology, SS Annunziata Hospital, "G. D'Annunzio" University of Chieti, Chieti, Italy. · Division of Oncology/Unit of Urology URI, IRCCS Ospedale San Raffaele, Via Olgettina 60, 20132, Milan, MI, Italy. · Department of Urology, Medical University of Vienna, Vienna, Austria. · Pubmed 29063268
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada; Division of Oncology/Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy. Electronic address: · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada; Department of Urology, University of Montreal Health Center, Montreal, Canada. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada; Martini-Clinic, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany. · Division of Oncology/Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Canada. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada. · Department of Urology, University of Montreal Health Center, Montreal, Canada. · Martini-Clinic, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany. · Pubmed 28753853
  • Department of Medical Oncology, Cantonal Hospital St. Gallen and University of Berne, Switzerland. Electronic address: · Department of Medical Oncology, The Institute of Cancer Research/Royal Marsden, London, UK. · Oregon Health & Science University Knight Cancer Institute, OR, USA. · Department of Medical Oncology, Weill Cornell Medicine, New York, NY, USA. · Department of Radiation Oncology, Genito Urinary Oncology, Prostate Brachytherapy Unit, Goustave Roussy, Paris, France. · Department of Radiation Oncology, Princess Margaret Cancer Centre and University of Toronto, Toronto, ON, USA. · Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, New York, NY, USA. · Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain. · Department of Urology, Gangnam Severance Hospital, Yonsei University Health System, Seoul, Korea. · Department of Urology, The Christie and Salford Royal Hospitals, Manchester, UK. · Department of Medical Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark. · Monash University and Eastern Health, Eastern Health Clinical School, Box Hill, Australia. · Department of Urology, Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil. · Department of Medical Oncology, Division of Haematology/Oncology, Columbia University Medical Center, New York, NY, USA. · Department of Clinical Oncology and Genetics, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK. · Department of Medical Oncology, University of Texas MD Anderson Cancer Center, TX, USA. · Department of Urology, University of California, Davis School of Medicine, CA, USA. · Department of Nuclear Medicine, Policlinico S. Orsola, Università di Bologna, Italy. · Department of Radiation Oncology, University of California, San Francisco, CA, USA. · Department of Medical Oncology, Gustave Roussy, University of Paris Sud, Paris, France. · Department of Surgery, Department of Anatomy and Developmental Biology, Faculty of Medicine, Nursing and Health Sciences, Monash University. · Department of Urology, Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada. · Department of Clinical trials and Statistics, Duke University, Durham, NC, USA. · Department of Urology, University Hospital Köln, Köln, Germany. · Department of Medicine, Division of Medical Oncology, University of Washington and Fred Hutchinson Cancer Research Center, WA, USA. · Department of Clinical Oncology, Clinical Oncology Queen Elizabeth Hospital Birmingham and University of Birmingham, Birmingham, UK. · Department of Medical Oncology, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Department of Clinical Oncology, Tampere University Hospital, Faculty of Medicine and Life Sciences, University of Tampere, Finland. · Department of Urology, American University of Beirut Medical Center, Beirut, Lebanon. · Department of Urology, Medical University of Vienna, Vienna, Austria. · Department of Genitourinary Medical Oncology, MD Anderson Cancer Centre, Houston, TX, USA. · Department of Medical Oncology Hospital Israelita Albert Einstein and Department of Medical Oncology Beneficência Portuguesa de São Paulo. · Department of Medical Oncology and Epidemiology, Vanderbilt University Medical Center, Division of Hematology/Oncology, Nashville, TN, USA. · Department of Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Urology, University Hospital Nord St. Etienne, St. Etienne, France. · Department of Radiation Oncology, Tata Memorial Centre, Mumbai, India. · Department of Medical Oncology, Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, The Tisch Cancer Institute, New York, NY, USA. · Department of Radiation Oncology, Ghent University Hospital, Ghent, Belgium. · Department of Radiology, Mount Vernon Cancer Centre and Institute of Cancer Research, London, UK. · Department of Clinical Oncology, Royal Marsden NHS Foundation Trust, Sutton, UK. · Department of Pathology, University of Washington, WA, USA. · Department of Pathology, University of Bern and the Inselspital, Bern (CH). · Department of Medical Oncology, Clinical Medicine and Urology at the Helen Diller Family Comprehensive Cancer Center at the University of, California, San Francisco, CA, USA. · Department of Urology, Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada. · Department of Medical Oncology, Tulane Cancer Center, New Orleans, LA, USA. · Department of Medical Oncology, Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Centre, New York, NY, USA. · Department of Medical Oncology, Department of Oncology, Assaf Harofeh Medical Centre, Tel-Aviv University, Sackler School of Medicine, Zerifin, Israel. · Department of Urology, Carolina Urologic Research Center, Myrtle Beach, SC, USA. · Department of Medical Oncology, Massachusetts General Hospital Cancer Centre, Boston, MA, USA. · Prostate Cancer Foundation, Santa Monica, CA, USA. · Department of Medical Oncology, San Camillo Forlanini Hospital, Rome, Italy. · Department of Urology, Toho University Sakura Medical Center, Japan. · Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK. · Department of Medical Oncology, Princess Margaret Cancer Centre and University of Toronto, Toronto, ON, Canada. · Department of Urology, Cliniques Universitaires Saint Luc, Brussels, Belgium. · Department of Oncology and Haemato-oncology, Università degli Studi di Milano. Radiation Oncology 1, Prostate Cancer Program, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Department of Radiation Oncology, Klinik für Strahlentherapie und Radioonkologie des Universitätsklinikum Ulm, Albert-Einstein-Allee, Ulm, Germany. · Department of Medical Oncology, Cantonal Hospital St. Gallen and University of Berne, Switzerland. · Pubmed 28655541
  • Robert H. Lurie Comprehensive Cancer Center, Chicago, IL · University of Montreal Hospital Center, Montreal, QC, Canada · San Camillo Forlanini Hospital, Rome, Italy · Pubmed 30281993
  • Glenn Heller, Memorial Sloan Kettering Cancer Center, New York, NY · Robert McCormack and Thian Kheoh, Janssen Research & Development, Raritan, NJ · Arturo Molina, Janssen Research & Development, Los Angeles, CA · Matthew R. Smith, Massachusetts General Hospital, Boston, MA · Robert Dreicer, University of Virginia Medical School, Charlottesville, VA · Fred Saad, University of Montreal, Montreal, Quebec, Canada · Ronald de Wit, Erasmus Medical Center, Rotterdam, Netherlands · Dana T. Aftab, Exelixis, South San Francisco, CA · Mohammed Hirmand, Medivation, San Francisco, CA · Ana Limon-Carrera, Takeda Oncology, Cambridge, MA · Karim Fizazi, Institut Gustave Roussy, Villejuif, and University of Paris Sud, Orsay, France · Martin Fleisher, Memorial Sloan Kettering Cancer Center, New York, NY · Johann S. de Bono, The Institute of Cancer Research, and The Royal Marsden Hospital, Sutton, Surrey, United Kingdom · and Howard I. Scher, Memorial Sloan Kettering Cancer Center, and Weill Cornell Medical College, New York, NY. · Pubmed 29894273
2017
  • University of Montreal Hospital Center (CHUM), Montreal, Quebec, Canada. · Pubmed 28657926
  • Fred Saad, Centre Hospitalier de l'Université de Montréal, Université de Montréal, Montreal, Quebec, Canada. · Pubmed 28300482
  • Carolina Urologic Research Center, Myrtle Beach, SC. Electronic address: · Department of Urology, Uro-Oncology, Robot-assisted and Reconstructive Urological Surgery, University Hospital of Cologne, Cologne, Germany. · Department of Urology, Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada. · Pubmed 28797685
  • University of Colorado, Denver, CO. Electronic address: · Yale University, New Haven, CT. · Carolina Urologic Research Center, Myrtle Beach, SC. · Centre Hospitalier de L'Universite de Montreal, Montreal, QC, Canada. · Memorial Sloan Kettering Cancer Center, New York, NY. · Comprehensive Cancer Centers of Nevada, Las Vegas, NV. · Medical University of South Carolina, Charleston, SC. · Banner MD Anderson Cancer Center, Gilbert, AZ. · Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA. · Queen's University Belfast, Belfast, Northern Ireland, UK. · Université Catholique de Louvain, Brussels, Belgium. · Comprehensive Prostate Center, Nashville, TN. · Lancaster Urology, Lancaster, PA. · Icahn School of Medicine at Mount Sinai, New York, NY. · NRG Immunotherapy and Immunomodulation Committee, Scottsdale, AZ. · University of Washington, Seattle, WA. · Pubmed 28302580
  • OHSU Knight Cancer Institute, Portland, OR, USA. Electronic address: · Juravinski Cancer Centre, Hamilton, ON, Canada. · Centre Hospitalier de l'Université de Montréal, Institut du Cancer de Montréal, Montréal, QC, Canada. · P A Herzen Moscow Cancer Research Institute, Ministry of Healthcare of the Russian Federation, Moscow, Russia. · N N Blokhin Cancer Research Center, Ministry of Healthcare of the Russian Federation, Moscow, Russia. · Centre Leon Berard, Lyon, France. · Institute Paoli-Calmettes, Marseille, France. · Centre François Baclesse, Caen, France. · University of British Columbia, BC Cancer Agency-Vancouver Centre, Vancouver, BC, Canada. · The Clatterbridge Cancer Centre, Bebington, UK. · Trial Architecture Consulting, Washington, DC, USA. · OncoGenex Pharmaceuticals, Bothell, WA, USA. · Gustave Roussy, University of Paris Saclay, Villejuif, France. · Pubmed 29033099
  • Stéphane Oudard, Georges Pompidou European Hospital, Rene Descartes University · Mustapha Chadjaa · Sanofi, Paris · Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif · Antoine Thiery-Vuillemin, Centre Hospitalier Universitaire Minjoz Besançon, Besançon, France · Lisa Sengeløv, Herlev Hospital, Herlev · Gedske Daugaard, Copenhagen University Hospital, Rigshospitalet, Copenhagen · Steinbjørn Hansen, Odense University Hospital, Odense, Denmark · Fred Saad, Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada · Marie Hjälm-Eriksson, Karolinska University Hospital, Stockholm, Sweden · Jacek Jassem, Medical University of Gdansk, Gdansk, Poland · Orazio Caffo, Santa Chiara Hospital, Trento, Italy · Daniel Castellano, University Hospital 12 de Octubre, Madrid, Spain · Paul N. Mainwaring, Icon Cancer Care, Brisbane, Queensland, Australia · John Bernard, Sanofi, Cambridge, MA · Liji Shen, Sanofi, Bridgewater, NJ · and Oliver Sartor, Tulane Cancer Center, New Orleans, LA. · Pubmed 28753384
  • Emmanuel S. Antonarakis and Mario A. Eisenberger, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD · Scott T. Tagawa, Giuseppe Galletti, Daniel Worroll, Karla Ballman, Ada Gjyrezi, Shinsuke Tasaki, Luigi Portella, Yang Bai, Brian J. Kirby, David M. Nanus, and Paraskevi Giannakakou, Weill Cornell Medicine/Meyer Cancer Center · Che-Kai Tsao, Mount Sinai Medical Center, New York · Timothy B. Lannin, Shalu Suri, Conor N. Gruber, Erica D. Pratt, and Brian J. Kirby, Cornell University, Ithaca, NY · Marie Vanhuyse, Medical Oncology, Montréal General Hospital · Fred Saad, University of Montreal Hospital Center, Montreal · John Stewart, Atef Zaher, and Wei Zhou, Sanofi, Laval, Quebec, Canada · Guru Sonpavde, University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL · Scott North, University of Alberta, Cross Cancer Institute, Edmonton, Alberta, Canada · Costantine Albany, Indiana University School of Medicine, Indianapolis, IN · and Ted Szatrowski, Sanofi, Bridgewater, NJ. · Pubmed 28632486
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada; Martini Clinic, Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany. Electronic address: · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada; Department of Urology, University of Montreal Health Center, Montreal, Canada. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada; Department of Urology and Division of Experimental Oncology, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy. · Department of Urology, University of Montreal Health Center, Montreal, Canada. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada; Department of Urology, SS Annunziata Hospital, G.D. Annunzio University of Chieti, Chieti, Italy. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada; Martini Clinic, Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Department of Urology, Academic Hospital Braunschweig, Braunschweig, Germany. · Department of Radiation Oncology, University of Montreal Health Center, Montreal, Canada. · Martini Clinic, Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Martini Clinic, Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Pubmed 28546065
  • Department of Medicine, Division of Medical Oncology, University of British Columbia, BC Cancer Agency, Vancouver Prostate Centre, Vancouver, BC, Canada. Electronic address: · Department of Medicine, Division of Medical Oncology, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Trial Architecture Consulting, Washington, DC, USA. · Centre Antoine Lacassagne, Nice, France. · Florida Cancer Specialists, Fort Myers, FL, USA. · Department of Urology, Tübingen, Germany. · Institut Paoli Calmette, Department of Cancer Medicine, Marseille, France. · Department of Urology, University Hospital Schleswig-Holstein, Lübeck, Germany. · University of Tübingen, Tübingen, Germany. · Netherlands Cancer Institute and Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands. · Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, ON, Canada. · Durham Regional Cancer Centre, Oshawa, ON, Canada. · Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada. · OncoGenex Pharmaceuticals, Bothell, WA, USA. · Department of Medicine, Division of Medical Oncology, University of British Columbia, BC Cancer Agency, Vancouver Prostate Centre, Vancouver, BC, Canada. · Drug Development Unit, Royal Marsden Hospital and Institute of Cancer Research, London, UK. · Pubmed 28283282
  • Tomasz M. Beer, Oregon Health and Science University, Portland, OR · Eugene D. Kwon, Mayo Clinic, Rochester, MN · Charles G. Drake, Johns Hopkins University, Baltimore, MD · Karim Fizazi, University of Paris-Sud, Villejuif · Gwenaelle Gravis, Institut Paoli-Calmettes, Marseille, France · Christopher Logothetis, University of Texas MD Anderson Cancer Center, Houston, TX · Vinod Ganju, Monash University, Melbourne, Victoria · Siobhan S. Ng, St John of God Hospital, Subiaco, Western Australia · Francis X. Parnis, Adelaide Cancer Centre, Adelaide, South Australia, Australia · Jonathan Polikoff, Southern California Permanente Medical Group, San Marcos, CA · Fred Saad, Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada · Piotr Humanski, Niepubliczny Zaklad Opieki Zdrowotnej Specjalista, Kutno, Poland · Josep M. Piulats, Institut Català d'Oncologia, Barcelona · Javier Puente, Hospital Clínico San Carlos, Madrid, Spain · Pablo Gonzalez Mella, Instituto Oncologico, Viña del Mar · Pablo Gonzalez Mella, Fundación Arturo Lopez Pérez, Santiago, Chile · Dirk Jaeger, University Hospital, Heidelberg, Germany · Fabio A. Franke, Hospital de Caridade de Ijuí, Ijuí, Brazil · Roman Carvajal, Hospital Regional Valentin Gomez Farias, Zapopan, Mexico · Lisa Sengeløv, Herlev Hospital, Herlev, Denmark · M. Brent McHenry, Bristol-Myers Squibb, Wallingford, CT · Arvind Varma, DOCS Inc, New York, NY · Alfonsus J. van den Eertwegh, VU University Medical Center, Amsterdam · and Winald Gerritsen, Radboud University, Nijmegen, the Netherlands. · Pubmed 28034081
  • Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Cancer Medicine, Institute Gustave Roussy, Villejuif, France. · Department of Oncology, University of Paris, Paris, France. · Janssen Oncology Research & Development, Raritan, New Jersey. · Janssen Research & Development, Menlo Park, California. · Millennium Pharmaceuticals Inc., Cambridge, Massachusetts. · Department of Surgery, University of Montréal, Montréal, Québec, Canada. · Prostate Cancer Targeted Therapy Group, The Institute of Cancer Research and the Royal Marsden NHS Foundation Trust, London, United Kingdom. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Medicine, Weill Cornell Medical College, New York, New York. · Pubmed 27678453
  • Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA. Electronic address: · Duke Cancer Institute, Durham, NC, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Institut Gustave-Roussy, Villejuif, France. · San Camillo and Forlanini Hospitals, Rome, Italy. · University of Washington, Seattle Cancer Care Alliance, Seattle, WA, USA. · Rigshospitalet, Copenhagen, Denmark. · UC Davis Cancer Center, Sacramento, CA, USA. · Asan Medical Center, Seoul, Korea. · Nippon Medical School, Tokyo, Japan. · Charité Universitätsmedizin, Berlin, Germany. · University of Montreal Hospital Center, Montreal, QC, Canada. · Skåne University Hospital, Malmö, Sweden. · Aarhus University Hospital, Aarhus, Denmark. · Radboud University Medical Center, Nijmegen, Netherlands. · Tampere University Hospital and University of Tampere, Tampere, Finland. · Medivation, San Francisco, CA, USA. · Astellas Pharma Europe, Leiden, The Netherlands. · Cliniques Universitaires Saint-Luc, Brussels, Belgium. · Pubmed 27477525
  • Janssen Research & Development, 920 Route 202, Raritan, NJ, 08869, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Janssen Research & Development, a Division of Janssen Pharmaceutica NV, Beerse, Belgium. · Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA. · University of Montréal, Montréal, QC, Canada. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, 920 Route 202, Raritan, NJ, 08869, USA. · Pubmed 27324190
  • Sunnybrook Health Sciences Centre, 2075 Bayview Ave, Toronto, ON, Canada. · Institut du cancer de Montréal and Centre de recherche du Centre hospitalier de l'Université de Montréal, 900 St Denis St, Montreal, QC, Canada. · McGill University and McGill University Health Centre, 1001 Decarie Blvd, Montreal, QC, Canada. · University Health Network, 610 University Ave, Toronto, ON, Canada. · Manitoba Prostate Centre, 675 McDermot Ave, Winnipeg, MB, Canada. · Department of Surgery Université de Montréal, 2900 Edouard Montpetit Blvd, Montreal, QC, Canada. · Terrry Fox Research Institute, 675 West 10th Avenue, Vancouver, BC, Canada. · Vancouver Prostate Centre, 2660 Oak St, Vancouver, BC, Canada. · Institut du cancer de Montréal and Centre de recherche du Centre hospitalier de l'Université de Montréal, 900 St Denis St, Montreal, QC, Canada. · Department of Surgery Université de Montréal, 2900 Edouard Montpetit Blvd, Montreal, QC, Canada. · Department of Medicine, Université de Montréal, 2900 Edouard Montpetit Blvd, Montreal, QC, Canada. · Pubmed 29078772
  • University of Montreal Hospital Center, Montreal, QC H2X 0A9, Canada. Electronic address: · Pubmed 28760402
  • Centre Hospitalier de I'Université de Montréal, Urology Division, CHUM - Pavillon R 900, rue St-Denis, porte R10-464, Montreal, Quebec H2X 0A9, Canada. · Pubmed 28508880
  • Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. Electronic address: · University of Montréal, Montréal, Québec, Canada. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College New York, NY, USA. · Radboud University Medical Centre, Nijmegen, The Netherlands. · The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, UK. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Janssen Research & Development, San Diego, CA, USA. · Johnson & Johnson Medical China, Shanghai, China. · Janssen Research & Development, Beerse, Belgium. · Janssen Global Services, Raritan, NJ, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Pubmed 28314611
  • Duke Cancer Institute, Durham, North Carolina. · Centre Hospitalier de l'Université de Montréal and CRCHUM, Montreal, Quebec, Canada. · Astellas Pharma, Inc., Leiden, Netherlands. · Astellas Pharma, Inc., Northbrook, Illinois. · Carolina Urologic Research Center, Myrtle Beach, South Carolina. · Institut Gustave Roussy, University of Paris Sud, Paris, France. · Medivation, Inc., San Francisco, California. · Sidney Kimmel Center for Prostate and Urologic Cancers and Memorial Sloan-Kettering Cancer Center, New York, New York. · Institute of Cancer Research, London, UK. · Pubmed 28171710
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada. · Martini-Clinic, Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Department of Urology, University of Montreal Health Center, Montreal, Canada. · Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy. · Department of Urology, Medical University of Vienna, Vienna, Austria. · Department of Urology, University Hcoospital Hamburg-Eppendorf, Hamburg, Germany. · Department of Urology, Academic Hospital Braunschweig, Braunschweig, Germany. · Pubmed 28156003
  • Urology Division, Centre Hospitalier de I'Université de Montréal, CHUM - Pavillon R 900, rue St-Denis, porte R10-464, Montreal, Quebec H2X 0A9, Canada. · Pubmed 27874064
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada. · Department of Urology, University Medical Center, Johannes Gutenberg University, Mainz, Germany. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada. · Unit of Urology, Division of Oncology, URI, IRCCS Ospedale San Raffaele, Milan, Italy. · Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Canada. · Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Martini-Clinic, Prostate Cancer Centre, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Department of Urology, University Medical Center, Johannes Gutenberg University, Mainz, Germany. · Department of Urology, University of Montreal Health Center, Montreal, Canada. · Pubmed 27796538
  • Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada; Université de Montréal Endowed Chair in Prostate Cancer, Montreal, Quebec, Canada; Centre de recherche du Centre Hospitalier de l'Université de Montréal and Institut du cancer de Montréal, Montreal, Quebec, Canada; Department of Surgery, Université de Montréal, Montreal, Quebec, Canada. Electronic address: · Université de Montréal Endowed Chair in Prostate Cancer, Montreal, Quebec, Canada; Department of Pathology and Cellular Biology, Université de Montréal, Montreal, Quebec, Canada. · Centre de recherche du Centre Hospitalier de l'Université de Montréal and Institut du cancer de Montréal, Montreal, Quebec, Canada; Department of Surgery, Université de Montréal, Montreal, Quebec, Canada. · Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada; Department of Surgery, Université de Montréal, Montreal, Quebec, Canada. · Centre de recherche du Centre Hospitalier de l'Université de Montréal and Institut du cancer de Montréal, Montreal, Quebec, Canada; Department of Medicine, Université de Montréal, Montreal, Quebec, Canada. · Centre de recherche du Centre Hospitalier de l'Université de Montréal and Institut du cancer de Montréal, Montreal, Quebec, Canada. · Metamark Genetics, Inc., Cambridge, Massachusetts. · Metamark Genetics, Inc., Cambridge, Massachusetts; Department of Epidemiology and Biostatistics, Texas A&M University, College Station, Texas. · Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada; Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada. · Pubmed 27725152
  • Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM)/Institut du Cancer de Montréal, Montreal, Canada. · Department of Surgery, Hôpital Saint Luc (CHUM), Montreal, Canada. · Department of Surgery, Université de Montréal, Montreal, Canada. · Department of Medicine, Université de Montréal, Montreal, Canada. · Pubmed 27577074
  • University Health Network, Toronto, ON, Canada. · Institut du Cancer de Montréal/Centre de recherche du CHUM, Montreal, QC, Canada. · Manitoba Prostate Center, Winnipeg, MB, Canada. · Centre de Santé et des Services Sociaux de Laval, Laval, QC, Canada. · Centre hospitalier de l'Université de Montréal (CHUM), Montreal, QC, Canada. · Vancouver Prostate Center, Vancouver, BC, Canada. · Centre de Santé et des Services Sociaux de Chicoutimi, Chicoutimi, QC, Canada. · Centre hospitalier de l'Université de Montréal (CHUM), Montreal, QC, Canada. · Institut du Cancer de Montréal/Centre de recherche du CHUM, Montreal, QC, Canada. · Pubmed 27447989
  • The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, UK. Electronic address: · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · Centre Hospitalier University of Montréal, Montréal, Québec, Canada. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, San Diego, CA, USA. · Johnson & Johnson Medical China, Shanghai, China. · Janssen Global Services, Raritan, NJ, USA. · University of Colorado Cancer Center, Aurora, CO, USA. · Pubmed 27402060
2016
  • University of Montreal Hospital Center (CHUM) and Montreal Cancer Institute/CRCHUM, CHUM - Pavillon R 900, rue St-Denis, porte R10-464, Montréal, Québec H2X 0A9, Canada. · Pubmed 27489183
  • Hematologist and Medical Oncologist, Notre-Dame Hospital, CHUM Research Center, Montreal, QC, Canada. · Associate Professor, Department of Pharmacy, Cancer Axis-Montreal Cancer Institute, Montreal, QC, Canada. · Hematologist and Medical Oncologist, Notre-Dame Hospital, CHUM Research Center, Montreal, QC, Canada.; Associate Professor, Department of Medicine, University of Montreal, QC, Canada. · Professor and Chief of Urology, CHUM-Pavillon R, Montreal, QC, Canada. · Pubmed 27168728
  • University of Warwick, Cancer Research Unit, Coventry, UK; Queen Elizabeth Hospital, Birmingham, UK. · Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada. Electronic address: · Pubmed 26905032
  • Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada. Electronic address: · Vall d' Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Kantonsspital St Gallen, St Gallen, Switzerland. · University Hospital, University Hospital Cologne, Germany. · Department of Oncology, Akershus University Hospital, Lørenskog, Norway. · Modular Informatics LLC, Thornwood NY, USA. · Biometrical Practice, BIOP, Basel, Switzerland. · Charité University Medicine Berlin, Berlin, Germany. · Karolinska University Hospital, Stockholm, Sweden. · Pharmaceuticals Division of Bayer, Whippany, NJ, USA. · Department of Oncology, San Luigi Hospital, Orbassano Turin, Italy. · University Hospital Carl-Gustav Carus, Dresden, Germany. · Bayer Pharma AG, Basel, Switzerland. · The Centre for Cancer Research and Cell Biology, Queen's University Belfast, Northern Ireland; Northern Ireland Cancer Centre, Belfast, Northern Ireland. · Pubmed 27473888
  • Department of Urology, UC Davis Comprehensive Cancer Center, Sacramento, CA, USA. Electronic address: · Medical Oncology Division, University of Washington/Seattle Cancer Care Alliance, Seattle, WA, USA. · Department of Urology, Medical University of South Carolina, Charleston, SC, USA. · Division of Urologic Surgery, Washington University School of Medicine, St. Louis, MO, USA. · Department of Surgery, University of Montreal Health Center, Montreal, Canada. · Copenhagen Prostate Cancer Center, Rigshospitalet, University of Copenhagen, Denmark. · Department of Urology, Charité-Universitätsmedizin Berlin, Berlin, Germany. · Department of Urology, Asan Medical Center, Seoul, South Korea. · Department of Urology, Nippon Medical School Hospital, Tokyo, Japan. · Division of Medical Oncology and Urology, Duke Cancer Institute, Durham, NC, USA. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Department of Cancer Medicine, Institut Gustave-Roussy, Villejuif, France. · Drug Development Unit, Institute of Cancer Research, Royal Marsden Hospital, London, UK. · Department of Early Clinical Development, Medivation, Inc., San Francisco, CA, USA. · Department of Medical Affairs, Medivation, Inc., San Francisco, CA, USA. · Department of Biostatistics, Medivation, Inc., San Francisco, CA, USA. · Astellas Pharma, Inc., Northbrook, IL, USA. · Department of Hematology and Medical Oncology, OHSU Knight Cancer Institute, Portland, OR, USA. · Department of Urology, Cliniques Universitaires Saint-Luc, Brussels, Belgium. · Pubmed 27006332
  • Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Electronic address: · Janssen Research & Development, San Diego, CA, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · University of Montréal, Montréal, Québec, Canada. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Monash University and Eastern Health, Victoria, Australia. · ZNA Middelheim Oncology Clinic, Medical Oncology, Antwerp, Belgium. · Churchill Hospital, Oxford, UK. · Janssen Research & Development, Menlo Park, CA, USA. · Janssen Research & Development, Beerse, Belgium. · The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, UK. · Georges Pompidou Hospital, University René Descartes, Paris, France. · Pubmed 26508309
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Québec, Canada; Department of Urology and Division of Experimental Oncology, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy. Electronic address: · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Québec, Canada; Martini-Clinic, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Québec, Canada; Department of Urology, University of Montreal Health Center, Montreal, Québec, Canada. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Québec, Canada; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Québec, Canada. · Department of Urology and Division of Experimental Oncology, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy. · Department of Urology, Medical University of Vienna and General Hospital, Vienna, Austria. · Department of Urology, University of Montreal Health Center, Montreal, Québec, Canada. · Pubmed 27478167
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada; Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy. Electronic address: · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada; Department of Urology, University of Montreal Health Center, Montreal, Canada. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada; Martini-Clinic, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Canada. · Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy. · Department of Urology, Medical University of Vienna and General Hospital, Vienna, Austria. · Martini-Clinic, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Department of Urology, University of Montreal Health Center, Montreal, Canada. · Pubmed 26951945
  • Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Institut du Cancer de Montréal, Montréal, Quebec, Canada. Faculté de Pharmacie, Université de Montréal, Pavillon Jean-Coutu, Montréal, Quebec, Canada. · Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Institut du Cancer de Montréal, Montréal, Quebec, Canada. · Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Institut du Cancer de Montréal, Montréal, Quebec, Canada. Faculté de Pharmacie, Université de Montréal, Pavillon Jean-Coutu, Montréal, Quebec, Canada. · Pubmed 26253870
  • Martini-Klinik am Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada. · Department of Urology, University of Montreal Health Center, Montreal, Canada. · Unit of Urology, Division of Oncology, URI, IRCCS Ospedale San Raffaele, Milan, Italy. · Martini-Klinik am Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany. · INRS-Institut Armand-Frappier, Institut national de la recherche scientifique, Université du Québec, Laval, Canada. · Department of Social and Preventive Medicine, University of Montreal, Montreal, Canada. · Pubmed 26108732
2015
  • University of Montreal Hospital Center, Montreal, Quebec, Canada. Electronic address: · Pubmed 25168615
  • Montréal University Health Centre, Montréal, Canada. Electronic address: · Department of Cancer Medicine, Gustave Roussy Institute, University of Paris Sud, Villejuif, France. · Pubmed 26282624
  • Division of Urology, Department of Surgery, Centre Hospitalier de I'Université de Montréal, Montréal, Quebec, Canada. Electronic address: · Department of Urology, Charité Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany. · Pubmed 25709051
  • Centre Hospitalier de l'Université de Montréal, University of Montreal, CHUM Pavillon R, 900 rue St Denis, Montreal, QC H2X 0A9, Canada. · Pubmed 25600097
  • Millennium Pharmaceuticals, Inc, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited (D.B.M., H.S., H.F.), Cambridge, Massachusetts 02139 · and University of Montreal Hospital Center (F.S.), Montreal, Québec, Canada H2X 0A9. · Pubmed 26502357
  • Janssen Research & Development, Raritan, New Jersey. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California. · Janssen Research & Development, Beerse, Belgium. · Harvard Medical School, Massachusetts General Hospital Cancer Center, Boston, Massachusetts. · University of Montreal, Montreal, Quebec, Canada. · Janssen Research & Development, Los Angeles, California. · Janssen Research & Development, Raritan, New Jersey. · Pubmed 25829400
  • Centre Hospitalier de l'Université de Montréal/CRCHUM, Montréal, QC, Canada. Electronic address: · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Universitatea de Medicina si Farmacie, Bucharest, Romania. · University of Athens Medical School, Athens, Greece. · Auckland City Hospital, Auckland, New Zealand. · Florida Cancer Specialists, Fort Myers, FL, USA. · Institute of Cancer Sciences, University of Glasgow, Glasgow, UK. · The Adelaide and Meath Hospital, Incorporating the National Children's Hospital, Dublin, Ireland. · University Hospital Carl Gustav Carus Dresden, Dresden, Germany. · Gunma University Graduate School of Medicine, Gunma, Japan. · Millennium Pharmaceuticals, Inc, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA. · The University of Tokyo Research Center for Advanced Science and Technology, Tokyo, Japan. · University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Cleveland Clinic, Cleveland, OH, USA. · Millennium Pharmaceuticals, Inc, Cambridge, MA, USA. · Erasmus University Medical Center, Rotterdam, Netherlands. · Pubmed 25701170
  • Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif · Stephane Oudard, Université Paris Descartes, Paris, France · Robert Jones, Institute of Cancer Sciences, University of Glasgow, Glasgow · Johann De Bono, The Institute of Cancer Research, London, United Kingdom · Eleni Efstathiou, University of Athens Medical School, Athens · George Fountzilas, Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece · Fred Saad, University of Montreal Hospital Center, Montreal, Canada · Ronald de Wit, Erasmus University Medical Center, Rotterdam, the Netherlands · Felipe Melo Cruz, ABC Foundation School of Medicine, Santo André · Flavio Carcano, Hospital de Cancer de Barretos, Barretos, Brazil · Albertas Ulys, Institut of Oncology, Vilnius University, Vilnius, Lithuania · Neeraj Agarwal, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT · David Agus, University of Southern California, Los Angeles, CA · Daniel P. Petrylak, Yale University Cancer Center, New Haven, CT · Shih-Yuan Lee, Bindu Tejura, Niels Borgstein, Takeda Pharmaceuticals International · Iain J. Webb, Millennium: The Takeda Oncology Company, Cambridge, MA · Robert Dreicer, Cleveland Clinic, Cleveland, OH · Joaquim Bellmunt, University Hospital del Mar-IMIM, Barcelona, Spain. · Pubmed 25624429
  • Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. Electronic address: · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · University of Montréal, Montréal, Québec, Canada. · Radboud University Medical Centre, Nijmegen, Netherlands. · San Camillo and Forlanini Hospitals, Rome, Italy. · Charité Berlin, Berlin, Germany. · MD Anderson Cancer Center, Houston, TX, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona, Spain. · University of Colorado Cancer Center and University of Colorado School of Medicine, Aurora, CO, USA. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · University of Western Sydney School of Medicine and Ingham Institute, Liverpool, Australia. · The Institute of Cancer Research and the Royal Marsden Hospital, Sutton, United Kingdom. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, Raritan, NJ, USA. · Janssen Research & Development, Menlo Park, CA, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Pubmed 25601341
  • University of Montreal Hospital Centre, Montreal, QC, Canada. Electronic address: · Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, UK. · Carolina Urologic Research Center, Myrtle Beach, SC, USA. · Gustave Roussy, Cancer Campus Grand Paris, University of Paris Sud, Villejuif, France. · Medivation, Inc., San Francisco, CA, USA. · Astellas Global Medical Affairs, Inc., Northbrook, IL, USA. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Pubmed 25171902
  • Vattikuti Urology Institute and VUI Center for Outcomes Research Analytics and Evaluation, Henry Ford Hospital, Detroit, MI, USA. Electronic address: · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Centre, Montreal, QC, Canada. · Department of Urology, Vita Salute San Raffaele University, Milan, Italy. · Vattikuti Urology Institute and VUI Center for Outcomes Research Analytics and Evaluation, Henry Ford Hospital, Detroit, MI, USA. · Martini Clinic, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany. · Pubmed 28723433
  • Epidemiology and Biostatistics Unit, Institut national de la recherche scientifique-Institut Armand-Frappier, University of Quebec, 531 Boul. des Prairies, Laval, QC, H7V 1B7, Canada. · Epidemiology and Biostatistics Unit, Institut national de la recherche scientifique-Institut Armand-Frappier, University of Quebec, 531 Boul. des Prairies, Laval, QC, H7V 1B7, Canada. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, 1058, rue St-Denis, Montreal, QC, H2X 3 J4, Canada. · Department of Surgery, Division of Urology, Centre Hospitalier de l'Université de Montréal, 1058, rue St-Denis, Montreal, QC, H2X 3 J4, Canada. · Department of Surgery (Urology), McGill University Health Centre, 1650 Cedar Avenue, Montreal, QC, H3G 1A4, Canada. · Department of Surgery, Division of Urology, Centre Hospitalier de l'Université de Montréal, 1058, rue St-Denis, Montreal, QC, H2X 3 J4, Canada. · Epidemiology and Biostatistics Unit, Institut national de la recherche scientifique-Institut Armand-Frappier, University of Quebec, 531 Boul. des Prairies, Laval, QC, H7V 1B7, Canada. · Department of Social and Preventive Medicine, University of Montreal, 7101 Avenue du Parc, Montreal, QC, Canada. · Pubmed 26385727
  • Martini-Klinik am Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany; Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada. Electronic address: · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada; Division of Oncology, URI, IRCCS Ospedale San Raffaele, Milan, Italy. · INRS-Institut Armand-Frappier, Institut national de la recherche scientifique, Université du Québec, Laval, Canada. · Martini-Klinik am Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany. · Department of Urology, University of Montreal Health Center, Montreal, Canada. · INRS-Institut Armand-Frappier, Institut national de la recherche scientifique, Université du Québec, Laval, Canada; Department of Social and Preventive Medicine, University of Montreal, Canada. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada; Department of Urology, University of Montreal Health Center, Montreal, Canada. · Pubmed 26278366
  • Institut du cancer de Montréal / Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), 900 rue St-Denis, Montreal, Canada. · Visiopharm, Argen Allé 3, Hoersholm, Denmark. · Institut du cancer de Montréal / Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), 900 rue St-Denis, Montreal, Canada; Department of Medicine, Université de Montréal, Montreal, Canada. · Institut du cancer de Montréal / Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), 900 rue St-Denis, Montreal, Canada; Division of Urology, CHUM and Department of Surgery, Université de Montréal, Montreal, Canada. · Pubmed 26186215
  • Department of Surgery, University of Montreal, Montreal, Quebec, Canada. · Pubmed 26181183
  • University of Montréal, Montréal, Québec, Canada. Electronic address: · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · University Hospital Leuven, Leuven, Belgium. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · Institute of Cancer Research and Royal Marsden Hospital, Sutton, UK. · MD Anderson Cancer Center, Houston, TX, USA. · University of Western Sydney School of Medicine, Ingham Institute, Liverpool, Australia. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Hematology and Oncology Clinics of Australia, Brisbane, Australia. · Sarah Cannon Research Institute, Nashville, TN, USA. · Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA. · Cross Cancer Institute, Edmonton, Alberta, Canada. · Laval University, Québec City, Québec, Canada. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, Raritan, NJ, USA. · Janssen Research & Development, San Diego, CA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Janssen Research & Development, Menlo Park, CA, USA. · Pubmed 25985882
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, 264 Blvd. Rene-Levesque E. Room 228, Montreal, QC, H2X 1P1, Canada. · Department of Urology, University of Montreal Health Center, Montreal, QC, Canada. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, 264 Blvd. Rene-Levesque E. Room 228, Montreal, QC, H2X 1P1, Canada. · Martini-Clinic, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany. · Division of Oncology, Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy. · INRS-Institut Armand-Frappier, Institut National de la Recherche Scientifique, Laval, QC, Canada. · University of Montreal Hospital Research Centre (CRCHUM), Montreal, QC, Canada. · Department of Radiation Oncology, University of Montreal Health Center, Montreal, QC, Canada. · Martini-Clinic, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany. · Pubmed 25854524
  • Martini-Klinik am Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, 264 Blvd. Rene-Levesque E. Room 228, Montreal, QC, H2X 1P1, Canada. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, 264 Blvd. Rene-Levesque E. Room 228, Montreal, QC, H2X 1P1, Canada. · Department of Urology, University of Montreal Health Center, Montreal, QC, Canada. · Division of Oncology, Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy. · INRS-Institut Armand-Frappier, Institut national de la recherche scientifique, Université du Québec, Laval, QC, Canada. · Martini-Klinik am Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany. · Department of Social and Preventive Medicine, University of Montreal, Montreal, QC, Canada. · Pubmed 25824539
  • Metamark Genetics Inc., Cambridge, Massachusetts. · Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, Canada. · Department of Pathology, Yale University Medical School, New Haven, Connecticut. · Urology Austin, Austin, Texas. · Impacts Inc., Montreal, Quebec, Canada. · Dana-Farber Cancer Institute, Boston, Massachusetts. · Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio. · Department of Anatomic Pathology, Cleveland Clinic, Cleveland, Ohio. · Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada. · Department of Pathology, Urology and Oncology, Johns Hopkins Hospital, Baltimore, Maryland. · Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada. · Pubmed 25733599
  • VUI Center for Outcomes Research, Analytics and Evaluation, Henry Ford Health System, Detroit, MI. · Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. · Department of Urology, Yale University, New Haven, CN. · VUI Center for Outcomes Research, Analytics and Evaluation, Henry Ford Health System, Detroit, MI; Division of Urologic Oncology and Center for Surgery and Public Health, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. · Department of Urology, University of Minnesota, Minneapolis, MN. · Department of Urology, Maine Medical Center, Portland, ME. · Department of Urology, David Geffen School of Medicine, University of California, Los Angeles, CA. · Division of Urologic Oncology and Center for Surgery and Public Health, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. · Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. · Division of Urology, University of Montreal Hospital Center, Montreal, Canada. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada. · Division of Urologic Oncology and Center for Surgery and Public Health, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. Electronic address: · Pubmed 25623683
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Centre, Montreal, Canada; Department of Urology, Vita Salute San Raffaele University, Milan, Italy. Electronic address: · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Centre, Montreal, Canada. · Department of Urology, Medical University of Vienna, Vienna, Austria. · Department of Surgery, Division of Urology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. · Martini-Klinik, Prostate Cancer Center, University-Hospital Hamburg-Eppendorf, Hamburg, Germany. · Department of Surgery, Division of Urology, Centre Hospitalier de l'Université de Montréal, Montreal, Canada. · Department of Urology, Vita Salute San Raffaele University, Milan, Italy. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Centre, Montreal, Canada; Department of Surgery, Division of Urology, Centre Hospitalier de l'Université de Montréal, Montreal, Canada. · Pubmed 25547676
  • Department of Urology, Ruhr University Bochum, Marien Hospital, Herne, Germany. Electronic address: · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Québec, Canada. · Department of Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. · Department of Urology, University of California (UCLA), Los Angeles, CA. · Division of Urologic Surgery and Center for Surgery and Public Health, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. · Department of Urology, Yale School of Medicine, New Haven, CT. · Department of Urology, Georgetown University Hospital, Washington, DC. · Vattikuti Urology Institute, Henry Ford Health System, Detroit, MI. · Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. · CRCHUM, Centre Hospitalier de l׳Université de Montréal, Montreal, Québec, Canada. · Department of Urology, University of Minnesota, Minneapolis, MN. · Department of Urology, Ruhr University Bochum, Marien Hospital, Herne, Germany. · Division of Urologic Surgery and Center for Surgery and Public Health, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Vattikuti Urology Institute, Henry Ford Health System, Detroit, MI. · Pubmed 25443265
2014
  • University of Montreal, Montreal, Quebec, Canada. · Pubmed 25029395
  • Ethan Basch, Ronald C. Chen, and Stacie B. Dusetzina, University of North Carolina, Chapel Hill · Derek Raghavan, Carolinas Health Care/Levine Cancer Institute, Charlotte, NC · D. Andrew Loblaw, Odette Cancer Centre, Sunnybrook Health Sciences Centre · Ted Wootton, Patient Representatives, Toronto · Sebastian Hotte and Cindy Walker-Dilks, McMaster University · Cindy Walker-Dilks, Cancer Care Ontario, Hamilton · Eric Winquist, London Health Sciences Centre, London, Ontario · Fred Saad, University of Montreal, Montreal, Quebec, Canada · Thomas K. Oliver and R. Bryan Rumble, American Society of Clinical Oncology, Alexandria, VA · Michael Carducci, Johns Hopkins University, Baltimore, MD · James N. Frame, Charleston Area Medical Center Health Systems, Charleston, WV · Kristina Garrels, Private Practice, Fargo, ND · Michael W. Kattan, Cleveland Clinic, Cleveland, OH · Mary-Ellen Taplin, Dana-Farber Cancer Institute, Boston, MA · James Williams, Pennsylvania Prostate Cancer Coalition, Camp Hill, PA · Charles L. Bennett, South Carolina College of Pharmacy, Columbia, SC · and Katherine S. Virgo, Emory University, Atlanta, GA. · Pubmed 25199761
  • Claude-Bernard-Lyon-1 University and Department of Medical Oncology, Centre Léon-Bérard, Lyon, France. Electronic address: · Multidisciplinary Oncology Institute, Clinique de Genolier, Genolier, Switzerland. · H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA. · Claude-Bernard-Lyon-1 University and Department of Medical Oncology, Centre Léon-Bérard, Lyon, France. · Department of Urology, University Hospitals, Leuven, Belgium. · Department of Urology, Queen Mary University of London, London, UK. · Division of Surgery and Interventional Science, University College London, London, UK. · Department of Clinical Therapeutics, University of Athens Medical School, Athens, Greece. · Irish Cancer Society and University College Dublin, Dublin, Ireland. · Department of Urology, RWTH University Aachen, Aachen, Germany. · Guy's and St Thomas' NHS Trust, London, UK. · Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, USA. · University Hospital, Saint-Etienne, France. · Georges Pompidou Hospital, Department of Oncology, Paris, France. · University College London Hospitals, London, UK. · Uro‑Oncology Clinic, Centre Hospitalier de l'Université de Montreal, Montreal, QC, Canada. · Pubmed 25079103
  • Montefiore Medical Center, 111 East 210th Street, New York, NY 10467, USA. · Centre Hospitalier de I'Université de Montréal, Hôpital Notre-Dame, 1560 Sherbrooke East, Montreal, QC H2L 4M1, Canada. · Pubmed 24821212
  • Princess Margaret Hospital, Toronto, ON, Canada. Electronic address: · Durham VA Medical Center and Duke University Medical Center, Durham, NC, USA. · BC Cancer Agency, Vancouver, BC, Canada. · Seattle Cancer Centre Alliance, Seattle, WA, USA. · Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. · Royal Marsden NHS Foundation Trust, Sutton, UK. · Tulane Cancer Center, New Orleans, LA, USA. · University of Montreal Hospital Center, Montreal, PQ, Canada. · Pubmed 23957948
  • Department of Medical Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA. Electronic address: · Academic Unit of Clinical Oncology, Weston Park Hospital, CR-UK/YCR Sheffield Cancer Research Centre, Sheffield, UK. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Department of Urology, University Hospital Charité, Berlin, Germany. · Division of Urology, Centre Hospitalier de l'Université de Montréal, CRCHUM, Montréal, QC, Canada. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Tisch Cancer Center Institute, Mount Sinai School of Medicine, New York, NY, USA. · Pubmed 23706567
  • Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. Electronic address: · Hospital Universitario 12 de Octubre, Madrid, Spain. · Rigshospitalet, Copenhagen, Denmark. · National Institute of Oncology, Budapest, Hungary. · McMaster University, Hamilton, ON, Canada. · ICON Cancer Care, Brisbane, QLD, Australia. · University of Montreal, Montreal, QC, Canada. · Center for Oncology, Hospital Sírio-Libanês, São Paulo, Brazil. · OncoCare Cancer Centre, Singapore. · Centro Oncologico Belenus, Cuernavaca, Mexico. · University of Pisa, Pisa, Italy. · Janssen Research & Development, Horsham, PA, USA. · Janssen Research & Development, Beerse, Belgium. · Janssen Scientific Affairs, Horsham, PA, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Global Services, Raritan, NJ, USA. · Janssen Research & Development, Menlo Park, CA, USA. · Duke Cancer Institute, Durham, NC, USA. · Pubmed 25242048
  • Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. Electronic address: · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. · MD Anderson Cancer Center, Houston, TX, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · University of Western Sydney School of Medicine, Penrith, Australia. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Hematology & Oncology Clinics of Australia, Brisbane, Australia. · Sarah Cannon Research Institute, Nashville, TN, USA. · Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA. · Cross Cancer Institute, Edmonton, Alberta, Canada. · Laval University, Québec City, Québec, Canada. · University Hospital Leuven, Leuven, Belgium. · Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. · University of Colorado Cancer Center and University of Colorado School of Medicine, Aurora, CO, USA. · University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, Raritan, NJ, USA. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA. · Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Janssen Research & Development, Menlo Park, CA, USA. · CRCHUM, University of Montréal, Montréal, Québec, Canada. · Pubmed 24647231
  • Matthew R. Smith and Philip Saylor, Massachusetts General Hospital Cancer Center, Boston, MA · Susan Halabi and Ben Sanford, Alliance Statistics and Data Center, Duke University Medical Center, Durham, NC · Charles J. Ryan and Eric J. Small, University of California at San Francisco, San Francisco, CA · Walter Stadler, University of Chicago · Nirmala Bhoopalam, Loyola University of Chicago, Chicago, IL · Arif Hussain, University of Maryland, Baltimore, MD · Nicholas Vogelzang, Nevada Cancer Research Foundation CCOP, Las Vegas, NV · Ralph J. Hauke, University of Nebraska, Omaha, NE · J. Paul Monk, Ohio State University, Columbus, OH · W. Kevin Kelly, Thomas Jefferson University, Philadelphia, PA · Michael Morris, Memorial Sloan-Kettering Cancer Center, New York, NY · Fred Saad, Centre Hospitalier de l'Université de Montréal, Montreal, Canada. · Pubmed 24590644
  • M. Dror Michaelson, Massachusetts General Hospital Cancer Center, Boston, MA · Stephane Oudard, George Pompidou European Hospital, Rene Descartes University, Paris · Nadine Houede, Institut Bergonie, Bordeaux · Tristan Maurina, CHU de Besançon, Hôpital Jean Minjoz, Besançon, France · Yen-Chuan Ou, Taichung Veterans General Hospital, Taichung, Taiwan · Lisa Sengeløv, Herlev Hospital, Herlev · Gedske Daugaard, Rigshospitalet, Copenhagen, Denmark · Fred Saad, University of Montreal, Montreal, Canada · Peter Ostler, Mount Vernon Hospital, Northwood, Middlesex · Robert Jones, Beatson West of Scotland Cancer Centre, Glasgow · Amit Bahl, Bristol Haematology and Oncology Centre, Bristol, UK · Arnulf Stenzl, Eberhard-Karls-University Medical School, Tübingen · Juergen Gschwend, Technical University of Munich, Munich, Germany · Fredrik Laestadius and Anders Ullèn, Karolinska University Hospital, Stockholm, Sweden · Daniel Castellano, I_12 Research Institute, University Hospital 12 de Octubre, Madrid, Spain · Edna Chow Maneval, Shaw-Ling Wang, and Isan Chen, Pfizer Oncology, La Jolla, CA · and Maria Jose Lechuga and Jolanda Paolini, Pfizer Oncology, Milan, Italy. · Pubmed 24323035
  • Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada. Electronic address: · Pubmed 22633317
  • Departments of Surgery and Urology, University of Montreal Health Center, Montréal, Quebec, Canada H2X 0A9. · Pubmed 25130993
  • Associated Medical Professionals of New York, Syracuse, NY. · SUNY Upstate Medical University, Syracuse, NY. · Faculty of Medicine, University of Montreal, Montreal, Quebec, Canada. · Associated Medical Professionals of New York, Syracuse, NY. Electronic address: · Division of Urology, University of Montreal Hospital Center, Montreal, Quebec, Canada. · Pubmed 24976229
  • Centre Hospitalier de I'Université de Montréal, Urology Division, Hôpital Notre-Dame, 1560 Sherbrooke Rast, Montreal, QC H2L 4M1, Canada. · Pubmed 24731994
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada. · Urological Research Institute, Vita-Salute San Raffaele University, San Raffaele Hospital, San Raffaele Scientific Institute, Milan, Italy. · Department of Urology, University of Montreal Health Center, Montreal, Canada. · Martini-clinic, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany. · Division of Urologic Surgery and Center for Surgery and Public Health, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Pubmed 24612110
  • Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. Electronic address: · Janssen Research & Development, Los Angeles, CA, USA. · Medical University of Vienna, Vienna, Austria. · University of Montreal, Montreal, QC, Canada. · University of Washington, Seattle, WA, USA. · British Columbia Cancer Agency, Vancouver, BC, Canada. · Janssen Research & Development, Raritan, NJ, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Pubmed 24099659
  • University of Montreal Hospital Center, Montreal, Quebec, Canada. Electronic address: · Department of Urology, Charité Berlin, Berlin, Germany. · Pubmed 23506965
2013
  • Department of Oncology, Cancer Clinical Trials Centre, University of Sheffield, Weston Park Hospital, Cancer Research Centre, Sheffield, UK. · College of Medicine, Penn State Milton S. Hershey Medical Center, Hershey, PA, USA. · Clinical and Translational Oncology Research Unit, Instituto de Medicina Molecular, Lisbon, Portugal. · Department of Statistics and Actuarial Science, University of Waterloo, Waterloo, ON, Canada. · Division of Urology, Centre Hospitalier de l'Université de Montréal, Hôpital Notre-Dame, Montréal, QC, Canada. · Department of Oncology, Cancer Clinical Trials Centre, University of Sheffield, Weston Park Hospital, Cancer Research Centre, Sheffield, UK; Department of Oncology and Clinical Research, Cancer Research UK Centre, St James's Hospital, Leeds, UK. · Department of Clinical Therapeutics, University of Athens School of Medicine, Athens, Greece. · Department of Oncology, Division of Medical Oncology, McMaster University, Juravinski Cancer Centre, Hamilton, ON, Canada. · Division of Breast Oncology, Tokyo Medical University, Tokyo, Japan. · Genitourinary Malignancies Program, Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Department of Medicine, University Hospital Brugmann, ULB, Brussels, Belgium. · Pubmed 26909273
  • Matthew R. Smith, Massachusetts General Hospital Cancer Center, Boston, MA · Fred Saad, University of Montreal Hospital Center, Montreal, Quebec, Canada · Stephane Oudard, Georges Pompidou Hospital, Paris · Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France · Neal Shore, Carolina Urological Research Center, Myrtle Beach, SC · Paul Sieber, Urological Associates of Lancaster, Lancaster, PA · Bertrand Tombal, Université Catholique de Louvain Cliniques Universitaires Saint Luc, Bruxelles, Belgium · Ronaldo Damiao, Hospital Universitario Pedro Ernesto, Rio de Janeiro, Brazil · Gavin Marx, Sydney Haematology and Oncology Clinic, University of Sydney, Wahroonga, New South Wales, Australia · Kurt Miller, Charité Berlin, Berlin, Germany · Peter Van Veldhuizen, Kansas City Veterans Affairs Medical Center, Kansas City, MO · Juan Morote, Hospital Vall d'Hebron, Barcelona, Spain · and Zhishen Ye, Roger Dansey, and Carsten Goessl, Amgen, Thousand Oaks, CA. · Pubmed 24043751
  • Professor and Chair, Division of Urology, University of Montreal Hospital Center and CRCHUM, CHUM, 1560 Sherbrooke East, Montreal Quebec H2L 4M1, Canada. · Pubmed 23904859
2012
  • Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, D-20246 Hamburg, Germany. · Pubmed 22409467
  • Centre Hospitalier de l'Université de Montréal, Hôpital Notre-Dame, Montréal, QC, Canada. · Pubmed 22307372
  • Centre Hospitalier de l'Université de Montréal and CRCHUM, 1560 Sherbrooke East, Montréal, Quebec H2L 4M1, Canada. · Pubmed 21864229
  • Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada. · Pubmed 21163673
  • University of Montreal Health Center, Montreal, Quebec, Canada H2L 4M1. · Pubmed 22112794
2011
  • CRCUM-Université de Montréal, Hamilton, Ontario, Canada. · Pubmed 21788353
2010
  • Centre Hospitalier de l'Université de Montréal, Hôpital Notre-Dame, Canada. · Pubmed 21110764
  • Centre Hospitalier de l'Université de Montréal, Quebec, Canada. · Pubmed 20682370
  • Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada. · Pubmed 20489645
  • Centre Hospitalier de i'Université de Montréal, Hôpital Notre-Dame, Montréal, Quebec, Canada. · Pubmed 21056263
2019
  • Centre de recherche du CHUM (CRCHUM)/Institut du Cancer de Montréal, Montreal, Quebec, Canada. · Pubmed 30671574
2018
  • Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, Quebec, Canada. · Pubmed 30015690
  • Department of Radiation Oncology, University of Montreal Health Center, Montreal, Quebec, Canada. · Pubmed 30281009
2017
  • Division of Urology, Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada. · Pubmed 28644302
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada. · Pubmed 27486887
2015
  • a 1 Institut du cancer de Montréal, Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Quebec, Canada. · Pubmed 26313417
  • Department of Radiation Oncology, Centre hospitalier de l'Université de Montréal (CHUM), Montreal, Canada. · Pubmed 26271398
  • aFaculty of Medicine, University of Montreal bDepartment of Urology, University of Montreal Hospital Center/Centre hospitalier de l'Université de Montréal (CHUM), Montreal, Canada. · Pubmed 26262831
2014
  • aDepartment of Medical Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, New York, USA bCentre Hospitalier de I'Université de Montréal, Hôpital Notre-Dame, Montreal, Canada. · Pubmed 25166424
  • Authors' Affiliations: Royal Marsden NHS Foundation Trust and The Institute of Cancer Research UK, Sutton; Institut Català d'Oncologia, L'Hospitalet, Barcelona; University of Surrey, Surrey, United Kingdom; Yale University Cancer Center, New Haven; Centre Hospitalier de l'Universite de Montreal, Montreal; A Coruña University Hospital, A Coruña, Spain; Kantonsspital St. Gallen, St. Gallen, Switzerland; Fox Chase Cancer Center, Philadelphia, Pennsylvania; Pfizer Inc, Groton, Connecticut; and Lady Davis Institute for Medical Research, Jewish General Hospital and McGill University, Montreal, Quebec, Canada. · Pubmed 24536060
2013
  • Centre de Recherche, Centre Hospitalier de l'Université de Montréal, 1560 Sherbrooke East, Montréal, QC H2L 4M1, Canada. · Pubmed 23797341
  • Vancouver Prostate Centre and Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia bThe Division of Urology, University of Montreal Hospital Center (CHUM), University of Montreal, Montreal, Quebec, Canada. · Pubmed 23385973
  • Authors' Affiliations: Departments of Radiation Oncology, Medical Biophysics, Medical Oncology, Laboratory Medicine and Pathology and Biostatistics, University of Toronto; Radiation Medicine Program, Princess Margaret Hospital, University Health Network; Informatics and Bio-Computing Platform, Ontario Institute for Cancer Research, Toronto, Ontario; Department of Cancer Genetics and Developmental Biology, British Columbia Cancer Research Centre; Laboratory for Advanced Genome Analysis - Vancouver Prostate Centre, Vancouver, British Columbia; Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada; Center for Prostate Disease Research, Department of Surgery, Uniformed Services University of the Health Sciences, Rockville, Maryland; Division of Urology, University of Montreal Health Center, Montreal, Quebec; Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario; and Department of Pathology and Laboratory Medicine and Oncology, University of Calgary, Calgary, Alberta, Canada. · Pubmed 23918607
  • Département de Biochimie, Université de Montréal, Montréal, Québec H3C 3J7, Canada. · Pubmed 23599344
  • Centre de recherche du Centre hospitalier de l'Université de Montréal, Institut du cancer de Montréal, and Faculty of Medicine, Université de Montréal, Montréal, Québec, Canada. · Pubmed 23541563
2012
  • Centre de recherche du Centre hospitalier de l'Université de Montréal and Institut du cancer de Montréal, Montreal, Quebec, Canada. · Pubmed 22871982
  • Centre de recherche du Centre hospitalier de l'Université de Montréal and Institut du cancer de Montréal, Montreal, Quebec, Canada. · Pubmed 21932427
2011
  • Departments of Surgery and Urology, Centre Hospitalier de l'Université de Montréal, 1560 Sherbrooke East, Montreal, Quebec H2L 4M1, Canada. · Pubmed 21161451
  • Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CR-CHUM) and Institut du Cancer de Montréal, Montreal, Quebec, Canada. · Pubmed 21438025
  • Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CR-CHUM)/Institut du Cancer de Montréal, Québec, Canada. · Pubmed 21271611
2010
  • Department of Surgery/Urology, Centre Hospitalier de l'Université de Montréal, Hôpital Notre-Dame, Montréal, Quebec, Canada. · Pubmed 20224416
  • Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM) and Institut du cancer de Montréal, Montreal, Quebec, Canada. · Pubmed 20711410
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada. · Pubmed 20381269
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, QC, Canada. · Pubmed 20117287
Probable:    Miscellaneous institutions in Montreal      
2019
  • Centre de recherche du Centre hospitalier de l'Université de Montréal, Centre hospitalier de l'Université de Montréal, Montreal, Quebec, Canada. · Institut du cancer de Montréal, Montreal, Quebec, Canada. · Research Institute of the McGill University Health Centre, McGill University Health Centre, Montreal, Quebec, Canada. · Axe Oncologie, Centre de recherche du Centre hospitalier universitaire de Québec-Université Laval, Centre hospitalier universitaire de Québec-Université Laval, Quebec, Quebec, Canada. · Centre de recherche sur le cancer, Université Laval, Quebec, Quebec, Canada. · Département de chirurgie, Université Laval, Quebec, Quebec, Canada. · Vancouver Prostate Centre, Vancouver, British Columbia, Canada. · University Health Network, Toronto, Ontario, Canada. · Pubmed 31265453
2018
  • Centre de recherche du Centre hospitalier de l'Université de Montréal, Montreal, QC, Canada. · Institut du cancer de Montréal, Montreal, QC, Canada. · Department of Pathology, Centre hospitalier de l'Université de Montréal, Montreal, QC, Canada. · Department of Pathology and Cellular Biology, University of Montréal, Montreal, QC, Canada. · Department of Engineering Physics, Polytechnique Montréal, Montreal, QC, Canada. · Thayer School of Engineering, Dartmouth College, Hanover, NH, USA. · Télécom Physique Strasbourg, University of Strasbourg, Strasbourg, France. · Division of Urology, Centre hospitalier de l'Université de Montréal, Montreal, QC, Canada. · Department of Surgery, Université de Montréal, Montréal, QC, Canada. · Pubmed 29542855
  • Division of Urology, Department of Surgery, Montreal University, Montreal, Canada. · Division of Robotic Urology, Department of Surgery, "Hôpital Sacré Coeur de Montréal", Montreal, Canada. · Division of Robotic Urology, Department of Surgery, "Hôpital Saint-Luc", Montreal, Canada. · Division of Urology, Department of Surgery, Montreal University, Montreal, Canada. · Division of Robotic Urology, Department of Surgery, "Hôpital Sacré Coeur de Montréal", Montreal, Canada. · Division of Robotic Urology, Department of Surgery, "Hôpital Saint-Luc", Montreal, Canada. · Pubmed 29052761
2016
  • Matthew Smith, Massachusetts General Hospital, Boston, MA · Johann De Bono, Royal Marsden Hospital, Sutton · Syed Hussain, University of Liverpool, Liverpool, United Kingdom · Cora Sternberg, San Camillo and Forlanini Hospitals, Rome · Ugo De Giorgi, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori-Istituto di Ricovero e Cura a Carattere Scientifico, Meldola · Giorgio Cruciani, Istituto Tumori Romagna, Lugo di Romagna, Italy · Sylvestre Le Moulec, Hôpital d'Instruction des Armées Val-de-Grâce · Stéphane Oudard, European Hospital Georges Pompidou and Paris Descartes University, Paris · Antoine Thiery-Vuillemin, Jean Minjoz Hospital, Besançon · Nadine Houédé, Institut de Cancérologie du Gard-Centre Hospitalier Universitaire Caremeau, Nîmes · Karim Fizazi, Institute Gustave Roussy, University of Paris Sud, Villejuif, France · Michael Krainer, Medical University of Vienna, Vienna, Austria · Andries Bergman, Netherlands Cancer Institute, Amsterdam · Ronald De Wit, Erasmus University Medical Center and Cancer Institute, Rotterdam, the Netherlands · Wolfgang Hoelzer, Praxis für Urologie · Kurt Miller, Charité-Universitätsmedizin Berlin, Berlin · Martin Bögemann, University of Muenster Medical Center, Muenster · Susan Feyerabend, Studienpraxis Urologie, Nürtingen · Arnulf Stenzl, University Hospital, Tübingen, Germany · Fred Saad, Centre Hospitalier de I'Université de Montréal, Montreal, Quebec, Canada · Elaine Lam, University of Colorado Anschutz Medical Campus, Aurora, CO · Jonathan Polikoff, Kaiser Permanente Medical Group, San Diego · David Ramies, Colin Hessel, and Aaron Weitzman, Exelixis, South San Francisco, CA · and Paul Mainwaring, Hematology and Oncology Clinics of Australia, Brisbane, Queensland, Australia. · Pubmed 27400947
  • 1 McGill University Health Centre and Research Institute , Montréal, Canada . · 2 PROCURE Alliance , Montréal, Canada . · 3 Montréal University Health Centre , Montréal, Canada . · 4 Québec University Health Centre , Québec, Canada . · 5 Sherbrooke University Health Centre , Sherbrooke, Canada . · Pubmed 27327090
2015
  • Department of Medical Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, 111 E 210 St, Bronx, NY 10467, USA. · Centre Hospitalier de I'Université de Montréal, Montreal, Canada. · Pubmed 26445599
  • Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA. Electronic address: · Academic Unit of Clinical Oncology, Weston Park Hospital, CR-UK/YCR Sheffield Cancer Research Centre, Sheffield, UK. · Department of Genitourinary Medical Oncology, Stanford Alexander Tissue Derivatives Laboratory, David H. Koch Center for Applied Research of Genitourinary Cancers, Houston, TX, USA; Department of Clinical Therapeutics, University of Athens, Athens, Greece. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Department of Genitourinary Medical Oncology, Stanford Alexander Tissue Derivatives Laboratory, David H. Koch Center for Applied Research of Genitourinary Cancers, Houston, TX, USA. · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · Department of Internal Medicine, Section of Medical Oncology, UAB Medical Center, Birmingham, AL, USA. · Department of Medicine and Urology, Tulane University, New Orleans, LA, USA. · Centre Hospitalier de I'Université de Montréal, Montreal, Quebec, Canada. · Pubmed 26153564
2012
  • Goodman Cancer Research Centre, Montréal, Québec, Canada. · Pubmed 22282656
Probable:    Universitat Hamburg      
2012
  • Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, D-20246 Hamburg, Germany. · Pubmed 22409467
2012
  • Institute of Pathology, Prostate Cancer Center and Section for Translational Prostate Cancer Research at the Clinic of Urology at University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Pubmed 22705054
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 224 total) written by Fred Saad about Prostatic Neoplasms:

  • Improving research for prostate cancer survivorship: A statement from the Survivorship Research in Prostate Cancer (SuRECaP) working group. 2020
  • Testosterone Breakthrough Rates during Androgen Deprivation Therapy for Castration Sensitive Prostate Cancer. 2020
  • Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019. 2020
  • Survival outcomes of radical prostatectomy vs. external beam radiation therapy in prostate cancer patients with Gleason Score 9-10 at biopsy: A population-based analysis. 2020
  • Bone-targeted therapy in castration-resistant prostate cancer: where do we stand? 2019
  • Emerging therapeutic targets for patients with advanced prostate cancer. 2019
  • Radium-223 in asymptomatic patients with castration-resistant prostate cancer and bone metastases treated in an international early access program. 2019
  • Androgen Receptor Modulation Optimized for Response-Splice Variant: A Phase 3, Randomized Trial of Galeterone Versus Enzalutamide in Androgen Receptor Splice Variant-7-expressing Metastatic Castration-resistant Prostate Cancer. 2019
  • V-ATPase-associated prorenin receptor is upregulated in prostate cancer after PTEN loss. 2019
  • The Effect of Lymph Node Dissection in Metastatic Prostate Cancer Patients Treated with Radical Prostatectomy: A Contemporary Analysis of Survival and Early Postoperative Outcomes. 2019
Show List of Full Article Records
Google Searches

Learn more about Fred Saad using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Universite de Montreal
Miscellaneous institutions in Montreal
Universitat Hamburg
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Universite de Montreal
2020
  • Division of Hematology/Medical Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA. · Duke University Medical Center, Durham, NC. · University of Washington School of Medicine, Fred Hutchinson Cancer Research Center, Seattle, WA. · Department of Urology, University of California San Francisco, San Francisco, CA. · Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA. · Department of Medicine, Division of Hematology/Oncology, University of California San Diego, San Diego, CA. · Department of Psychiatry and Center for Behavior Genetics of Aging, University of California San Diego, San Diego, CA. · School of Medical and Health Sciences, Exercise Medicine Research Institute, Edith Cowan University, Joondalup, Western Australia, Australia. · Department of Medicine, University of Chicago, Chicago, IL. · Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL. · Department of Radiation Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA. · Department of Medical Oncology and Developmental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA. · Department of Medicine, Cardio-oncology Program, Vanderbilt University Medical Center, Nashville, TN. · Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA. · Department of Urology, Moores Comprehensive Cancer Center, University of California San Diego, San Diego, CA. · Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada. · Prostate Cancer Foundation, Santa Monica, CA. · Department of Hematology and Oncology, Northwestern University, Chicago, IL. · Division of Hematology, Medical Oncology, and Transplantation, University of Minnesota, Minneapolis, MN. Electronic address: · Pubmed 31734020
  • Centre Hospitalier de l'Université de Montréal, University of Montreal, Montreal, Quebec, Canada. · Mount Sinai Hospital, Princess Margaret Cancer Centre (UHN), Toronto General Hospital (UHN), University of Toronto, Toronto, Ontario, Canada. · British Colombia Cancer Agency, University of British Columbia (UBC), Vancouver, British Columbia. · McGill University, Montreal, Quebec, Canada. · McMaster University, Hamilton, Ontario, Canada. · Laval University, Quebec City, Quebec, Canada. · Kaleidoscope Strategic Inc., Toronto, Ontario, Canada. · Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada. · Pubmed 32096678
  • Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; Universita della Svizzera Italiana, Lugano, Switzerland; Cantonal Hospital, St. Gallen, Switzerland; University of Bern, Bern, Switzerland; Division of Cancer Science, University of Manchester, Manchester, UK. Electronic address: · University College London Cancer Institute, London, UK. · Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA. · Dana-Farber Cancer Institute, Boston, MA, USA; Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Department of Urology, Skåne University Hospital, Malmö, Sweden. · Genito Urinary Oncology, Prostate Brachytherapy Unit, Goustave Roussy, Paris, France. · Unit of Urology/Division of Oncology, URI, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy. · Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK; Christie NHS Trust, Manchester, UK; CRUK Manchester Institute and Cancer Centre, Manchester, UK. · BC Cancer, Vancouver Prostate Centre, University of British Columbia, Vancouver, British Columbia, Canada. · The Christie and Salford Royal Hospitals, Manchester, UK. · Monash University and Eastern Health, Victoria, Australia. · The Institute of Cancer Research/Royal Marsden NHS Foundation Trust, Surrey, UK. · Division of Haematology/Oncology, Columbia University Medical Center, New York, NY, USA. · Department of Medical Oncology, Hospital Universitario Marques de Valdecilla, IDIVAL, Santander, Cantabria, Spain. · The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · University of California Davis School of Medicine, Sacramento, CA, USA. · Policlinico S.Orsola, Università di Bologna, Italy. · University of California San Francisco, San Francisco, CA, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Department of Surgery, Monash University, Melbourne, Australia; Prostate Cancer Research Program, Monash University, Melbourne, Australia; Department Anatomy & Developmental Biology, Faculty of Nursing, Medicine & Health Sciences, Monash University, Melbourne, Australia. · Urological Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada. · Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, USA. · Department of Urology, Uro-Oncology, Robot-Assisted and Reconstructive Urology, University of Cologne, Cologne, Germany; Department of Urology, Medical University, Vienna, Austria. · Department of Oncology, Akershus University Hospital, Lørenskog, Norway. · University of Washington, Seattle, WA, USA; Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia. · Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA. · The Institute of Cancer Research, London, UK. · Division of Medical Oncology, National Cancer Centre, Singapore. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell Medical College, New York, NY, USA. · Department of Urology, American University of Beirut Medical Center, Beirut, Lebanon; Naef K. Basile Cancer Institute (NKBCI), American University of Beirut Medical Center, Beirut, Lebanon. · Oncology institute, Shamir Medical Center and Faculty of medicine, Tel-Aviv University, Israel. · Department of Genitourinary Medical Oncology, MD Anderson Cancer Centre, Houston, TX, USA; Department of Clinical Therapeutics, David H. Koch Centre, University of Athens Alexandra Hospital, Athens, Greece. · Beneficiência Portuguesa de São Paulo, São Paulo, SP, Brazil; Departamento de Oncologia, Hospital Israelita Albert Einstein, São Paulo, SP, Brazil. · UK. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · University Hospital Nord, St Etienne, France. · National Institute of Oncology, University hospital, Rabat, Morocco. · Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia. · Tata Memorial Centre, Mumbai, India. · Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, The Tisch Cancer Institute, New York, NY, USA. · Radiation Oncology, Ghent University Hospital, Ghent, Belgium. · Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, Northern Ireland, UK; Radiotherapy Department, Cancer Centre, Belfast City Hospital, Belfast, Northern Ireland, UK. · Mount Vernon Cancer Centre and Institute of Cancer Research, London, UK. · Royal Marsden Hospital and Institute of Cancer Research, Sutton, UK. · Comprehensive Oncology Centre, Hong Kong Sanatorium & Hospital, The Chinese University of Hong Kong, Hong Kong. · Department of Laboratory Medicine, University of Washington, Seattle, WA, USA. · University of California Los Angeles, Los Angeles, CA, USA. · UCSF Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Bern Center for Precision Medicine, Bern, Switzerland; Department for Biomedical Research, University of Bern, Bern, Switzerland. · Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA. · Centre Hospitalier de Université de Montréal, Montreal, Canada. · Instituto Alexander Fleming, Buenos Aires, Argentina. · Tulane Cancer Center, New Orleans, LA, USA. · Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weill Cornell Medical College, New York, NY, USA. · Carolina Urologic Research Center, Myrtle Beach, SC, USA. · Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Prostate Cancer Foundation, Santa Monica, CA, USA. · Division of Hematology and Oncology, Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, USA. · Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Toho University Sakura Medical Center, Chiba, Japan. · MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK. · Cliniques Universitaires Saint Luc, Brussels, Belgium. · Department of Urology, M.A. Aydınlar Acıbadem University, Altunizade Hospital, Istanbul, Turkey. · Radboud University Medical Center, Nijmegen, The Netherlands. · Department of Radiation Oncology, University Hospital La Princesa, Health Research Institute, Madrid, Spain. · University of Bern, Bern, Switzerland; Department of Medical Oncology and Haematology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland. · Pubmed 32001144
  • Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada. Electronic address: · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Urology Unit, ASST Spedali Civili of Brescia, Department of Medical and Surgical Specialties, Radiological Science and Public Health, University of Brescia, Italy. · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology, San Luigi Gonzaga Hospital, University of Turin, Turin, Italy. · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy. · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada. · Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy. · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Brunswick Science and Technology, Montreal, Quebec, Canada. · Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Pubmed 31653563
2019
  • Department of Urology, La Paz University Hospital, Madrid, Spain - · Instituto de Investigación Hospital Universitario La Paz (IdiPAZ), Madrid, Spain - · Department of Urology, La Paz University Hospital, Madrid, Spain. · Instituto de Investigación Hospital Universitario La Paz (IdiPAZ), Madrid, Spain. · Department of Urology, Institute Mutualiste Montsouris, Paris, France. · Department of Medical Oncology, Federico II University, Naples, Italy. · Division of Medical Oncology, Mauriziano Hospital, Turin, Italy. · Department of Oncology, University of Turin, Turin, Italy. · Virginia Commonwealth University, Richmond, VA, USA. · Tulane Cancer Center, Tulane University Medical School, New Orleans, LA, USA. · Unit of Cancer Prognostics and Health Outcomes, University of Montreal Health Center, Montreal, QC, Canada. · Department of Urology, Andros Men's and Gynos Women's Health Institutes, Arnhem, the Netherlands. · Pubmed 31353876
  • Centre Hospitalier de l'Université de Montréal/CRCHUM, Montréal, Quebec, Canada. Electronic address: · Carolina Urologic Research Center, Myrtle Beach, SC, USA. · Duke Cancer Institute, Durham, NC, USA. · Pfizer, San Diego, CA, USA. · Pfizer, New York, NY, USA. · Pubmed 30913454
  • Department of Urology, University Hospital Cologne, Cologne, Germany. · Division of Cancer Sciences, University of Manchester and the Christie, Manchester, UK. · Medical Oncology and Haematology, Kantonsspital St Gallen, St Gallen, Switzerland. · University of Bern, Bern, Switzerland. · Department of Oncology, Akershus University Hospital, Lørenskog, Norway. · Genitourinary Oncology Service, Institute of Oncology, Meir Medical Center, Kfar-Saba, Israel. · Department of Clinical Oncology, The Centre for Cancer Research and Cell Biology, Queen's University Belfast and the Northern Ireland Cancer Centre, Belfast, Northern Ireland, UK. · Department of Medical Oncology, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Department of Urology, University Hospital Carl-Gustav Carus, Dresden, Germany. · Department of Urology, Charité University Medicine Berlin, Berlin, Germany. · Pharmaceutical Division of Bayer, Whippany, NJ, USA. · Department of Oncology, Karolinska University Hospital, Stockholm, Sweden. · Department of Urology, Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, QC, Canada. · Pubmed 30612558
  • Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address: · Medical Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA. · Oncology Strategic Advisor and Board Member (formerly Tokai Pharmaceuticals), East Greenwich, RI, USA. · Vertex Pharmaceuticals (formerly Tokai Pharmaceuticals), Boston, MA, USA. · Trial Architecture Consulting, Chevy Chase, MD, USA. · Urology, University of Montreal Hospital Center, Montreal, Canada. · Urology, Johns Hopkins University, Baltimore, MD, USA. · Medical Oncology, Royal Marsden/The Institute of Cancer Research, London, UK. · Pubmed 31542304
  • Goodman Cancer Research Center, McGill University, Montréal, Québec, Canada. · Department of Biochemistry, McGill University, Montréal, Québec, Canada. · Institut de Pharmacologie de Sherbrooke, Department of Surgery and Urology, Université de Sherbrooke, Sherbrooke, Québec, Canada. · Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Institut du Cancer de Montréal, Montréal, Québec, Canada. · Department of Pathology, CHUM, Université de Montréal, Montréal, Québec, Canada. · Prostate Cancer Translational Research Laboratory, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Cancer Program, Biomedicine Discovery Institute, Department of Anatomy and Developmental Biology, Monash University, Melbourne, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia. · Department of Medicine, Université de Montréal, Montréal, Québec, Canada. · Department of Surgery, CHUM, Université de Montréal, Montréal, Québec, Canada. · Pubmed 31452834
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Division of Experimental Oncology/Unit of Urology, Urological Research Institute (URI), IRCCS San Raffaele Scientific Institute, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy. Electronic address: · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Martini Klinik, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Academic Department of Urology, IRCCS Policlinico San Donato, University of Milan, Milan, Italy. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Division of Experimental Oncology/Unit of Urology, Urological Research Institute (URI), IRCCS San Raffaele Scientific Institute, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy. · Division of Experimental Oncology/Unit of Urology, Urological Research Institute (URI), IRCCS San Raffaele Scientific Institute, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy. · Martini Klinik, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Department of Urology, Medical University of Vienna, Vienna, Austria. · Pubmed 31411992
  • Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology, University Hospital Frankfurt am Main, Frankfurt am Main, Germany. Electronic address: · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy. · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Academic Department of Urology, IRCCS Policlinico San Donato, University of Milan, Milan, Italy. · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology, SS Annunziata Hospital, "G.D'Annunzio" University of Chieti, Chieti, Italy. · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada. · Department of Urology, University Hospital Frankfurt am Main, Frankfurt am Main, Germany. · Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy. · Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Pubmed 31411975
  • Division of Urology, Centre Hospitalier de I'Université de Montréal, Montreal, Quebec, Canada. · Pubmed 31312041
  • Centre de recherche du Centre hospitalier de l'Université de Montréal, Centre hospitalier de l'Université de Montréal, Montreal, Quebec, Canada. · Institut du cancer de Montréal, Montreal, Quebec, Canada. · Research Institute of the McGill University Health Centre, McGill University Health Centre, Montreal, Quebec, Canada. · Axe Oncologie, Centre de recherche du Centre hospitalier universitaire de Québec-Université Laval, Centre hospitalier universitaire de Québec-Université Laval, Quebec, Quebec, Canada. · Centre de recherche sur le cancer, Université Laval, Quebec, Quebec, Canada. · Département de chirurgie, Université Laval, Quebec, Quebec, Canada. · Vancouver Prostate Centre, Vancouver, British Columbia, Canada. · University Health Network, Toronto, Ontario, Canada. · Pubmed 31265453
  • Goodman Cancer Research Centre, Department of Medicine, McGill University, Montréal, Québec, Canada. · Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada; Institut du Cancer de Montréal, Montréal, Québec, Canada. · Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada; Institut du Cancer de Montréal, Montréal, Québec, Canada; Department of Medicine, Université de Montréal, Montréal, Québec, Canada. · Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada; Institut du Cancer de Montréal, Montréal, Québec, Canada; Department of Surgery, Université de Montréal, Montréal, Québec, Canada. · Goodman Cancer Research Centre, Department of Medicine, McGill University, Montréal, Québec, Canada. Electronic address: · Pubmed 31202437
  • Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada. Electronic address: · Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy. · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology, European Institute of Oncology, Milan, Italy. · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Urology Unit, ASST Spedali Civili of Brescia. Department of Medical and Surgical Specialties, Radiological Science and Public Health, University of Brescia, Italy. · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology, San Luigi Gonzaga Hospital, University of Turin, Turin, Italy. · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada. · Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy. · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Division of Urology, University of Montréal Hospital Center, Montréal, Québec, Canada. · Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Pubmed 31129038
  • Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada. Electronic address: · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology, University Frankfurt am Main, Frankfurt, Germany. · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology, Division of Experimental Oncology, Urological Research Institute (URI), IRCCS San Raffaele Scientific Institute, Milan, Italy. · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology, European Institute of Oncology, Milan, Italy. · Department of Urology, Spedali Civili Hospital, University of Brescia, Brescia, Italy. · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada. · Department of Urology, Division of Experimental Oncology, Urological Research Institute (URI), IRCCS San Raffaele Scientific Institute, Milan, Italy. · Department of Urology, Medical University of Vienna, Vienna, Austria. · Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Pubmed 31103337
  • Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada. Electronic address: · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology, University Frankfurt am Main, Frankfurt, Germany. · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy. · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology, European Institute of Oncology, Milan, Italy. · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada. · Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy. · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada. · Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Pubmed 31080021
  • Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Axe Cancer, Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, QC, Canada. · T. Boone Pickens Academic Tower, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Département de pharmacologie et de physiologie, Université de Montréal, Montreal, QC, Canada. · Centre de Recherche du Centre Hospitalier Universitaire de Montréal (CRCHUM)/Institut du Cancer de Montréal, Montreal, QC, Canada. · Département d'Urologie du Centre Hospitalier Universitaire de Montréal (CHUM) et Institut du Cancer de Montréal / CRCHUM, Montreal, QC, Canada. · Centre Hospitalier de l'Université de Montréal (Département de pathologie), Département de pathologie et axe cancer, Université de Montréal (Département de pathologie et de biologie cellulaire) et Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, Canada. · NIDCR, National Institutes of Health, Bethesda, MD, USA. · Faculté de Pharmacie, Université de Montréal et Institut du Cancer de Montréal / CRCHUM, Axe Cancer, Montreal, QC, Canada. · Pubmed 31069142
  • Department of Pathology, Centre hospitalier de l'Université de Montréal, 1051 Sanguinet, Montréal, Québec, H2X 0C1, Canada. · Centre de recherche du Centre hospitalier de l'Université de Montréal and Institut du cancer de Montréal, 900 Saint-Denis, Montréal, Québec, H2X 0A9, Canada. · Department of Radiation Oncology, Centre Hospitalier de l'Université de Montréal, 1051 Sanguinet, Montréal, Québec, H2X 0C1, Canada. · Department of Medicine, Université de Montréal, Montréal, Québec, H3C 3J7, Canada. · Laboratoire d'Uro-Oncologie Expérimentale, Centre de Recherche du Centre Hospitalier Universitaire de Québec-Université-Laval, Hôpital L'Hôtel-Dieu de Québec, 10 McMahon, Québec, G1R 3S1, Canada. · Department of Urology, Centre Hospitalier de l'Université de Montréal, 1051 Sanguinet, Montréal, Québec, H2X 0C1, Canada. · Department of Urology, Centre Hospitalier Universitaire de Québec-Université-Laval, Hôpital L'Hôtel-Dieu de Québec, 11 Côte du Palais, Québec, G1R 2J6, Canada. · Department of Pathology, Centre hospitalier de l'Université de Montréal, 1051 Sanguinet, Montréal, Québec, H2X 0C1, Canada. · Centre de recherche du Centre hospitalier de l'Université de Montréal and Institut du cancer de Montréal, 900 Saint-Denis, Montréal, Québec, H2X 0A9, Canada. · Pubmed 31018850
  • Division of Urology, Department of Surgery, McGill University Health Centre, Montreal, Quebec, Canada. · Department of Oncology, McGill University, Montreal, Quebec, Canada. · Biobank, PROCURE, Mount Royal, Quebec, Canada. · Department of Surgery, Université de Montréal, Montreal, Quebec, Canada. · Department of Surgery, Université de Sherbrooke, Sherbrooke, Quebec, Canada. · Department of Surgery, Laval University, Quebec City, Quebec, Canada. · Psychosocial Oncology Program, McGill University Health Centre, Montreal, Quebec, Canada. · Pubmed 30762265
  • Division of Urology, Department of Surgery and Cancer Research Center, Centre Hospitalier Universitaire (CHU) de Québec-Université Laval, Québec, Québec, Canada. · Biochemistry Service, Medical Laboratory Department, CHU de Québec-Université Laval, Québec, Québec, Canada. · Pharmacy Faculty, Université Laval and CHU de Québec-Université Laval, Québec, Québec, Canada. · Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada. · Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada. · Pubmed 30673630
  • Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany. Electronic address: · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology and Division of Experimental Oncology, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy. · Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Academic Department of Urology, IRCCS Policlinico San Donato, University of Milan, Milan, Italy. · Department of Urology, Medical University of Vienna, Vienna, Austria. · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada. · Department of Urology and Division of Experimental Oncology, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy. · Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Pubmed 30366880
  • Division of Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy; Centre de recherche du Centre Hospitalier de l'Université de Montréal (CR-CHUM) and Institut du cancer de Montréal, Montréal, Québec, Canada. Electronic address: · Centre de recherche du Centre Hospitalier de l'Université de Montréal (CR-CHUM) and Institut du cancer de Montréal, Montréal, Québec, Canada; Academic Department of Urology, IRCCS Policlinico San Donato, University of Milan, Milan, Italy. · Centre de recherche du Centre Hospitalier de l'Université de Montréal (CR-CHUM) and Institut du cancer de Montréal, Montréal, Québec, Canada; Department of Urology, SS Annunziata Hospital, "G. D'Annunzio" University of Chieti, Chieti, Italy. · Centre de recherche du Centre Hospitalier de l'Université de Montréal (CR-CHUM) and Institut du cancer de Montréal, Montréal, Québec, Canada; Martini Klinik, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Centre de recherche du Centre Hospitalier de l'Université de Montréal (CR-CHUM) and Institut du cancer de Montréal, Montréal, Québec, Canada. · Division of Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy. · Vattikuti Urology Institute and VUI Center for Outcomes Research Analytics and Evaluation (VCORE), Henry Ford Hospital, Henry Ford Health System, Detroit, MI. · Martini Klinik, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Department of Urology, Medical University of Vienna, Vienna, Austria. · Pubmed 30342845
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, QC, Canada. · Centre de recherche du Centre Hospitalier de l'Université de Montréal (CR-CHUM) and Institut du Cancer de Montréal, Montreal, QC, Canada. · Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany. · Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, QC, Canada. · Centre de recherche du Centre Hospitalier de l'Université de Montréal (CR-CHUM) and Institut du Cancer de Montréal, Montreal, QC, Canada. · Academic Department of Urology, IRCCS Policlinico San Donato, University of Milan, Milan, Italy. · Division of Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy. · Vita-Salute San Raffaele University, Milan, Italy. · Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany. · Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Department of Urology, Medical University of Vienna, Vienna, Austria. · Pubmed 30315358
  • Department of Urology, University Hospitals Leuven, Leuven, Belgium; Nuclear Medicine & Molecular Imaging, KU Leuven, Leuven, Belgium. Electronic address: · Division of Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy. · Department of Radiation Oncology, Brigham and Women's Hospital and Dana Farber Cancer Institute, Boston, MA, USA. · Urology Service at the Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Oncology in the Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Medical Institutions, Baltimore, MD, USA. · The Vancouver Prostate Centre & Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada. · Department of Radiation Oncology, University Hospitals Leuven, Leuven, Belgium. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Urology, Centre Hospitalier de l'Université de Montréal, University of Montreal, Montreal, Quebec, Canada. · Dana-Farber Cancer Institute, Boston, MA, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Pubmed 30286948
  • Department of Urology, McGill University Health Centre, Montreal, QC, Canada. · Department of Oncology, McGill University, 5100 Boulevard de Maisonneuve West, Room 720F, Montreal, QC, H4A 3T2, Canada. · Department of Urology, McGill University Health Centre, Montreal, QC, Canada. · Cancer Research Program, McGill University Health Centre - Research Institute, Montreal, QC, Canada. · PROCURE, Mont-Royal, Montreal, QC, Canada. · Department of Oncology, McGill University, 5100 Boulevard de Maisonneuve West, Room 720F, Montreal, QC, H4A 3T2, Canada. · Department of Surgery, Université de Montréal, Montreal, QC, Canada. · Department of Surgery, Université de Sherbrooke, Sherbrooke, QC, Canada. · Department of Surgery, Laval University, Laval, QC, Canada. · Department of Pathology, McGill University, Montreal, QC, Canada. · Department of Pathology and Cell Biology, Université de Montreal, Montreal, QC, Canada. · Department of Pathology, Université de Sherbrooke, Sherbrooke, QC, Canada. · Department of Pathology, Laval University, Laval, QC, Canada. · Pubmed 30136199
  • Department of Urology, McGill University Health Centre, Montreal, QC, Canada. · Division of Cancer Epidemiology, Department of Oncology, McGill University, Montreal, QC, Canada. · Department of Pathology, McGill University Health Centre, Montreal, QC, Canada. · PROCURE, Mount Royal, QC, Canada. · Department of Surgery, Université de Montréal, Montreal, QC, Canada. · Department of Surgery, Université de Sherbrooke, Sherbrooke, QC, Canada. · Department of Surgery, Laval University, Quebec City, QC, Canada. · Department of Pathology, Laval University, Quebec City, QC, Canada. · Department of Pathology, Université de Sherbrooke, Sherbrooke, QC, Canada. · Department of Pathology and Cell Biology, Université de Montreal, Montreal, QC, Canada. · Pubmed 30113732
  • Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada. Electronic address: · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy. · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Academic Department of Urology, IRCCS Policlinico San Donato, University of Milan, Milan, Italy. · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology, SS Annunziata Hospital, "G.D'Annunzio" University of Chieti, Chieti, Italy. · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada. · Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Department of Urology, Medical University of Vienna, Vienna, Austria. · Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy. · Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Pubmed 29802052
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada. · Martini-Clinic, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany. · Department of Pathology and Cellular Biology, Université de Montréal, Montreal, Canada. · Department of Medecine, Université de Montréal, Montreal, Canada. · Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy. · Institut du Cancer de Montreal and Centre de recherche du centre hospitalier de l'Université de Montréal, Montreal, QC, Canada. · Research Institute of McGill University Health Center and Department of Surgery (Urology), McGill University, Montreal, QC, Canada. · CHU de Québec, Quebec City, Quebec, Canada. · Division of Urology, Department of Surgery, University Health Network, University of Toronto, Toronto, ON, Canada. · Vancouver Prostate Centre & Department of Urologic Science, University of British Columbia, Vancouver, BC, Canada. · Department of Surgery, Université de Montréal, Montreal, Canada. · Pubmed 29623528
  • Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Division of Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy. Electronic address: · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Academic Department of Urology, IRCCS Policlinico San Donato, University of Milan, Milan, Italy. · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology, SS Annunziata Hospital, "G. D'Annunzio" University of Chieti, Chieti, Italy. · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada. · Division of Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy. · Vattikuti Urology Institute and VUI Center for Outcomes Research Analytics and Evaluation (VCORE), Henry Ford Hospital, Henry Ford Health System, Detroit, MI, USA. · Department of Urology, Medical University of Vienna, Vienna, Austria. · Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Pubmed 29366856
  • Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, QC, Canada. Electronic address: · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, QC, Canada; Department of Urology, SS Annunziata Hospital, "G.D'Annunzio" University of Chieti, Chieti, Italy. · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, QC, Canada; Academic Department of Urology, IRCCS Policlinico San Donato, University of Milan, Milan, Italy. · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, QC, Canada; Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy. · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, QC, Canada. · Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, QC, Canada. · Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy. · VUI Center for Outcomes Research, Analytics and Evaluation, Vattikuti Urology Institute, Henry Ford Health System, Detroit, MI, USA. · Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Pubmed 29306731
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Division of Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy. Electronic address: · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology, SS Annunziata Hospital, "G. D'Annunzio" University of Chieti, Chieti, Italy. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Martini Klinik, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Academic Department of Urology, IRCCS Policlinico San Donato, University of Milan, Milan, Italy. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada. · Division of Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy. · Department of Urology, Medical University of Vienna, Vienna, Austria. · Martini Klinik, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Pubmed 29249688
2018
  • Centre Hospitalier de l'Université de Montreal, Montreal Cancer Institute/CRCHUM, Montreal, Canada. · Pubmed 30074925
  • The Royal Marsden National Health Service Foundation Trust-Institute of Cancer Research, Sutton, United Kingdom. · King's College, London, United Kingdom. · Carolina Urologic Research Center, Myrtle Beach, South Carolina. · University Hospital Heidelberg, Heidelberg, Germany. · Baylor University Medical Center, Dallas, Texas. · Skåne University Hospital, Lund, Sweden. · Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, the Netherlands. · Memorial Sloan Kettering Cancer Center, New York, New York. · Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada. · Pubmed 30326033
  • Department of Urology, University of Minnesota, Minneapolis, MN, USA. · University of Melbourne, Department of Surgery, Urology Unit and Olivia Newton-John Cancer Research Institute Austin Health, Melbourne, Victoria, Australia. · Department of Surgical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Department of Urology, University of Minnesota, Minneapolis, MN, USA. · Department of Radiation Oncology and Developmental Radiotherapeutics, University of British Columbia, Kelowna, British Columbia, Canada. · Division of Urology, Centre Hospitalier de l'Université de Montreal, University of Montreal, Montreal, Québec, Canada. · University of Melbourne, Department of Surgery, Urology Unit and Olivia Newton-John Cancer Research Institute Austin Health, Melbourne, Victoria, Australia. · Department of Surgical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Pubmed 30065357
  • Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada. · Département De Médecine Oncologique, Institut Gustave Roussy, Université Paris-Saclay, Paris, France. · Pubmed 30015691
  • Division of Urology, Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada. · Department of Medical Oncology, San Camillo-Forlanini Hospital, Rome, Italy. · Radboud University Medical Centre, Nijmegen, Netherlands. · Amgen (Europe) GmbH, Zug, Switzerland. · Service d'Urologie, Institut de Recherche Clinique, Université Catholique de Louvain, Brussels, Belgium. Electronic address: · Pubmed 29787892
  • Centre Hospitalier de l'Université de Montréal, Université de Montréal, Montreal, QC, Canada. Electronic address: · Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. · Cancer Outcomes Research Program, Lineberger Comprehensive Cancer Center, University of North Carolina, NC, USA. · University of Duisburg-Essen, German Cancer Consortium (DKTK), partner site University Hospital Essen, Essen, Germany; Ruprecht-Karls University Heidelberg, Heidelberg, Germany. · Center for Personalized Nanomedicine, University of Queensland, Brisbane, QLD, Australia. · Georges Pompidou Hospital, Paris, France. · VA Portland Health Care System, Portland and Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA. · Janssen Research & Development, Horsham, PA, USA. · Janssen Research & Development, Spring House, PA, USA. · Clinical Outcomes Solutions, Tucson, AZ, USA. · Janssen Research & Development, Raritan, NJ, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Pubmed 30213449
  • Erasmus MC Cancer Institute, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands. · Erasmus MC Cancer Institute, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands. · Janssen Research & Development, 1400 McKean Road, Spring House, PA, 19477, USA. · Janssen Research & Development BE, Turnhoutseweg 30, Beerse, Belgium. · Janssen Research & Development, 920 Route 202 South, Raritan, NJ, 08869, USA. · Janssen Research & Development, 10990 Wilshire Blvd., Suite 1200, Los Angeles, CA, 90024, USA. · Research Department of Oncology, UCL Cancer Institute, 72 Huntley Street, London, WC1E 6DD, UK. · ARENSIA Exploratory Medicine's Research Unit, The Institute of Oncology, 30 N.Testemitanu str., 2025, Chişinău, Republic of Moldova. · GHS Cancer Institute, 900 West Faris Road, Greenville, SC, 29615, USA. · Centre Hospitalier de l'Université de Montréal/CRCHUM, 900, rue St-Denis, porte R04-446, Montreal, Québec, H2X 0A9, Canada. · Pubmed 29974203
  • From the Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago (M.H.), and Astellas Pharma, Northbrook (D.P., A.K.) - both in Illinois · Institut Gustave Roussy, University of Paris Sud, Villejuif, France (K.F.) · the University of Montreal Hospital Center, Montreal (F.S.) · Herlev Hospital, Herlev, Denmark (P.R.) · Carolina Urologic Research Center, Myrtle Beach, SC (N.S.) · State University of Campinas (Unicamp), Campinas, Brazil (U.F.) · Kiev City Clinical Hospital 3, Kiev, Ukraine (P.I.) · Pfizer, San Francisco (E.D., K.M.) · and the Department of Medical Oncology, San Camillo Forlanini Hospital, Rome (C.N.S.). · Pubmed 29949494
  • The Christie and Salford Royal Hospitals, Manchester, UK. Electronic address: · Maria Skłodowska-Curie Memorial Cancer Centre, Warsaw, Poland. · Hertzen Moscow Cancer Research Institute, Moscow, Russia. · Catalan Institute of Oncology, Hospital Josep Trueta, Girona, Spain. · Velindre Cancer Centre, Cardiff University, Cardiff, UK. · Masaryk Memorial Cancer Institute, Brno, Czech Republic. · Ospedale Vito Fazzi, Lecce, Italy. · Medical University of Gdańsk, Gdańsk, Poland. · Centre Léon Bérard, Lyon, France. · Sharp HealthCare, San Diego, CA, USA. · AstraZeneca, Gaithersburg, MD, USA. · AstraZeneca, Cambridge, UK. · AstraZeneca, Macclesfield, UK. · Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada. · Pubmed 29880291
  • Division of Urology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada. Electronic address: · Division of Radiation Oncology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada. · Department of Urology, Queen's University, Kingston, Ontario, Canada. · Division of Urology, Paul Ouellette Clinic, Granby, Quebec, Canada. · Division of Urology, McMaster University, Hamilton, Ontario, Canada. · Division of Urology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada. · Division of Urology, Université de Montreal, Montreal, Quebec, Canada. · Pubmed 29534997
  • From the Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston (M.R.S.) · Centre Hospitalier de l'Université de Montréal, Université de Montréal, Montreal (F.S.) · Guy's, King's and St. Thomas' Hospitals, Great Maze Pond, London (S.C.) · Georges Pompidou Hospital, Paris (S.O.) · University of Duisburg-Essen and German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany (B.A.H.) · Veterans Affairs Portland Health Care System, Portland, and Knight Cancer Institute, Oregon Health and Science University, Portland (J.N.G.) · Spanish National Cancer Research Center, Madrid, and Hospitales Universitarios Virgen de la Victoria y Regional, Institute of Biomedical Research in Malaga, Malaga - both in Spain (D.O.) · Centre for Personalised Nanomedicine, University of Queensland, Brisbane, Australia (P.N.M.) · St. Mary's Hospital of Catholic University, Seoul, South Korea (J.Y.L.) · Yokohama City University Medical Center, Yokohama, Japan (H.U.) · Janssen Research and Development, Los Angeles (A.L.-G., G.C.T., B.M.E., Y.S., Y.C.P., W.R.R., M.K.Y.) · and Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco (E.J.S.). · Pubmed 29420164
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada; Centre de Recherche du Centre Hospitalier de l'Université de Montréal and Institut du Cancer de Montréal, Montreal, Canada; Division of Oncology/Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy. Electronic address: · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada; Centre de Recherche du Centre Hospitalier de l'Université de Montréal and Institut du Cancer de Montréal, Montreal, Canada; Martini Klinik, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada; Centre de Recherche du Centre Hospitalier de l'Université de Montréal and Institut du Cancer de Montréal, Montreal, Canada; Academic Department of Urology, IRCCS Policlinico San Donato, University of Milan, Milan, Italy. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada; Centre de Recherche du Centre Hospitalier de l'Université de Montréal and Institut du Cancer de Montréal, Montreal, Canada; Department of Urology, SS Annunziata Hospital, G. D'Annunzio University of Chieti, Chieti, Italy. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada; Centre de Recherche du Centre Hospitalier de l'Université de Montréal and Institut du Cancer de Montréal, Montreal, Canada. · Division of Oncology/Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy. · Martini Klinik, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Department of Urology, Medical University of Vienna, Vienna, Austria. · Pubmed 31102624
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Centre de recherche du Centre Hospitalier de l'Université de Montréal, Institut du cancer de Montréal, Montréal, Québec, Canada; Division of Oncology, Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy. Electronic address: · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Centre de recherche du Centre Hospitalier de l'Université de Montréal, Institut du cancer de Montréal, Montréal, Québec, Canada; Division of Oncology, Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Centre de recherche du Centre Hospitalier de l'Université de Montréal, Institut du cancer de Montréal, Montréal, Québec, Canada; Martini Klinik, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Centre de recherche du Centre Hospitalier de l'Université de Montréal, Institut du cancer de Montréal, Montréal, Québec, Canada; Academic Department of Urology, IRCCS Policlinico San Donato, University of Milan, Milan, Italy. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Centre de recherche du Centre Hospitalier de l'Université de Montréal, Institut du cancer de Montréal, Montréal, Québec, Canada; Department of Urology, SS Annunziata Hospital, G. D'Annunzio University of Chieti, Chieti, Italy. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Centre de recherche du Centre Hospitalier de l'Université de Montréal, Institut du cancer de Montréal, Montréal, Québec, Canada. · Martini Klinik, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Department of Urology, Medical University of Vienna, Vienna, Austria. · Division of Oncology, Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy. · Pubmed 31100253
  • Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada. Electronic address: · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology, SS Annunziata Hospital, G. D'Annunzio University of Chieti, Chieti, Italy. · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Academic Department of Urology, IRCCS Policlinico San Donato, University of Milan, Milan, Italy. · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology and Division of Experimental Oncology, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy. · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada. · Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Department of Urology and Division of Experimental Oncology, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy. · Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Pubmed 31100241
  • Department of Radiation Oncology, Centre hospitalier de l'Université de Montréal, Montréal, QC, Canada. · CRCHUM-Centre de recherche du Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada. · Department of Epidemiology, Biostatistics and Occupational Health, McGill University, 1020 Pine Avenue West, Montreal, QC H3A 1A2, Canada. · Lady Davis Institute for Medical Research, Jewish General Hospital, 3755 Côte Ste. Catherine, Montreal, QC H3T 1E2, Canada. · Department of Urology, University of Montreal Health Center, Montreal, Canada. · Pubmed 30471220
  • Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada. · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada. · Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy. · Academic Department of Urology, IRCCS Policlinico San Donato, University of Milan, Milan, Italy. · Department of Urology, SS Annunziata Hospital, "G. D'Annunzio" University of Chieti, Chieti, Italy. · Centre Hospitalier de l'Université de Montréal, Montreal, Canada. · Department of Urology, Medical University of Vienna, Vienna, Austria. · Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Pubmed 30425350
  • Genetics and Molecular Biology PhD Program, Emory University, Atlanta 30322, Georgia. · Department of Urology, Emory University School of Medicine, Atlanta 30322, Georgia. · Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM)/Institut du cancer de Montréal, Montreal, QC H2X 0A9, Canada. · MSTP/MD PhD, Emory University, Atlanta 30322, Georgia. · Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta 30322, Georgia. · Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta 30322, Georgia. · Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM)/Institut du cancer de Montréal, Montreal, QC H2X 0A9, Canada. · Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM)/Institut du cancer de Montréal, Montreal, QC H2X 0A9, Canada. · Division of Cancer Biology and Therapeutics, Departments of Surgery & Biomedical Sciences, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA. · Division of Cancer Biology and Therapeutics, Departments of Surgery & Biomedical Sciences, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA. · Department of Radiation Oncology, Emory University School of Medicine, Atlanta 30322, Georgia. · Winship Cancer Institute of Emory University, Atlanta 30322, Georgia. · Winship Cancer Institute of Emory University, Atlanta 30322, Georgia. · Department of Human Genetics, Emory University, Atlanta 30322, Georgia. · Department of Urology, Emory University School of Medicine, Atlanta 30322, Georgia. · Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta 30322, Georgia. · Winship Cancer Institute of Emory University, Atlanta 30322, Georgia. · Atlanta VA Medical Center, Decatur, GA 30033, USA. · Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM)/Institut du cancer de Montréal, Montreal, QC H2X 0A9, Canada. · Department of Pathology and Cellular Biology, Université de Montréal, Montreal, QC H3C 3J7, Canada. · Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM)/Institut du cancer de Montréal, Montreal, QC H2X 0A9, Canada. · Department of Medicine, Université de Montréal, Montreal, QC H3C 3J7, Canada. · Department of Urology, Emory University School of Medicine, Atlanta 30322, Georgia. · Winship Cancer Institute of Emory University, Atlanta 30322, Georgia. · Atlanta VA Medical Center, Decatur, GA 30033, USA. · Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM)/Institut du cancer de Montréal, Montreal, QC H2X 0A9, Canada. · Department of Surgery, Université de Montréal, Montreal, QC H3C 3J7, Canada. · Université de Montréal Endowed Chair in Prostate Cancer, Montreal, QC H3C 3J7, Canada. · Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta 30322, Georgia. · Winship Cancer Institute of Emory University, Atlanta 30322, Georgia. · Pubmed 30314329
  • Urologic Oncology, Studienpraxis Urologie, Steinengrabenstr. 17, Nürtingen, 72622, Germany. Electronic address: · Urologic Oncology, Centre Hospitalier de L'Université de Montréal/CRCHUM, 900 Rue St-Denis, Porte R10-464, Montréal, Québec, H2X 0A9, Canada. Electronic address: · Global Market Access Oncology, Janssen Global Services, 700 US Highway 202 South Raritan, NJ, 08869, USA. Electronic address: · Health Economics & Market Access EMEA, Janssen, 50-100 Holmers Farm Way, High Wycombe, Buckinghamshire, HP12 4EG, UK. Electronic address: · Health Economics & Market Access EMEA, Janssen, Turnhoutseweg 30, 2340, Beerse, Belgium. Electronic address: · Health Economics & Market Access EMEA, Janssen, Turnhoutseweg 30, 2340, Beerse, Belgium. Electronic address: · Clinical Oncology, Janssen Research & Development BE, Antwerpsesteenweg 15, 2340, Beerse, Belgium. Electronic address: · Modeling & Simulation, Evidera, Metro Building, Sixth Floor, 1 Butterwick, London, W6 8DL, UK. Electronic address: · Meta Research, Evidera, Metro Building, Sixth Floor, 1 Butterwick, London, W6 8DL, UK. Electronic address: · Meta Research, Evidera, Metro Building, Sixth Floor, 1 Butterwick, London, W6 8DL, UK. Electronic address: · Gustave Roussy, University of Paris Sud, 114 Rue Edouard Vaillant, 94800 Villejuif, France. Electronic address: · Pubmed 30218976
  • Institut du cancer de Montréal and Centre de recherche du Centre hospitalier de l'Université de Montréal, 900, St-Denis St, room R10-464, Montréal, Québec, H2X 0A9, Canada. · Research Institute of McGill University Health Center and Department of Surgery (Urology), McGill University, Montréal, Québec, Canada. · CHU de Québec-Université Laval and Department of Surgery, Université Laval, Québec City, Québec, Canada. · Department of Pathology, McGill University Health Centre, Montréal, Québec, Canada. · Department of Medical Biophysics and Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada. · University Health Network, Toronto, ON, Canada. · University of Manitoba and Manitoba Prostate Centre, Winnipeg, MB, Canada. · Vancouver Prostate Centre, Vancouver, BC, Canada. · Division of Urology, Department of Surgery of University Health Network, University of Toronto, Toronto, ON, Canada. · Department of Urologic Sciences, Vancouver, BC, Canada. · Cancer Prognostics and Health Outcomes Unit, Centre hospitalier de l'Université de Montréal, Montréal, Québec, Canada. · Department of Surgery, Université de Montréal, Montréal, Québec, Canada. · Sunnybrook Health Sciences Centre, Toronto, ON, Canada. · Department of Pathology and Molecular Medicine, Queen's University, Kingston, ON, Canada. · Department of Genetics and Pathology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil. · Department of Pathology and Cellular Biology, Université de Montréal, Montréal, Québec, Canada. · Department of Medicine, Université de Montréal, Montréal, Québec, Canada. · Institut du cancer de Montréal and Centre de recherche du Centre hospitalier de l'Université de Montréal, 900, St-Denis St, room R10-464, Montréal, Québec, H2X 0A9, Canada. · Department of Surgery, Université de Montréal, Montréal, Québec, Canada. · Pubmed 30200929
  • Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada. · Academic Department of Urology, IRCCS Policlinico San Donato, University of Milan, Milan, Italy. · Department of Urology and Division of Experimental Oncology, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy. · Department of Urology, SS Annunziata Hospital, "G.D'Annunzio" University of Chieti, Chieti, Italy. · Department of Urology, University Hospital Frankfurt am Main, Frankfurt am Main, Germany. · Department of Urology, Medical University of Vienna, Vienna, Austria. · Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Pubmed 30146729
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CR-CHUM), Montréal, Québec, Canada; Institut du Cancer de Montréal, Montréal, Québec, Canada; Martini-Klinik, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Electronic address: · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CR-CHUM), Montréal, Québec, Canada; Institut du Cancer de Montréal, Montréal, Québec, Canada; Division of Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CR-CHUM), Montréal, Québec, Canada; Institut du Cancer de Montréal, Montréal, Québec, Canada; Academic Department of Urology, IRCCS Policlinico San Donato, University of Milan, Milan, Italy. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology, SS Annunziata Hospital, "G. D'Annunzio" University of Chieti, Chieti, Italy. · Martini-Klinik, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CR-CHUM), Montréal, Québec, Canada; Institut du Cancer de Montréal, Montréal, Québec, Canada. · Division of Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy. · Department of Urology, Medical University of Vienna, Vienna, Austria. · Martini-Klinik, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Pubmed 30037529
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Division of Oncology, Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy. Electronic address: · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Martini Klinik, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Academic Department of Urology, IRCCS Policlinico San Donato, University of Milan, Milan, Italy. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Division of Oncology, Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy. · Division of Oncology, Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy. · Martini Klinik, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Department of Urology, Medical University of Vienna, Vienna, Austria. · Pubmed 29954690
  • Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Division of Urology, Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada. Electronic address: · Division of Urology, Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Academic Department of Urology, IRCCS Policlinico San Donato, University of Milan, Milan, Italy. · Division of Urology, Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy. · Division of Urology, Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology, SS Annunziata Hospital, "G.D'Annunzio" University of Chieti, Chieti, Italy. · Division of Urology, Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada. · Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy. · Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Pubmed 29887241
  • Sunnybrook Health Sciences Centre, 2075 Bayview Ave, Toronto, ON, Canada. · Bloomberg Faculty of Nursing, University of Toronto, Toronto, ON, Canada. · Institut du cancer de Montréal and Centre de recherche du Centre hospitalier de l'Université de Montréal, 900, St Denis St, Montréal, QC, Canada. · McGill University and McGill University Health Centre, 1001 Decarie Blvd, Montreal, QC, Canada. · Manitoba Prostate Centre, 675 McDermot Ave, Winnipeg, MB, Canada. · University Health Network, 610 University Ave, Toronto, ON, Canada. · Department of Surgery Université de Montréal, 2900 Edouard Montpetit Blvd, Montreal, QC, Canada. · Vancouver Prostate Centre, 2660 Oak St, Vancouver, BC, Canada. · Terry Fox Research Institute, 675 West 10th Avenue, Vancouver, BC, Canada. · Institut du cancer de Montréal and Centre de recherche du Centre hospitalier de l'Université de Montréal, 900, St Denis St, Montréal, QC, Canada. · Department of Surgery Université de Montréal, 2900 Edouard Montpetit Blvd, Montreal, QC, Canada. · U of M Endowed Chair in Prostate Cancer, University of Montreal Hospital Center (CHUM), Montreal Cancer Institute/CRCHUM, CHUM - Pavillon R, 900, rue St-Denis, porte R10-464, Montréal, QC, H2X 0A9, Canada. · Department of Medicine, Université de Montréal, 2900 Edouard-Montpetit Blvd, Montreal, QC, Canada. · Pubmed 29884180
  • University of Montreal Hospital Center, Montreal, Quebec, Canada. · Pubmed 29799991
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Centre de recherche du Centre Hospitalier de l'Université de Montréal (CR-CHUM) and Institut du cancer de Montréal, Montréal, Québec, Canada; Academic Department of Urology, IRCCS Policlinico San Donato, University of Milan, Milan, Italy. Electronic address: · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Centre de recherche du Centre Hospitalier de l'Université de Montréal (CR-CHUM) and Institut du cancer de Montréal, Montréal, Québec, Canada; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg- Eppendorf, Hamburg, Germany. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Centre de recherche du Centre Hospitalier de l'Université de Montréal (CR-CHUM) and Institut du cancer de Montréal, Montréal, Québec, Canada; Division of Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy, Vita-Salute San Raffaele University, Milan, Italy. · Centre de recherche du Centre Hospitalier de l'Université de Montréal (CR-CHUM) and Institut du cancer de Montréal, Montréal, Québec, Canada. · Department of Urology, Istituto Europeo di Oncologia, Milan, Italy. · Department of Urology, Medical University of Vienna, Vienna, Austria. · Martini-Klinik Prostate Cancer Center, University Hospital Hamburg- Eppendorf, Hamburg, Germany. · Martini-Klinik Prostate Cancer Center, University Hospital Hamburg- Eppendorf, Hamburg, Germany; Department of Urology, University Hospital Hamburg- Eppendorf, Hamburg, Germany. · Department of Urology, IRCCS Fondazione Ca' Granda-Ospedale Maggiore Policlinico University of Milan, Milan, Italy. · Division of Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy, Vita-Salute San Raffaele University, Milan, Italy. · Academic Department of Urology, IRCCS Policlinico San Donato, University of Milan, Milan, Italy. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Centre de recherche du Centre Hospitalier de l'Université de Montréal (CR-CHUM) and Institut du cancer de Montréal, Montréal, Québec, Canada. · Pubmed 29784507
  • Exercise Medicine Research Institute, Edith Cowan University, Perth, Western Australia, Australia. · School of Human Movement and Nutrition Sciences, University of Queensland, Brisbane, Queensland, Australia. · School of Medical and Health Science, Edith Cowan University, Perth, Western Australia, Australia. · Department of Urology, University of California San Francisco, San Francisco, California, USA. · Institute for Health Research, University of Notre Dame Australia, Fremantle, Western Australia, Australia. · Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USA. · Faculty of Kinesiology, Sport, and Recreation, University of Alberta, Edmonton, Alberta, Canada. · Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK. · School of Medicine, Trinity College Dublin, Dublin, Ireland. · University Hospitals Bristol, NHS Foundation Trust, Bristol, UK. · Institute for Health Promotion Research, University of Texas Health, San Antonio, Texas, UK. · Department of Epidemiology, Harvard TH Chan School of Public Health, Boston, Massachusetts, USA. · Division of Gerontology and Geriatric Medicine, University of Washington, Seattle, Washington, USA. · University of Canberra Research Institute for Sport and Exercise, University of Canberra, Canberra, Australia. · Cancer Trials Ireland, Dublin, Ireland. · Movember Foundation, Melbourne, Victoria, Australia. · Department of Medicine, University of California San Francisco, San Francisco, California, USA. · Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA. · Department of Urology, Centre Hospitalier de L'Universite de Montreal, Montreal, Quebec, Canada. · Pubmed 29764892
  • Urology, Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada. · Pubmed 29750917
  • Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada. · Département de Radiologie, Radio-oncologie et Médecine Nucléaire, Université de Montréal, Montréal, Québec, Canada. · Département de Chirurgie, Service d'urologie, Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada. · Pubmed 29722070
  • Division of Oncology/Unit of Urology URI, IRCCS Ospedale San Raffaele, Via Olgettina 60, 20132, Milan, MI, Italy. · Vita-Salute San Raffaele University, Milan, Italy. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, QC, Canada. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, QC, Canada. · Department of Urology, SS Annunziata Hospital, "G. D'Annunzio" University of Chieti, Chieti, Italy. · Martini Klinik, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Division of Oncology/Unit of Urology URI, IRCCS Ospedale San Raffaele, Via Olgettina 60, 20132, Milan, MI, Italy. · Vita-Salute San Raffaele University, Milan, Italy. · Department of Urology, Medical University of Vienna, Vienna, Austria. · Pubmed 29717358
  • Department of Pathology, Centre hospitalier de l'Université de Montréal (CHUM), Montréal, Québec, Canada. · Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Institut du cancer de Montréal, Montréal, Québec, Canada. · CHU de Québec-Université Laval, Québec, Canada. · Département de Médecine, Faculté de Médecine, Université de Montréal, Montréal, Montréal, Canada. · Laboratoire d'Uro-Oncologie Expérimentale, Centre de recherche du CHU de Québec-Université Laval, Hôpital L'Hôtel-Dieu de Québec, Québec, Canada. · Department of Urology, Centre Hospitalier de l'Université de Montréal (CHUM), Québec, Canada. · Pubmed 29603326
  • Centre de recherche du Centre hospitalier de l'Université de Montréal, Montreal, QC, Canada. · Institut du cancer de Montréal, Montreal, QC, Canada. · Department of Pathology, Centre hospitalier de l'Université de Montréal, Montreal, QC, Canada. · Department of Pathology and Cellular Biology, University of Montréal, Montreal, QC, Canada. · Department of Engineering Physics, Polytechnique Montréal, Montreal, QC, Canada. · Thayer School of Engineering, Dartmouth College, Hanover, NH, USA. · Télécom Physique Strasbourg, University of Strasbourg, Strasbourg, France. · Division of Urology, Centre hospitalier de l'Université de Montréal, Montreal, QC, Canada. · Department of Surgery, Université de Montréal, Montréal, QC, Canada. · Pubmed 29542855
  • Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada. · Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy. · Department of Urology, SS Annunziata Hospital, "G.D'Annunzio" University of Chieti, Chieti, Italy. · Academic Department of Urology, IRCCS Policlinico San Donato, University of Milan, Milan, Italy. · Department of Urology, Medical University of Vienna, Vienna, Austria. · Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Pubmed 29460290
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Division of Oncology/Unit of Urology; Urological Research Institute; IRCCS Ospedale San Raffaele, Milan, Italy. Electronic address: · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Division of Oncology/Unit of Urology; Urological Research Institute; IRCCS Ospedale San Raffaele, Milan, Italy. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Martini-Clinic, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology, University of Montreal Health Center, Montreal, Quebec, Canada. · Division of Oncology/Unit of Urology; Urological Research Institute; IRCCS Ospedale San Raffaele, Milan, Italy. · Martini-Clinic, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany. · Department of Urology, University of Montreal Health Center, Montreal, Quebec, Canada. · Pubmed 29426698
  • Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, QC, Canada. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, QC, Canada. · Department of Urology, University of Montreal Health Center, Montreal, QC, Canada. · Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy. · Department of Urology, SS Annunziata Hospital, "G.D'Annunzio" University of Chieti, Chieti, Italy. · Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Department of Urology, Academic Hospital Braunschweig, Braunschweig, Germany. · Department of Urology, University of Vienna, Vienna, Austria. · Pubmed 29339806
  • Glenn Heller, Martin Fleisher, and Howard I. Scher, Memorial Sloan Kettering Cancer Center · Howard I. Scher, Weill Cornell Medical College, New York, NY · Robert McCormack, Janssen Research & Development, Raritan, NJ · Thian Kheoh and Arturo Molina, Janssen Research & Development, Los Angeles · Dana T. Aftab, Exelixis, South San Francisco · Mohammad Hirmand, Medivation, San Francisco, CA · Matthew R. Smith, Massachusetts General Hospital, Boston · Ana Limon, Takeda Oncology, Cambridge, MA · Robert Dreicer, University of Virginia Medical School, Charlottesville, VA · Fred Saad, University of Montreal, Montreal, Quebec, Canada · Ronald de Wit, Erasmus Medical Center, Rotterdam, the Netherlands · Karim Fizazi, Institut Gustave Roussy, Villejuif, and University of Paris Sud, Orsay, France · and Johann S. de Bono, The Institute of Cancer Research, and The Royal Marsden Hospital, Sutton, Surrey, United Kingdom. · Pubmed 29272162
  • Division of Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Via Olgettina 60, 20132, Milan, MI, Italy. · Vita-Salute San Raffaele University, Milan, Italy. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, QC, Canada. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, QC, Canada. · Martini Klinik, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Department of Urology, SS Annunziata Hospital, "G. D'Annunzio" University of Chieti, Chieti, Italy. · Division of Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Via Olgettina 60, 20132, Milan, MI, Italy. · Vita-Salute San Raffaele University, Milan, Italy. · Department of Urology, ASL Abruzzo 2, Chieti, Italy. · Pubmed 29129028
  • Division of Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele and Vita-Salute San Raffaele University, Milan, Italy. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, QC, Canada. · Department of Urology, SS Annunziata Hospital, 'G. D'Annunzio' University of Chieti, Chieti, Italy. · Martini Klinik, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Vattikuti Urology Institute and VUI Center for Outcomes Research Analytics and Evaluation (VCORE), Henry Ford Hospital, Henry Ford Health System, Detroit, MI, USA. · Department of Urology, Medical University of Vienna, Vienna, Austria. · Pubmed 29124911
  • Division of Oncology/Unit of Urology URI, IRCCS Ospedale San Raffaele, Via Olgettina 60, 20132, Milan, MI, Italy. · Vita-Salute San Raffaele University, Milan, Italy. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, QC, Canada. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, QC, Canada. · Martini Klinik, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Department of Urology, SS Annunziata Hospital, "G. D'Annunzio" University of Chieti, Chieti, Italy. · Division of Oncology/Unit of Urology URI, IRCCS Ospedale San Raffaele, Via Olgettina 60, 20132, Milan, MI, Italy. · Department of Urology, Medical University of Vienna, Vienna, Austria. · Pubmed 29063268
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada; Division of Oncology/Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy. Electronic address: · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada; Department of Urology, University of Montreal Health Center, Montreal, Canada. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada; Martini-Clinic, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany. · Division of Oncology/Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Canada. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada. · Department of Urology, University of Montreal Health Center, Montreal, Canada. · Martini-Clinic, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany. · Pubmed 28753853
  • Department of Medical Oncology, Cantonal Hospital St. Gallen and University of Berne, Switzerland. Electronic address: · Department of Medical Oncology, The Institute of Cancer Research/Royal Marsden, London, UK. · Oregon Health & Science University Knight Cancer Institute, OR, USA. · Department of Medical Oncology, Weill Cornell Medicine, New York, NY, USA. · Department of Radiation Oncology, Genito Urinary Oncology, Prostate Brachytherapy Unit, Goustave Roussy, Paris, France. · Department of Radiation Oncology, Princess Margaret Cancer Centre and University of Toronto, Toronto, ON, USA. · Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, New York, NY, USA. · Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain. · Department of Urology, Gangnam Severance Hospital, Yonsei University Health System, Seoul, Korea. · Department of Urology, The Christie and Salford Royal Hospitals, Manchester, UK. · Department of Medical Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark. · Monash University and Eastern Health, Eastern Health Clinical School, Box Hill, Australia. · Department of Urology, Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil. · Department of Medical Oncology, Division of Haematology/Oncology, Columbia University Medical Center, New York, NY, USA. · Department of Clinical Oncology and Genetics, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK. · Department of Medical Oncology, University of Texas MD Anderson Cancer Center, TX, USA. · Department of Urology, University of California, Davis School of Medicine, CA, USA. · Department of Nuclear Medicine, Policlinico S. Orsola, Università di Bologna, Italy. · Department of Radiation Oncology, University of California, San Francisco, CA, USA. · Department of Medical Oncology, Gustave Roussy, University of Paris Sud, Paris, France. · Department of Surgery, Department of Anatomy and Developmental Biology, Faculty of Medicine, Nursing and Health Sciences, Monash University. · Department of Urology, Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada. · Department of Clinical trials and Statistics, Duke University, Durham, NC, USA. · Department of Urology, University Hospital Köln, Köln, Germany. · Department of Medicine, Division of Medical Oncology, University of Washington and Fred Hutchinson Cancer Research Center, WA, USA. · Department of Clinical Oncology, Clinical Oncology Queen Elizabeth Hospital Birmingham and University of Birmingham, Birmingham, UK. · Department of Medical Oncology, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Department of Clinical Oncology, Tampere University Hospital, Faculty of Medicine and Life Sciences, University of Tampere, Finland. · Department of Urology, American University of Beirut Medical Center, Beirut, Lebanon. · Department of Urology, Medical University of Vienna, Vienna, Austria. · Department of Genitourinary Medical Oncology, MD Anderson Cancer Centre, Houston, TX, USA. · Department of Medical Oncology Hospital Israelita Albert Einstein and Department of Medical Oncology Beneficência Portuguesa de São Paulo. · Department of Medical Oncology and Epidemiology, Vanderbilt University Medical Center, Division of Hematology/Oncology, Nashville, TN, USA. · Department of Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Urology, University Hospital Nord St. Etienne, St. Etienne, France. · Department of Radiation Oncology, Tata Memorial Centre, Mumbai, India. · Department of Medical Oncology, Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, The Tisch Cancer Institute, New York, NY, USA. · Department of Radiation Oncology, Ghent University Hospital, Ghent, Belgium. · Department of Radiology, Mount Vernon Cancer Centre and Institute of Cancer Research, London, UK. · Department of Clinical Oncology, Royal Marsden NHS Foundation Trust, Sutton, UK. · Department of Pathology, University of Washington, WA, USA. · Department of Pathology, University of Bern and the Inselspital, Bern (CH). · Department of Medical Oncology, Clinical Medicine and Urology at the Helen Diller Family Comprehensive Cancer Center at the University of, California, San Francisco, CA, USA. · Department of Urology, Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada. · Department of Medical Oncology, Tulane Cancer Center, New Orleans, LA, USA. · Department of Medical Oncology, Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Centre, New York, NY, USA. · Department of Medical Oncology, Department of Oncology, Assaf Harofeh Medical Centre, Tel-Aviv University, Sackler School of Medicine, Zerifin, Israel. · Department of Urology, Carolina Urologic Research Center, Myrtle Beach, SC, USA. · Department of Medical Oncology, Massachusetts General Hospital Cancer Centre, Boston, MA, USA. · Prostate Cancer Foundation, Santa Monica, CA, USA. · Department of Medical Oncology, San Camillo Forlanini Hospital, Rome, Italy. · Department of Urology, Toho University Sakura Medical Center, Japan. · Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK. · Department of Medical Oncology, Princess Margaret Cancer Centre and University of Toronto, Toronto, ON, Canada. · Department of Urology, Cliniques Universitaires Saint Luc, Brussels, Belgium. · Department of Oncology and Haemato-oncology, Università degli Studi di Milano. Radiation Oncology 1, Prostate Cancer Program, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Department of Radiation Oncology, Klinik für Strahlentherapie und Radioonkologie des Universitätsklinikum Ulm, Albert-Einstein-Allee, Ulm, Germany. · Department of Medical Oncology, Cantonal Hospital St. Gallen and University of Berne, Switzerland. · Pubmed 28655541
  • Robert H. Lurie Comprehensive Cancer Center, Chicago, IL · University of Montreal Hospital Center, Montreal, QC, Canada · San Camillo Forlanini Hospital, Rome, Italy · Pubmed 30281993
  • Glenn Heller, Memorial Sloan Kettering Cancer Center, New York, NY · Robert McCormack and Thian Kheoh, Janssen Research & Development, Raritan, NJ · Arturo Molina, Janssen Research & Development, Los Angeles, CA · Matthew R. Smith, Massachusetts General Hospital, Boston, MA · Robert Dreicer, University of Virginia Medical School, Charlottesville, VA · Fred Saad, University of Montreal, Montreal, Quebec, Canada · Ronald de Wit, Erasmus Medical Center, Rotterdam, Netherlands · Dana T. Aftab, Exelixis, South San Francisco, CA · Mohammed Hirmand, Medivation, San Francisco, CA · Ana Limon-Carrera, Takeda Oncology, Cambridge, MA · Karim Fizazi, Institut Gustave Roussy, Villejuif, and University of Paris Sud, Orsay, France · Martin Fleisher, Memorial Sloan Kettering Cancer Center, New York, NY · Johann S. de Bono, The Institute of Cancer Research, and The Royal Marsden Hospital, Sutton, Surrey, United Kingdom · and Howard I. Scher, Memorial Sloan Kettering Cancer Center, and Weill Cornell Medical College, New York, NY. · Pubmed 29894273
2017
  • University of Montreal Hospital Center (CHUM), Montreal, Quebec, Canada. · Pubmed 28657926
  • Fred Saad, Centre Hospitalier de l'Université de Montréal, Université de Montréal, Montreal, Quebec, Canada. · Pubmed 28300482
  • Carolina Urologic Research Center, Myrtle Beach, SC. Electronic address: · Department of Urology, Uro-Oncology, Robot-assisted and Reconstructive Urological Surgery, University Hospital of Cologne, Cologne, Germany. · Department of Urology, Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada. · Pubmed 28797685
  • University of Colorado, Denver, CO. Electronic address: · Yale University, New Haven, CT. · Carolina Urologic Research Center, Myrtle Beach, SC. · Centre Hospitalier de L'Universite de Montreal, Montreal, QC, Canada. · Memorial Sloan Kettering Cancer Center, New York, NY. · Comprehensive Cancer Centers of Nevada, Las Vegas, NV. · Medical University of South Carolina, Charleston, SC. · Banner MD Anderson Cancer Center, Gilbert, AZ. · Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA. · Queen's University Belfast, Belfast, Northern Ireland, UK. · Université Catholique de Louvain, Brussels, Belgium. · Comprehensive Prostate Center, Nashville, TN. · Lancaster Urology, Lancaster, PA. · Icahn School of Medicine at Mount Sinai, New York, NY. · NRG Immunotherapy and Immunomodulation Committee, Scottsdale, AZ. · University of Washington, Seattle, WA. · Pubmed 28302580
  • OHSU Knight Cancer Institute, Portland, OR, USA. Electronic address: · Juravinski Cancer Centre, Hamilton, ON, Canada. · Centre Hospitalier de l'Université de Montréal, Institut du Cancer de Montréal, Montréal, QC, Canada. · P A Herzen Moscow Cancer Research Institute, Ministry of Healthcare of the Russian Federation, Moscow, Russia. · N N Blokhin Cancer Research Center, Ministry of Healthcare of the Russian Federation, Moscow, Russia. · Centre Leon Berard, Lyon, France. · Institute Paoli-Calmettes, Marseille, France. · Centre François Baclesse, Caen, France. · University of British Columbia, BC Cancer Agency-Vancouver Centre, Vancouver, BC, Canada. · The Clatterbridge Cancer Centre, Bebington, UK. · Trial Architecture Consulting, Washington, DC, USA. · OncoGenex Pharmaceuticals, Bothell, WA, USA. · Gustave Roussy, University of Paris Saclay, Villejuif, France. · Pubmed 29033099
  • Stéphane Oudard, Georges Pompidou European Hospital, Rene Descartes University · Mustapha Chadjaa · Sanofi, Paris · Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif · Antoine Thiery-Vuillemin, Centre Hospitalier Universitaire Minjoz Besançon, Besançon, France · Lisa Sengeløv, Herlev Hospital, Herlev · Gedske Daugaard, Copenhagen University Hospital, Rigshospitalet, Copenhagen · Steinbjørn Hansen, Odense University Hospital, Odense, Denmark · Fred Saad, Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada · Marie Hjälm-Eriksson, Karolinska University Hospital, Stockholm, Sweden · Jacek Jassem, Medical University of Gdansk, Gdansk, Poland · Orazio Caffo, Santa Chiara Hospital, Trento, Italy · Daniel Castellano, University Hospital 12 de Octubre, Madrid, Spain · Paul N. Mainwaring, Icon Cancer Care, Brisbane, Queensland, Australia · John Bernard, Sanofi, Cambridge, MA · Liji Shen, Sanofi, Bridgewater, NJ · and Oliver Sartor, Tulane Cancer Center, New Orleans, LA. · Pubmed 28753384
  • Emmanuel S. Antonarakis and Mario A. Eisenberger, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD · Scott T. Tagawa, Giuseppe Galletti, Daniel Worroll, Karla Ballman, Ada Gjyrezi, Shinsuke Tasaki, Luigi Portella, Yang Bai, Brian J. Kirby, David M. Nanus, and Paraskevi Giannakakou, Weill Cornell Medicine/Meyer Cancer Center · Che-Kai Tsao, Mount Sinai Medical Center, New York · Timothy B. Lannin, Shalu Suri, Conor N. Gruber, Erica D. Pratt, and Brian J. Kirby, Cornell University, Ithaca, NY · Marie Vanhuyse, Medical Oncology, Montréal General Hospital · Fred Saad, University of Montreal Hospital Center, Montreal · John Stewart, Atef Zaher, and Wei Zhou, Sanofi, Laval, Quebec, Canada · Guru Sonpavde, University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL · Scott North, University of Alberta, Cross Cancer Institute, Edmonton, Alberta, Canada · Costantine Albany, Indiana University School of Medicine, Indianapolis, IN · and Ted Szatrowski, Sanofi, Bridgewater, NJ. · Pubmed 28632486
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada; Martini Clinic, Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany. Electronic address: · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada; Department of Urology, University of Montreal Health Center, Montreal, Canada. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada; Department of Urology and Division of Experimental Oncology, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy. · Department of Urology, University of Montreal Health Center, Montreal, Canada. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada; Department of Urology, SS Annunziata Hospital, G.D. Annunzio University of Chieti, Chieti, Italy. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada; Martini Clinic, Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Department of Urology, Academic Hospital Braunschweig, Braunschweig, Germany. · Department of Radiation Oncology, University of Montreal Health Center, Montreal, Canada. · Martini Clinic, Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Martini Clinic, Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Pubmed 28546065
  • Department of Medicine, Division of Medical Oncology, University of British Columbia, BC Cancer Agency, Vancouver Prostate Centre, Vancouver, BC, Canada. Electronic address: · Department of Medicine, Division of Medical Oncology, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Trial Architecture Consulting, Washington, DC, USA. · Centre Antoine Lacassagne, Nice, France. · Florida Cancer Specialists, Fort Myers, FL, USA. · Department of Urology, Tübingen, Germany. · Institut Paoli Calmette, Department of Cancer Medicine, Marseille, France. · Department of Urology, University Hospital Schleswig-Holstein, Lübeck, Germany. · University of Tübingen, Tübingen, Germany. · Netherlands Cancer Institute and Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands. · Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, ON, Canada. · Durham Regional Cancer Centre, Oshawa, ON, Canada. · Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada. · OncoGenex Pharmaceuticals, Bothell, WA, USA. · Department of Medicine, Division of Medical Oncology, University of British Columbia, BC Cancer Agency, Vancouver Prostate Centre, Vancouver, BC, Canada. · Drug Development Unit, Royal Marsden Hospital and Institute of Cancer Research, London, UK. · Pubmed 28283282
  • Tomasz M. Beer, Oregon Health and Science University, Portland, OR · Eugene D. Kwon, Mayo Clinic, Rochester, MN · Charles G. Drake, Johns Hopkins University, Baltimore, MD · Karim Fizazi, University of Paris-Sud, Villejuif · Gwenaelle Gravis, Institut Paoli-Calmettes, Marseille, France · Christopher Logothetis, University of Texas MD Anderson Cancer Center, Houston, TX · Vinod Ganju, Monash University, Melbourne, Victoria · Siobhan S. Ng, St John of God Hospital, Subiaco, Western Australia · Francis X. Parnis, Adelaide Cancer Centre, Adelaide, South Australia, Australia · Jonathan Polikoff, Southern California Permanente Medical Group, San Marcos, CA · Fred Saad, Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada · Piotr Humanski, Niepubliczny Zaklad Opieki Zdrowotnej Specjalista, Kutno, Poland · Josep M. Piulats, Institut Català d'Oncologia, Barcelona · Javier Puente, Hospital Clínico San Carlos, Madrid, Spain · Pablo Gonzalez Mella, Instituto Oncologico, Viña del Mar · Pablo Gonzalez Mella, Fundación Arturo Lopez Pérez, Santiago, Chile · Dirk Jaeger, University Hospital, Heidelberg, Germany · Fabio A. Franke, Hospital de Caridade de Ijuí, Ijuí, Brazil · Roman Carvajal, Hospital Regional Valentin Gomez Farias, Zapopan, Mexico · Lisa Sengeløv, Herlev Hospital, Herlev, Denmark · M. Brent McHenry, Bristol-Myers Squibb, Wallingford, CT · Arvind Varma, DOCS Inc, New York, NY · Alfonsus J. van den Eertwegh, VU University Medical Center, Amsterdam · and Winald Gerritsen, Radboud University, Nijmegen, the Netherlands. · Pubmed 28034081
  • Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Cancer Medicine, Institute Gustave Roussy, Villejuif, France. · Department of Oncology, University of Paris, Paris, France. · Janssen Oncology Research & Development, Raritan, New Jersey. · Janssen Research & Development, Menlo Park, California. · Millennium Pharmaceuticals Inc., Cambridge, Massachusetts. · Department of Surgery, University of Montréal, Montréal, Québec, Canada. · Prostate Cancer Targeted Therapy Group, The Institute of Cancer Research and the Royal Marsden NHS Foundation Trust, London, United Kingdom. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Medicine, Weill Cornell Medical College, New York, New York. · Pubmed 27678453
  • Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA. Electronic address: · Duke Cancer Institute, Durham, NC, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Institut Gustave-Roussy, Villejuif, France. · San Camillo and Forlanini Hospitals, Rome, Italy. · University of Washington, Seattle Cancer Care Alliance, Seattle, WA, USA. · Rigshospitalet, Copenhagen, Denmark. · UC Davis Cancer Center, Sacramento, CA, USA. · Asan Medical Center, Seoul, Korea. · Nippon Medical School, Tokyo, Japan. · Charité Universitätsmedizin, Berlin, Germany. · University of Montreal Hospital Center, Montreal, QC, Canada. · Skåne University Hospital, Malmö, Sweden. · Aarhus University Hospital, Aarhus, Denmark. · Radboud University Medical Center, Nijmegen, Netherlands. · Tampere University Hospital and University of Tampere, Tampere, Finland. · Medivation, San Francisco, CA, USA. · Astellas Pharma Europe, Leiden, The Netherlands. · Cliniques Universitaires Saint-Luc, Brussels, Belgium. · Pubmed 27477525
  • Janssen Research & Development, 920 Route 202, Raritan, NJ, 08869, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Janssen Research & Development, a Division of Janssen Pharmaceutica NV, Beerse, Belgium. · Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA. · University of Montréal, Montréal, QC, Canada. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, 920 Route 202, Raritan, NJ, 08869, USA. · Pubmed 27324190
  • Sunnybrook Health Sciences Centre, 2075 Bayview Ave, Toronto, ON, Canada. · Institut du cancer de Montréal and Centre de recherche du Centre hospitalier de l'Université de Montréal, 900 St Denis St, Montreal, QC, Canada. · McGill University and McGill University Health Centre, 1001 Decarie Blvd, Montreal, QC, Canada. · University Health Network, 610 University Ave, Toronto, ON, Canada. · Manitoba Prostate Centre, 675 McDermot Ave, Winnipeg, MB, Canada. · Department of Surgery Université de Montréal, 2900 Edouard Montpetit Blvd, Montreal, QC, Canada. · Terrry Fox Research Institute, 675 West 10th Avenue, Vancouver, BC, Canada. · Vancouver Prostate Centre, 2660 Oak St, Vancouver, BC, Canada. · Institut du cancer de Montréal and Centre de recherche du Centre hospitalier de l'Université de Montréal, 900 St Denis St, Montreal, QC, Canada. · Department of Surgery Université de Montréal, 2900 Edouard Montpetit Blvd, Montreal, QC, Canada. · Department of Medicine, Université de Montréal, 2900 Edouard Montpetit Blvd, Montreal, QC, Canada. · Pubmed 29078772
  • University of Montreal Hospital Center, Montreal, QC H2X 0A9, Canada. Electronic address: · Pubmed 28760402
  • Centre Hospitalier de I'Université de Montréal, Urology Division, CHUM - Pavillon R 900, rue St-Denis, porte R10-464, Montreal, Quebec H2X 0A9, Canada. · Pubmed 28508880
  • Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. Electronic address: · University of Montréal, Montréal, Québec, Canada. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College New York, NY, USA. · Radboud University Medical Centre, Nijmegen, The Netherlands. · The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, UK. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Janssen Research & Development, San Diego, CA, USA. · Johnson & Johnson Medical China, Shanghai, China. · Janssen Research & Development, Beerse, Belgium. · Janssen Global Services, Raritan, NJ, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Pubmed 28314611
  • Duke Cancer Institute, Durham, North Carolina. · Centre Hospitalier de l'Université de Montréal and CRCHUM, Montreal, Quebec, Canada. · Astellas Pharma, Inc., Leiden, Netherlands. · Astellas Pharma, Inc., Northbrook, Illinois. · Carolina Urologic Research Center, Myrtle Beach, South Carolina. · Institut Gustave Roussy, University of Paris Sud, Paris, France. · Medivation, Inc., San Francisco, California. · Sidney Kimmel Center for Prostate and Urologic Cancers and Memorial Sloan-Kettering Cancer Center, New York, New York. · Institute of Cancer Research, London, UK. · Pubmed 28171710
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada. · Martini-Clinic, Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Department of Urology, University of Montreal Health Center, Montreal, Canada. · Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy. · Department of Urology, Medical University of Vienna, Vienna, Austria. · Department of Urology, University Hcoospital Hamburg-Eppendorf, Hamburg, Germany. · Department of Urology, Academic Hospital Braunschweig, Braunschweig, Germany. · Pubmed 28156003
  • Urology Division, Centre Hospitalier de I'Université de Montréal, CHUM - Pavillon R 900, rue St-Denis, porte R10-464, Montreal, Quebec H2X 0A9, Canada. · Pubmed 27874064
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada. · Department of Urology, University Medical Center, Johannes Gutenberg University, Mainz, Germany. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada. · Unit of Urology, Division of Oncology, URI, IRCCS Ospedale San Raffaele, Milan, Italy. · Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Canada. · Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Martini-Clinic, Prostate Cancer Centre, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Department of Urology, University Medical Center, Johannes Gutenberg University, Mainz, Germany. · Department of Urology, University of Montreal Health Center, Montreal, Canada. · Pubmed 27796538
  • Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada; Université de Montréal Endowed Chair in Prostate Cancer, Montreal, Quebec, Canada; Centre de recherche du Centre Hospitalier de l'Université de Montréal and Institut du cancer de Montréal, Montreal, Quebec, Canada; Department of Surgery, Université de Montréal, Montreal, Quebec, Canada. Electronic address: · Université de Montréal Endowed Chair in Prostate Cancer, Montreal, Quebec, Canada; Department of Pathology and Cellular Biology, Université de Montréal, Montreal, Quebec, Canada. · Centre de recherche du Centre Hospitalier de l'Université de Montréal and Institut du cancer de Montréal, Montreal, Quebec, Canada; Department of Surgery, Université de Montréal, Montreal, Quebec, Canada. · Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada; Department of Surgery, Université de Montréal, Montreal, Quebec, Canada. · Centre de recherche du Centre Hospitalier de l'Université de Montréal and Institut du cancer de Montréal, Montreal, Quebec, Canada; Department of Medicine, Université de Montréal, Montreal, Quebec, Canada. · Centre de recherche du Centre Hospitalier de l'Université de Montréal and Institut du cancer de Montréal, Montreal, Quebec, Canada. · Metamark Genetics, Inc., Cambridge, Massachusetts. · Metamark Genetics, Inc., Cambridge, Massachusetts; Department of Epidemiology and Biostatistics, Texas A&M University, College Station, Texas. · Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada; Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada. · Pubmed 27725152
  • Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM)/Institut du Cancer de Montréal, Montreal, Canada. · Department of Surgery, Hôpital Saint Luc (CHUM), Montreal, Canada. · Department of Surgery, Université de Montréal, Montreal, Canada. · Department of Medicine, Université de Montréal, Montreal, Canada. · Pubmed 27577074
  • University Health Network, Toronto, ON, Canada. · Institut du Cancer de Montréal/Centre de recherche du CHUM, Montreal, QC, Canada. · Manitoba Prostate Center, Winnipeg, MB, Canada. · Centre de Santé et des Services Sociaux de Laval, Laval, QC, Canada. · Centre hospitalier de l'Université de Montréal (CHUM), Montreal, QC, Canada. · Vancouver Prostate Center, Vancouver, BC, Canada. · Centre de Santé et des Services Sociaux de Chicoutimi, Chicoutimi, QC, Canada. · Centre hospitalier de l'Université de Montréal (CHUM), Montreal, QC, Canada. · Institut du Cancer de Montréal/Centre de recherche du CHUM, Montreal, QC, Canada. · Pubmed 27447989
  • The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, UK. Electronic address: · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · Centre Hospitalier University of Montréal, Montréal, Québec, Canada. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, San Diego, CA, USA. · Johnson & Johnson Medical China, Shanghai, China. · Janssen Global Services, Raritan, NJ, USA. · University of Colorado Cancer Center, Aurora, CO, USA. · Pubmed 27402060
2016
  • University of Montreal Hospital Center (CHUM) and Montreal Cancer Institute/CRCHUM, CHUM - Pavillon R 900, rue St-Denis, porte R10-464, Montréal, Québec H2X 0A9, Canada. · Pubmed 27489183
  • Hematologist and Medical Oncologist, Notre-Dame Hospital, CHUM Research Center, Montreal, QC, Canada. · Associate Professor, Department of Pharmacy, Cancer Axis-Montreal Cancer Institute, Montreal, QC, Canada. · Hematologist and Medical Oncologist, Notre-Dame Hospital, CHUM Research Center, Montreal, QC, Canada.; Associate Professor, Department of Medicine, University of Montreal, QC, Canada. · Professor and Chief of Urology, CHUM-Pavillon R, Montreal, QC, Canada. · Pubmed 27168728
  • University of Warwick, Cancer Research Unit, Coventry, UK; Queen Elizabeth Hospital, Birmingham, UK. · Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada. Electronic address: · Pubmed 26905032
  • Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada. Electronic address: · Vall d' Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Kantonsspital St Gallen, St Gallen, Switzerland. · University Hospital, University Hospital Cologne, Germany. · Department of Oncology, Akershus University Hospital, Lørenskog, Norway. · Modular Informatics LLC, Thornwood NY, USA. · Biometrical Practice, BIOP, Basel, Switzerland. · Charité University Medicine Berlin, Berlin, Germany. · Karolinska University Hospital, Stockholm, Sweden. · Pharmaceuticals Division of Bayer, Whippany, NJ, USA. · Department of Oncology, San Luigi Hospital, Orbassano Turin, Italy. · University Hospital Carl-Gustav Carus, Dresden, Germany. · Bayer Pharma AG, Basel, Switzerland. · The Centre for Cancer Research and Cell Biology, Queen's University Belfast, Northern Ireland; Northern Ireland Cancer Centre, Belfast, Northern Ireland. · Pubmed 27473888
  • Department of Urology, UC Davis Comprehensive Cancer Center, Sacramento, CA, USA. Electronic address: · Medical Oncology Division, University of Washington/Seattle Cancer Care Alliance, Seattle, WA, USA. · Department of Urology, Medical University of South Carolina, Charleston, SC, USA. · Division of Urologic Surgery, Washington University School of Medicine, St. Louis, MO, USA. · Department of Surgery, University of Montreal Health Center, Montreal, Canada. · Copenhagen Prostate Cancer Center, Rigshospitalet, University of Copenhagen, Denmark. · Department of Urology, Charité-Universitätsmedizin Berlin, Berlin, Germany. · Department of Urology, Asan Medical Center, Seoul, South Korea. · Department of Urology, Nippon Medical School Hospital, Tokyo, Japan. · Division of Medical Oncology and Urology, Duke Cancer Institute, Durham, NC, USA. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Department of Cancer Medicine, Institut Gustave-Roussy, Villejuif, France. · Drug Development Unit, Institute of Cancer Research, Royal Marsden Hospital, London, UK. · Department of Early Clinical Development, Medivation, Inc., San Francisco, CA, USA. · Department of Medical Affairs, Medivation, Inc., San Francisco, CA, USA. · Department of Biostatistics, Medivation, Inc., San Francisco, CA, USA. · Astellas Pharma, Inc., Northbrook, IL, USA. · Department of Hematology and Medical Oncology, OHSU Knight Cancer Institute, Portland, OR, USA. · Department of Urology, Cliniques Universitaires Saint-Luc, Brussels, Belgium. · Pubmed 27006332
  • Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Electronic address: · Janssen Research & Development, San Diego, CA, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · University of Montréal, Montréal, Québec, Canada. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Monash University and Eastern Health, Victoria, Australia. · ZNA Middelheim Oncology Clinic, Medical Oncology, Antwerp, Belgium. · Churchill Hospital, Oxford, UK. · Janssen Research & Development, Menlo Park, CA, USA. · Janssen Research & Development, Beerse, Belgium. · The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, UK. · Georges Pompidou Hospital, University René Descartes, Paris, France. · Pubmed 26508309
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Québec, Canada; Department of Urology and Division of Experimental Oncology, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy. Electronic address: · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Québec, Canada; Martini-Clinic, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Québec, Canada; Department of Urology, University of Montreal Health Center, Montreal, Québec, Canada. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Québec, Canada; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Québec, Canada. · Department of Urology and Division of Experimental Oncology, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy. · Department of Urology, Medical University of Vienna and General Hospital, Vienna, Austria. · Department of Urology, University of Montreal Health Center, Montreal, Québec, Canada. · Pubmed 27478167
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada; Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy. Electronic address: · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada; Department of Urology, University of Montreal Health Center, Montreal, Canada. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada; Martini-Clinic, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Canada. · Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy. · Department of Urology, Medical University of Vienna and General Hospital, Vienna, Austria. · Martini-Clinic, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Department of Urology, University of Montreal Health Center, Montreal, Canada. · Pubmed 26951945
  • Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Institut du Cancer de Montréal, Montréal, Quebec, Canada. Faculté de Pharmacie, Université de Montréal, Pavillon Jean-Coutu, Montréal, Quebec, Canada. · Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Institut du Cancer de Montréal, Montréal, Quebec, Canada. · Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Institut du Cancer de Montréal, Montréal, Quebec, Canada. Faculté de Pharmacie, Université de Montréal, Pavillon Jean-Coutu, Montréal, Quebec, Canada. · Pubmed 26253870
  • Martini-Klinik am Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada. · Department of Urology, University of Montreal Health Center, Montreal, Canada. · Unit of Urology, Division of Oncology, URI, IRCCS Ospedale San Raffaele, Milan, Italy. · Martini-Klinik am Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany. · INRS-Institut Armand-Frappier, Institut national de la recherche scientifique, Université du Québec, Laval, Canada. · Department of Social and Preventive Medicine, University of Montreal, Montreal, Canada. · Pubmed 26108732
2015
  • University of Montreal Hospital Center, Montreal, Quebec, Canada. Electronic address: · Pubmed 25168615
  • Montréal University Health Centre, Montréal, Canada. Electronic address: · Department of Cancer Medicine, Gustave Roussy Institute, University of Paris Sud, Villejuif, France. · Pubmed 26282624
  • Division of Urology, Department of Surgery, Centre Hospitalier de I'Université de Montréal, Montréal, Quebec, Canada. Electronic address: · Department of Urology, Charité Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany. · Pubmed 25709051
  • Centre Hospitalier de l'Université de Montréal, University of Montreal, CHUM Pavillon R, 900 rue St Denis, Montreal, QC H2X 0A9, Canada. · Pubmed 25600097
  • Millennium Pharmaceuticals, Inc, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited (D.B.M., H.S., H.F.), Cambridge, Massachusetts 02139 · and University of Montreal Hospital Center (F.S.), Montreal, Québec, Canada H2X 0A9. · Pubmed 26502357
  • Janssen Research & Development, Raritan, New Jersey. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California. · Janssen Research & Development, Beerse, Belgium. · Harvard Medical School, Massachusetts General Hospital Cancer Center, Boston, Massachusetts. · University of Montreal, Montreal, Quebec, Canada. · Janssen Research & Development, Los Angeles, California. · Janssen Research & Development, Raritan, New Jersey. · Pubmed 25829400
  • Centre Hospitalier de l'Université de Montréal/CRCHUM, Montréal, QC, Canada. Electronic address: · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Universitatea de Medicina si Farmacie, Bucharest, Romania. · University of Athens Medical School, Athens, Greece. · Auckland City Hospital, Auckland, New Zealand. · Florida Cancer Specialists, Fort Myers, FL, USA. · Institute of Cancer Sciences, University of Glasgow, Glasgow, UK. · The Adelaide and Meath Hospital, Incorporating the National Children's Hospital, Dublin, Ireland. · University Hospital Carl Gustav Carus Dresden, Dresden, Germany. · Gunma University Graduate School of Medicine, Gunma, Japan. · Millennium Pharmaceuticals, Inc, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA. · The University of Tokyo Research Center for Advanced Science and Technology, Tokyo, Japan. · University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Cleveland Clinic, Cleveland, OH, USA. · Millennium Pharmaceuticals, Inc, Cambridge, MA, USA. · Erasmus University Medical Center, Rotterdam, Netherlands. · Pubmed 25701170
  • Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif · Stephane Oudard, Université Paris Descartes, Paris, France · Robert Jones, Institute of Cancer Sciences, University of Glasgow, Glasgow · Johann De Bono, The Institute of Cancer Research, London, United Kingdom · Eleni Efstathiou, University of Athens Medical School, Athens · George Fountzilas, Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece · Fred Saad, University of Montreal Hospital Center, Montreal, Canada · Ronald de Wit, Erasmus University Medical Center, Rotterdam, the Netherlands · Felipe Melo Cruz, ABC Foundation School of Medicine, Santo André · Flavio Carcano, Hospital de Cancer de Barretos, Barretos, Brazil · Albertas Ulys, Institut of Oncology, Vilnius University, Vilnius, Lithuania · Neeraj Agarwal, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT · David Agus, University of Southern California, Los Angeles, CA · Daniel P. Petrylak, Yale University Cancer Center, New Haven, CT · Shih-Yuan Lee, Bindu Tejura, Niels Borgstein, Takeda Pharmaceuticals International · Iain J. Webb, Millennium: The Takeda Oncology Company, Cambridge, MA · Robert Dreicer, Cleveland Clinic, Cleveland, OH · Joaquim Bellmunt, University Hospital del Mar-IMIM, Barcelona, Spain. · Pubmed 25624429
  • Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. Electronic address: · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · University of Montréal, Montréal, Québec, Canada. · Radboud University Medical Centre, Nijmegen, Netherlands. · San Camillo and Forlanini Hospitals, Rome, Italy. · Charité Berlin, Berlin, Germany. · MD Anderson Cancer Center, Houston, TX, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona, Spain. · University of Colorado Cancer Center and University of Colorado School of Medicine, Aurora, CO, USA. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · University of Western Sydney School of Medicine and Ingham Institute, Liverpool, Australia. · The Institute of Cancer Research and the Royal Marsden Hospital, Sutton, United Kingdom. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, Raritan, NJ, USA. · Janssen Research & Development, Menlo Park, CA, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Pubmed 25601341
  • University of Montreal Hospital Centre, Montreal, QC, Canada. Electronic address: · Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, UK. · Carolina Urologic Research Center, Myrtle Beach, SC, USA. · Gustave Roussy, Cancer Campus Grand Paris, University of Paris Sud, Villejuif, France. · Medivation, Inc., San Francisco, CA, USA. · Astellas Global Medical Affairs, Inc., Northbrook, IL, USA. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Pubmed 25171902
  • Vattikuti Urology Institute and VUI Center for Outcomes Research Analytics and Evaluation, Henry Ford Hospital, Detroit, MI, USA. Electronic address: · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Centre, Montreal, QC, Canada. · Department of Urology, Vita Salute San Raffaele University, Milan, Italy. · Vattikuti Urology Institute and VUI Center for Outcomes Research Analytics and Evaluation, Henry Ford Hospital, Detroit, MI, USA. · Martini Clinic, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany. · Pubmed 28723433
  • Epidemiology and Biostatistics Unit, Institut national de la recherche scientifique-Institut Armand-Frappier, University of Quebec, 531 Boul. des Prairies, Laval, QC, H7V 1B7, Canada. · Epidemiology and Biostatistics Unit, Institut national de la recherche scientifique-Institut Armand-Frappier, University of Quebec, 531 Boul. des Prairies, Laval, QC, H7V 1B7, Canada. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, 1058, rue St-Denis, Montreal, QC, H2X 3 J4, Canada. · Department of Surgery, Division of Urology, Centre Hospitalier de l'Université de Montréal, 1058, rue St-Denis, Montreal, QC, H2X 3 J4, Canada. · Department of Surgery (Urology), McGill University Health Centre, 1650 Cedar Avenue, Montreal, QC, H3G 1A4, Canada. · Department of Surgery, Division of Urology, Centre Hospitalier de l'Université de Montréal, 1058, rue St-Denis, Montreal, QC, H2X 3 J4, Canada. · Epidemiology and Biostatistics Unit, Institut national de la recherche scientifique-Institut Armand-Frappier, University of Quebec, 531 Boul. des Prairies, Laval, QC, H7V 1B7, Canada. · Department of Social and Preventive Medicine, University of Montreal, 7101 Avenue du Parc, Montreal, QC, Canada. · Pubmed 26385727
  • Martini-Klinik am Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany; Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada. Electronic address: · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada; Division of Oncology, URI, IRCCS Ospedale San Raffaele, Milan, Italy. · INRS-Institut Armand-Frappier, Institut national de la recherche scientifique, Université du Québec, Laval, Canada. · Martini-Klinik am Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany. · Department of Urology, University of Montreal Health Center, Montreal, Canada. · INRS-Institut Armand-Frappier, Institut national de la recherche scientifique, Université du Québec, Laval, Canada; Department of Social and Preventive Medicine, University of Montreal, Canada. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada; Department of Urology, University of Montreal Health Center, Montreal, Canada. · Pubmed 26278366
  • Institut du cancer de Montréal / Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), 900 rue St-Denis, Montreal, Canada. · Visiopharm, Argen Allé 3, Hoersholm, Denmark. · Institut du cancer de Montréal / Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), 900 rue St-Denis, Montreal, Canada; Department of Medicine, Université de Montréal, Montreal, Canada. · Institut du cancer de Montréal / Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), 900 rue St-Denis, Montreal, Canada; Division of Urology, CHUM and Department of Surgery, Université de Montréal, Montreal, Canada. · Pubmed 26186215
  • Department of Surgery, University of Montreal, Montreal, Quebec, Canada. · Pubmed 26181183
  • University of Montréal, Montréal, Québec, Canada. Electronic address: · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · University Hospital Leuven, Leuven, Belgium. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · Institute of Cancer Research and Royal Marsden Hospital, Sutton, UK. · MD Anderson Cancer Center, Houston, TX, USA. · University of Western Sydney School of Medicine, Ingham Institute, Liverpool, Australia. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Hematology and Oncology Clinics of Australia, Brisbane, Australia. · Sarah Cannon Research Institute, Nashville, TN, USA. · Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA. · Cross Cancer Institute, Edmonton, Alberta, Canada. · Laval University, Québec City, Québec, Canada. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, Raritan, NJ, USA. · Janssen Research & Development, San Diego, CA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Janssen Research & Development, Menlo Park, CA, USA. · Pubmed 25985882
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, 264 Blvd. Rene-Levesque E. Room 228, Montreal, QC, H2X 1P1, Canada. · Department of Urology, University of Montreal Health Center, Montreal, QC, Canada. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, 264 Blvd. Rene-Levesque E. Room 228, Montreal, QC, H2X 1P1, Canada. · Martini-Clinic, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany. · Division of Oncology, Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy. · INRS-Institut Armand-Frappier, Institut National de la Recherche Scientifique, Laval, QC, Canada. · University of Montreal Hospital Research Centre (CRCHUM), Montreal, QC, Canada. · Department of Radiation Oncology, University of Montreal Health Center, Montreal, QC, Canada. · Martini-Clinic, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany. · Pubmed 25854524
  • Martini-Klinik am Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, 264 Blvd. Rene-Levesque E. Room 228, Montreal, QC, H2X 1P1, Canada. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, 264 Blvd. Rene-Levesque E. Room 228, Montreal, QC, H2X 1P1, Canada. · Department of Urology, University of Montreal Health Center, Montreal, QC, Canada. · Division of Oncology, Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy. · INRS-Institut Armand-Frappier, Institut national de la recherche scientifique, Université du Québec, Laval, QC, Canada. · Martini-Klinik am Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany. · Department of Social and Preventive Medicine, University of Montreal, Montreal, QC, Canada. · Pubmed 25824539
  • Metamark Genetics Inc., Cambridge, Massachusetts. · Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, Canada. · Department of Pathology, Yale University Medical School, New Haven, Connecticut. · Urology Austin, Austin, Texas. · Impacts Inc., Montreal, Quebec, Canada. · Dana-Farber Cancer Institute, Boston, Massachusetts. · Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio. · Department of Anatomic Pathology, Cleveland Clinic, Cleveland, Ohio. · Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada. · Department of Pathology, Urology and Oncology, Johns Hopkins Hospital, Baltimore, Maryland. · Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada. · Pubmed 25733599
  • VUI Center for Outcomes Research, Analytics and Evaluation, Henry Ford Health System, Detroit, MI. · Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. · Department of Urology, Yale University, New Haven, CN. · VUI Center for Outcomes Research, Analytics and Evaluation, Henry Ford Health System, Detroit, MI; Division of Urologic Oncology and Center for Surgery and Public Health, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. · Department of Urology, University of Minnesota, Minneapolis, MN. · Department of Urology, Maine Medical Center, Portland, ME. · Department of Urology, David Geffen School of Medicine, University of California, Los Angeles, CA. · Division of Urologic Oncology and Center for Surgery and Public Health, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. · Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. · Division of Urology, University of Montreal Hospital Center, Montreal, Canada. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada. · Division of Urologic Oncology and Center for Surgery and Public Health, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. Electronic address: · Pubmed 25623683
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Centre, Montreal, Canada; Department of Urology, Vita Salute San Raffaele University, Milan, Italy. Electronic address: · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Centre, Montreal, Canada. · Department of Urology, Medical University of Vienna, Vienna, Austria. · Department of Surgery, Division of Urology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. · Martini-Klinik, Prostate Cancer Center, University-Hospital Hamburg-Eppendorf, Hamburg, Germany. · Department of Surgery, Division of Urology, Centre Hospitalier de l'Université de Montréal, Montreal, Canada. · Department of Urology, Vita Salute San Raffaele University, Milan, Italy. · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Centre, Montreal, Canada; Department of Surgery, Division of Urology, Centre Hospitalier de l'Université de Montréal, Montreal, Canada. · Pubmed 25547676
  • Department of Urology, Ruhr University Bochum, Marien Hospital, Herne, Germany. Electronic address: · Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Québec, Canada. · Department of Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. · Department of Urology, University of California (UCLA), Los Angeles, CA. · Division of Urologic Surgery and Center for Surgery and Public Health, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. · Department of Urology, Yale School of Medicine, New Haven, CT. · Department of Urology, Georgetown University Hospital, Washington, DC. · Vattikuti Urology Institute, Henry Ford Health System, Detroit, MI. · Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. · CRCHUM, Centre Hospitalier de l׳Université de Montréal, Montreal, Québec, Canada. · Department of Urology, University of Minnesota, Minneapolis, MN. · Department of Urology, Ruhr University Bochum, Marien Hospital, Herne, Germany. · Division of Urologic Surgery and Center for Surgery and Public Health, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Vattikuti Urology Institute, Henry Ford Health System, Detroit, MI. · Pubmed 25443265
2014
  • University of Montreal, Montreal, Quebec, Canada. · Pubmed 25029395
  • Ethan Basch, Ronald C. Chen, and Stacie B. Dusetzina, University of North Carolina, Chapel Hill · Derek Raghavan, Carolinas Health Care/Levine Cancer Institute, Charlotte, NC · D. Andrew Loblaw, Odette Cancer Centre, Sunnybrook Health Sciences Centre · Ted Wootton, Patient Representatives, Toronto · Sebastian Hotte and Cindy Walker-Dilks, McMaster University · Cindy Walker-Dilks, Cancer Care Ontario, Hamilton · Eric Winquist, London Health Sciences Centre, London, Ontario · Fred Saad, University of Montreal, Montreal, Quebec, Canada · Thomas K. Oliver and R. Bryan Rumble, American Society of Clinical Oncology, Alexandria, VA · Michael Carducci, Johns Hopkins University, Baltimore, MD · James N. Frame, Charleston Area Medical Center Health Systems, Charleston, WV · Kristina Garrels, Private Practice, Fargo, ND · Michael W. Kattan, Cleveland Clinic, Cleveland, OH · Mary-Ellen Taplin, Dana-Farber Cancer Institute, Boston, MA · James Williams, Pennsylvania Prostate Cancer Coalition, Camp Hill, PA · Charles L. Bennett, South Carolina College of Pharmacy, Columbia, SC · and Katherine S. Virgo, Emory University, Atlanta, GA. · Pubmed 25199761
  • Claude-Bernard-Lyon-1 University and Department of Medical Oncology, Centre Léon-Bérard, Lyon, France. Electronic address: · Multidisciplinary Oncology Institute, Clinique de Genolier, Genolier, Switzerland. · H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA. · Claude-Bernard-Lyon-1 University and Department of Medical Oncology, Centre Léon-Bérard, Lyon, France. · Department of Urology, University Hospitals, Leuven, Belgium. · Department of Urology, Queen Mary University of London, London, UK. · Division of Surgery and Interventional Science, University College London, London, UK. · Department of Clinical Therapeutics, University of Athens Medical School, Athens, Greece. · Irish Cancer Society and University College Dublin, Dublin, Ireland. · Department of Urology, RWTH University Aachen, Aachen, Germany. · Guy's and St Thomas' NHS Trust, London, UK. · Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, USA. · University Hospital, Saint-Etienne, France. · Georges Pompidou Hospital, Department of Oncology, Paris, France. · University College London Hospitals, London, UK. · Uro‑Oncology Clinic, Centre Hospitalier de l'Université de Montreal, Montreal, QC, Canada. · Pubmed 25079103
  • Montefiore Medical Center, 111 East 210th Street, New York, NY 10467, USA. · Centre Hospitalier de I'Université de Montréal, Hôpital Notre-Dame, 1560 Sherbrooke East, Montreal, QC H2L 4M1, Canada. · Pubmed 24821212
  • Princess Margaret Hospital, Toronto, ON, Canada. Electronic address: · Durham VA Medical Center and Duke University Medical Center, Durham, NC, USA. · BC Cancer Agency, Vancouver, BC, Canada. · Seattle Cancer Centre Alliance, Seattle, WA, USA. · Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. · Royal Marsden NHS Foundation Trust, Sutton, UK. · Tulane Cancer Center, New Orleans, LA, USA. · University of Montreal Hospital Center, Montreal, PQ, Canada. · Pubmed 23957948
  • Department of Medical Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA. Electronic address: · Academic Unit of Clinical Oncology, Weston Park Hospital, CR-UK/YCR Sheffield Cancer Research Centre, Sheffield, UK. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Department of Urology, University Hospital Charité, Berlin, Germany. · Division of Urology, Centre Hospitalier de l'Université de Montréal, CRCHUM, Montréal, QC, Canada. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Tisch Cancer Center Institute, Mount Sinai School of Medicine, New York, NY, USA. · Pubmed 23706567
  • Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. Electronic address: · Hospital Universitario 12 de Octubre, Madrid, Spain. · Rigshospitalet, Copenhagen, Denmark. · National Institute of Oncology, Budapest, Hungary. · McMaster University, Hamilton, ON, Canada. · ICON Cancer Care, Brisbane, QLD, Australia. · University of Montreal, Montreal, QC, Canada. · Center for Oncology, Hospital Sírio-Libanês, São Paulo, Brazil. · OncoCare Cancer Centre, Singapore. · Centro Oncologico Belenus, Cuernavaca, Mexico. · University of Pisa, Pisa, Italy. · Janssen Research & Development, Horsham, PA, USA. · Janssen Research & Development, Beerse, Belgium. · Janssen Scientific Affairs, Horsham, PA, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Global Services, Raritan, NJ, USA. · Janssen Research & Development, Menlo Park, CA, USA. · Duke Cancer Institute, Durham, NC, USA. · Pubmed 25242048
  • Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. Electronic address: · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. · MD Anderson Cancer Center, Houston, TX, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · University of Western Sydney School of Medicine, Penrith, Australia. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Hematology & Oncology Clinics of Australia, Brisbane, Australia. · Sarah Cannon Research Institute, Nashville, TN, USA. · Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA. · Cross Cancer Institute, Edmonton, Alberta, Canada. · Laval University, Québec City, Québec, Canada. · University Hospital Leuven, Leuven, Belgium. · Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. · University of Colorado Cancer Center and University of Colorado School of Medicine, Aurora, CO, USA. · University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, Raritan, NJ, USA. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA. · Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Janssen Research & Development, Menlo Park, CA, USA. · CRCHUM, University of Montréal, Montréal, Québec, Canada. · Pubmed 24647231
  • Matthew R. Smith and Philip Saylor, Massachusetts General Hospital Cancer Center, Boston, MA · Susan Halabi and Ben Sanford, Alliance Statistics and Data Center, Duke University Medical Center, Durham, NC · Charles J. Ryan and Eric J. Small, University of California at San Francisco, San Francisco, CA · Walter Stadler, University of Chicago · Nirmala Bhoopalam, Loyola University of Chicago, Chicago, IL · Arif Hussain, University of Maryland, Baltimore, MD · Nicholas Vogelzang, Nevada Cancer Research Foundation CCOP, Las Vegas, NV · Ralph J. Hauke, University of Nebraska, Omaha, NE · J. Paul Monk, Ohio State University, Columbus, OH · W. Kevin Kelly, Thomas Jefferson University, Philadelphia, PA · Michael Morris, Memorial Sloan-Kettering Cancer Center, New York, NY · Fred Saad, Centre Hospitalier de l'Université de Montréal, Montreal, Canada. · Pubmed 24590644
  • M. Dror Michaelson, Massachusetts General Hospital Cancer Center, Boston, MA · Stephane Oudard, George Pompidou European Hospital, Rene Descartes University, Paris · Nadine Houede, Institut Bergonie, Bordeaux · Tristan Maurina, CHU de Besançon, Hôpital Jean Minjoz, Besançon, France · Yen-Chuan Ou, Taichung Veterans General Hospital, Taichung, Taiwan · Lisa Sengeløv, Herlev Hospital, Herlev · Gedske Daugaard, Rigshospitalet, Copenhagen, Denmark · Fred Saad, University of Montreal, Montreal, Canada · Peter Ostler, Mount Vernon Hospital, Northwood, Middlesex · Robert Jones, Beatson West of Scotland Cancer Centre, Glasgow · Amit Bahl, Bristol Haematology and Oncology Centre, Bristol, UK · Arnulf Stenzl, Eberhard-Karls-University Medical School, Tübingen · Juergen Gschwend, Technical University of Munich, Munich, Germany · Fredrik Laestadius and Anders Ullèn, Karolinska University Hospital, Stockholm, Sweden · Daniel Castellano, I_12 Research Institute, University Hospital 12 de Octubre, Madrid, Spain · Edna Chow Maneval, Shaw-Ling Wang, and Isan Chen, Pfizer Oncology, La Jolla, CA · and Maria Jose Lechuga and Jolanda Paolini, Pfizer Oncology, Milan, Italy. · Pubmed 24323035
  • Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada. Electronic address: · Pubmed 22633317
  • Departments of Surgery and Urology, University of Montreal Health Center, Montréal, Quebec, Canada H2X 0A9. · Pubmed 25130993
  • Associated Medical Professionals of New York, Syracuse, NY. · SUNY Upstate Medical University, Syracuse, NY. · Faculty of Medicine, University of Montreal, Montreal, Quebec, Canada. · Associated Medical Professionals of New York, Syracuse, NY. Electronic address: · Division of Urology, University of Montreal Hospital Center, Montreal, Quebec, Canada. · Pubmed 24976229
  • Centre Hospitalier de I'Université de Montréal, Urology Division, Hôpital Notre-Dame, 1560 Sherbrooke Rast, Montreal, QC H2L 4M1, Canada. · Pubmed 24731994
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada. · Urological Research Institute, Vita-Salute San Raffaele University, San Raffaele Hospital, San Raffaele Scientific Institute, Milan, Italy. · Department of Urology, University of Montreal Health Center, Montreal, Canada. · Martini-clinic, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany. · Division of Urologic Surgery and Center for Surgery and Public Health, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Pubmed 24612110
  • Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. Electronic address: · Janssen Research & Development, Los Angeles, CA, USA. · Medical University of Vienna, Vienna, Austria. · University of Montreal, Montreal, QC, Canada. · University of Washington, Seattle, WA, USA. · British Columbia Cancer Agency, Vancouver, BC, Canada. · Janssen Research & Development, Raritan, NJ, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Pubmed 24099659
  • University of Montreal Hospital Center, Montreal, Quebec, Canada. Electronic address: · Department of Urology, Charité Berlin, Berlin, Germany. · Pubmed 23506965
2013
  • Department of Oncology, Cancer Clinical Trials Centre, University of Sheffield, Weston Park Hospital, Cancer Research Centre, Sheffield, UK. · College of Medicine, Penn State Milton S. Hershey Medical Center, Hershey, PA, USA. · Clinical and Translational Oncology Research Unit, Instituto de Medicina Molecular, Lisbon, Portugal. · Department of Statistics and Actuarial Science, University of Waterloo, Waterloo, ON, Canada. · Division of Urology, Centre Hospitalier de l'Université de Montréal, Hôpital Notre-Dame, Montréal, QC, Canada. · Department of Oncology, Cancer Clinical Trials Centre, University of Sheffield, Weston Park Hospital, Cancer Research Centre, Sheffield, UK; Department of Oncology and Clinical Research, Cancer Research UK Centre, St James's Hospital, Leeds, UK. · Department of Clinical Therapeutics, University of Athens School of Medicine, Athens, Greece. · Department of Oncology, Division of Medical Oncology, McMaster University, Juravinski Cancer Centre, Hamilton, ON, Canada. · Division of Breast Oncology, Tokyo Medical University, Tokyo, Japan. · Genitourinary Malignancies Program, Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Department of Medicine, University Hospital Brugmann, ULB, Brussels, Belgium. · Pubmed 26909273
  • Matthew R. Smith, Massachusetts General Hospital Cancer Center, Boston, MA · Fred Saad, University of Montreal Hospital Center, Montreal, Quebec, Canada · Stephane Oudard, Georges Pompidou Hospital, Paris · Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France · Neal Shore, Carolina Urological Research Center, Myrtle Beach, SC · Paul Sieber, Urological Associates of Lancaster, Lancaster, PA · Bertrand Tombal, Université Catholique de Louvain Cliniques Universitaires Saint Luc, Bruxelles, Belgium · Ronaldo Damiao, Hospital Universitario Pedro Ernesto, Rio de Janeiro, Brazil · Gavin Marx, Sydney Haematology and Oncology Clinic, University of Sydney, Wahroonga, New South Wales, Australia · Kurt Miller, Charité Berlin, Berlin, Germany · Peter Van Veldhuizen, Kansas City Veterans Affairs Medical Center, Kansas City, MO · Juan Morote, Hospital Vall d'Hebron, Barcelona, Spain · and Zhishen Ye, Roger Dansey, and Carsten Goessl, Amgen, Thousand Oaks, CA. · Pubmed 24043751
  • Professor and Chair, Division of Urology, University of Montreal Hospital Center and CRCHUM, CHUM, 1560 Sherbrooke East, Montreal Quebec H2L 4M1, Canada. · Pubmed 23904859
2012
  • Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, D-20246 Hamburg, Germany. · Pubmed 22409467
  • Centre Hospitalier de l'Université de Montréal, Hôpital Notre-Dame, Montréal, QC, Canada. · Pubmed 22307372
  • Centre Hospitalier de l'Université de Montréal and CRCHUM, 1560 Sherbrooke East, Montréal, Quebec H2L 4M1, Canada. · Pubmed 21864229
  • Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada. · Pubmed 21163673
  • University of Montreal Health Center, Montreal, Quebec, Canada H2L 4M1. · Pubmed 22112794
2011
  • CRCUM-Université de Montréal, Hamilton, Ontario, Canada. · Pubmed 21788353
2010
  • Centre Hospitalier de l'Université de Montréal, Hôpital Notre-Dame, Canada. · Pubmed 21110764
  • Centre Hospitalier de l'Université de Montréal, Quebec, Canada. · Pubmed 20682370
  • Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada. · Pubmed 20489645
  • Centre Hospitalier de i'Université de Montréal, Hôpital Notre-Dame, Montréal, Quebec, Canada. · Pubmed 21056263
2019
  • Centre de recherche du CHUM (CRCHUM)/Institut du Cancer de Montréal, Montreal, Quebec, Canada. · Pubmed 30671574
2018
  • Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, Quebec, Canada. · Pubmed 30015690
  • Department of Radiation Oncology, University of Montreal Health Center, Montreal, Quebec, Canada. · Pubmed 30281009
2017
  • Division of Urology, Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada. · Pubmed 28644302
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada. · Pubmed 27486887
2015
  • a 1 Institut du cancer de Montréal, Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Quebec, Canada. · Pubmed 26313417
  • Department of Radiation Oncology, Centre hospitalier de l'Université de Montréal (CHUM), Montreal, Canada. · Pubmed 26271398
  • aFaculty of Medicine, University of Montreal bDepartment of Urology, University of Montreal Hospital Center/Centre hospitalier de l'Université de Montréal (CHUM), Montreal, Canada. · Pubmed 26262831
2014
  • aDepartment of Medical Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, New York, USA bCentre Hospitalier de I'Université de Montréal, Hôpital Notre-Dame, Montreal, Canada. · Pubmed 25166424
  • Authors' Affiliations: Royal Marsden NHS Foundation Trust and The Institute of Cancer Research UK, Sutton; Institut Català d'Oncologia, L'Hospitalet, Barcelona; University of Surrey, Surrey, United Kingdom; Yale University Cancer Center, New Haven; Centre Hospitalier de l'Universite de Montreal, Montreal; A Coruña University Hospital, A Coruña, Spain; Kantonsspital St. Gallen, St. Gallen, Switzerland; Fox Chase Cancer Center, Philadelphia, Pennsylvania; Pfizer Inc, Groton, Connecticut; and Lady Davis Institute for Medical Research, Jewish General Hospital and McGill University, Montreal, Quebec, Canada. · Pubmed 24536060
2013
  • Centre de Recherche, Centre Hospitalier de l'Université de Montréal, 1560 Sherbrooke East, Montréal, QC H2L 4M1, Canada. · Pubmed 23797341
  • Vancouver Prostate Centre and Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia bThe Division of Urology, University of Montreal Hospital Center (CHUM), University of Montreal, Montreal, Quebec, Canada. · Pubmed 23385973
  • Authors' Affiliations: Departments of Radiation Oncology, Medical Biophysics, Medical Oncology, Laboratory Medicine and Pathology and Biostatistics, University of Toronto; Radiation Medicine Program, Princess Margaret Hospital, University Health Network; Informatics and Bio-Computing Platform, Ontario Institute for Cancer Research, Toronto, Ontario; Department of Cancer Genetics and Developmental Biology, British Columbia Cancer Research Centre; Laboratory for Advanced Genome Analysis - Vancouver Prostate Centre, Vancouver, British Columbia; Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada; Center for Prostate Disease Research, Department of Surgery, Uniformed Services University of the Health Sciences, Rockville, Maryland; Division of Urology, University of Montreal Health Center, Montreal, Quebec; Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario; and Department of Pathology and Laboratory Medicine and Oncology, University of Calgary, Calgary, Alberta, Canada. · Pubmed 23918607
  • Département de Biochimie, Université de Montréal, Montréal, Québec H3C 3J7, Canada. · Pubmed 23599344
  • Centre de recherche du Centre hospitalier de l'Université de Montréal, Institut du cancer de Montréal, and Faculty of Medicine, Université de Montréal, Montréal, Québec, Canada. · Pubmed 23541563
2012
  • Centre de recherche du Centre hospitalier de l'Université de Montréal and Institut du cancer de Montréal, Montreal, Quebec, Canada. · Pubmed 22871982
  • Centre de recherche du Centre hospitalier de l'Université de Montréal and Institut du cancer de Montréal, Montreal, Quebec, Canada. · Pubmed 21932427
2011
  • Departments of Surgery and Urology, Centre Hospitalier de l'Université de Montréal, 1560 Sherbrooke East, Montreal, Quebec H2L 4M1, Canada. · Pubmed 21161451
  • Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CR-CHUM) and Institut du Cancer de Montréal, Montreal, Quebec, Canada. · Pubmed 21438025
  • Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CR-CHUM)/Institut du Cancer de Montréal, Québec, Canada. · Pubmed 21271611
2010
  • Department of Surgery/Urology, Centre Hospitalier de l'Université de Montréal, Hôpital Notre-Dame, Montréal, Quebec, Canada. · Pubmed 20224416
  • Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM) and Institut du cancer de Montréal, Montreal, Quebec, Canada. · Pubmed 20711410
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada. · Pubmed 20381269
  • Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, QC, Canada. · Pubmed 20117287
Miscellaneous institutions in Montreal
2019
  • Centre de recherche du Centre hospitalier de l'Université de Montréal, Centre hospitalier de l'Université de Montréal, Montreal, Quebec, Canada. · Institut du cancer de Montréal, Montreal, Quebec, Canada. · Research Institute of the McGill University Health Centre, McGill University Health Centre, Montreal, Quebec, Canada. · Axe Oncologie, Centre de recherche du Centre hospitalier universitaire de Québec-Université Laval, Centre hospitalier universitaire de Québec-Université Laval, Quebec, Quebec, Canada. · Centre de recherche sur le cancer, Université Laval, Quebec, Quebec, Canada. · Département de chirurgie, Université Laval, Quebec, Quebec, Canada. · Vancouver Prostate Centre, Vancouver, British Columbia, Canada. · University Health Network, Toronto, Ontario, Canada. · Pubmed 31265453
2018
  • Centre de recherche du Centre hospitalier de l'Université de Montréal, Montreal, QC, Canada. · Institut du cancer de Montréal, Montreal, QC, Canada. · Department of Pathology, Centre hospitalier de l'Université de Montréal, Montreal, QC, Canada. · Department of Pathology and Cellular Biology, University of Montréal, Montreal, QC, Canada. · Department of Engineering Physics, Polytechnique Montréal, Montreal, QC, Canada. · Thayer School of Engineering, Dartmouth College, Hanover, NH, USA. · Télécom Physique Strasbourg, University of Strasbourg, Strasbourg, France. · Division of Urology, Centre hospitalier de l'Université de Montréal, Montreal, QC, Canada. · Department of Surgery, Université de Montréal, Montréal, QC, Canada. · Pubmed 29542855
  • Division of Urology, Department of Surgery, Montreal University, Montreal, Canada. · Division of Robotic Urology, Department of Surgery, "Hôpital Sacré Coeur de Montréal", Montreal, Canada. · Division of Robotic Urology, Department of Surgery, "Hôpital Saint-Luc", Montreal, Canada. · Division of Urology, Department of Surgery, Montreal University, Montreal, Canada. · Division of Robotic Urology, Department of Surgery, "Hôpital Sacré Coeur de Montréal", Montreal, Canada. · Division of Robotic Urology, Department of Surgery, "Hôpital Saint-Luc", Montreal, Canada. · Pubmed 29052761
2016
  • Matthew Smith, Massachusetts General Hospital, Boston, MA · Johann De Bono, Royal Marsden Hospital, Sutton · Syed Hussain, University of Liverpool, Liverpool, United Kingdom · Cora Sternberg, San Camillo and Forlanini Hospitals, Rome · Ugo De Giorgi, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori-Istituto di Ricovero e Cura a Carattere Scientifico, Meldola · Giorgio Cruciani, Istituto Tumori Romagna, Lugo di Romagna, Italy · Sylvestre Le Moulec, Hôpital d'Instruction des Armées Val-de-Grâce · Stéphane Oudard, European Hospital Georges Pompidou and Paris Descartes University, Paris · Antoine Thiery-Vuillemin, Jean Minjoz Hospital, Besançon · Nadine Houédé, Institut de Cancérologie du Gard-Centre Hospitalier Universitaire Caremeau, Nîmes · Karim Fizazi, Institute Gustave Roussy, University of Paris Sud, Villejuif, France · Michael Krainer, Medical University of Vienna, Vienna, Austria · Andries Bergman, Netherlands Cancer Institute, Amsterdam · Ronald De Wit, Erasmus University Medical Center and Cancer Institute, Rotterdam, the Netherlands · Wolfgang Hoelzer, Praxis für Urologie · Kurt Miller, Charité-Universitätsmedizin Berlin, Berlin · Martin Bögemann, University of Muenster Medical Center, Muenster · Susan Feyerabend, Studienpraxis Urologie, Nürtingen · Arnulf Stenzl, University Hospital, Tübingen, Germany · Fred Saad, Centre Hospitalier de I'Université de Montréal, Montreal, Quebec, Canada · Elaine Lam, University of Colorado Anschutz Medical Campus, Aurora, CO · Jonathan Polikoff, Kaiser Permanente Medical Group, San Diego · David Ramies, Colin Hessel, and Aaron Weitzman, Exelixis, South San Francisco, CA · and Paul Mainwaring, Hematology and Oncology Clinics of Australia, Brisbane, Queensland, Australia. · Pubmed 27400947
  • 1 McGill University Health Centre and Research Institute , Montréal, Canada . · 2 PROCURE Alliance , Montréal, Canada . · 3 Montréal University Health Centre , Montréal, Canada . · 4 Québec University Health Centre , Québec, Canada . · 5 Sherbrooke University Health Centre , Sherbrooke, Canada . · Pubmed 27327090
2015
  • Department of Medical Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, 111 E 210 St, Bronx, NY 10467, USA. · Centre Hospitalier de I'Université de Montréal, Montreal, Canada. · Pubmed 26445599
  • Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA. Electronic address: · Academic Unit of Clinical Oncology, Weston Park Hospital, CR-UK/YCR Sheffield Cancer Research Centre, Sheffield, UK. · Department of Genitourinary Medical Oncology, Stanford Alexander Tissue Derivatives Laboratory, David H. Koch Center for Applied Research of Genitourinary Cancers, Houston, TX, USA; Department of Clinical Therapeutics, University of Athens, Athens, Greece. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Department of Genitourinary Medical Oncology, Stanford Alexander Tissue Derivatives Laboratory, David H. Koch Center for Applied Research of Genitourinary Cancers, Houston, TX, USA. · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · Department of Internal Medicine, Section of Medical Oncology, UAB Medical Center, Birmingham, AL, USA. · Department of Medicine and Urology, Tulane University, New Orleans, LA, USA. · Centre Hospitalier de I'Université de Montréal, Montreal, Quebec, Canada. · Pubmed 26153564
2012
  • Goodman Cancer Research Centre, Montréal, Québec, Canada. · Pubmed 22282656
Universitat Hamburg
2012
  • Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, D-20246 Hamburg, Germany. · Pubmed 22409467
2012
  • Institute of Pathology, Prostate Cancer Center and Section for Translational Prostate Cancer Research at the Clinic of Urology at University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Pubmed 22705054
34 Other Locations Show
Yearly article counts 42946271228211521813
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.